User:Meodipt/RClist
A large variety of New Psychoactive Substances, also known as "Designer Drugs", "Research Chemicals" or "Legal Highs", have been identified in recent years, and many subsequently banned, in many different jurisdictions around the world. (Germany Sweden UK/NZ Hungary Switzerland [1]Chile Poland) However the "traditional" illegal drugs banned under the UN conventions are generally not listed below, as these are banned in all jurisdictions so there is no need for comparison. Also note that there are a number of other NPS that have been anecdotally reported as having been sold, but are not listed here due to not having been identified by forensic laboratories or banned by the legislature of any of the jurisdictions listed below. Many of these can be found at other pages such as;
- List of designer drugs
- List of benzodiazepines
- List of opioids
- List of methylphenidate analogues
- List of phenyltropanes
- List of cocaine analogues
- List of AM cannabinoids
- List of CP cannabinoids
- List of HU cannabinoids
- List of JWH cannabinoids
- List of miscellaneous designer cannabinoids
- Synthetic cannabinoids
- Substituted phenethylamine
- Substituted amphetamine
- Substituted cathinone
- Substituted benzofuran
- Substituted phenylmorpholine
- Substituted methylenedioxyphenethylamine
- Substituted tryptamine
- Temporary class drug
- 2C (psychedelics)
- DOx
- 25-NB
- Lysergamides
- Arylcyclohexylamine
NPS reported by EMCDDA since 2005
[edit]Ref "Europol [2005-2016] Annual Report on the implementation of Council Decision 2005/387/JHA".
- Note that some common designer drugs such as BZP, TFMPP, MBDB, 2C-B, 2C-T-7 etc, are not listed here because they were reported by the EMCDDA prior to 2005. Also note that not all substances are novel, this is just the first time they were reported to the EU-wide Early Warning System. For instance, alpha-PPP and several associated cathinone derivatives were identified in Germany several years prior to 2005,[1] but were not reported in an EU-wide alert until many years later.
- A few compounds appear in the EMCDDA report for more than one year under different chemical names, in these cases the first mention has been listed here and subsequent mentions omitted.
- Not all novel substances are reported to the EWS, for instance nootropics, aphrodisiacs and anabolic agents are controlled under medicines law rather than drug law in most jurisdictions and so are often not reported as NPS, even though they may be previously unreported compounds in some cases. On the other hand some approved medicines appear in the list when they have been identified in designer drug products.
- Not all relevant laboratory results get reported to the EWS either, for instance 3,5-difluoromethcathinone and 3,5-dichloromethcathinone were identified inside the EU during this time period (Ireland, 2009),[2] but did not appear in the EMCDDA report for that year.
- Also, not all compounds listed here are actually psychoactive, a number of them have subsequently turned out to be synthesis byproducts which are not thought to have any significant psychoactive effect (e.g. DPIA, AM-1220 azepane, bisNBOMe-2C-B), while others are not the intended product but likely do still retain similar effects (e.g. alpha-naphyrone, 4-APB).
Common name | CAS number | Chemical name | First reported |
---|---|---|---|
mCPP | 6640-24-0 | 1-(3-Chlorophenyl)piperazine | February 2005 |
4-HO-DiPT | 63065-90-7 | 3-[2-(diisopropylamino)ethyl]-1H-indol-4-ol | March 2005 |
Methylone | 186028-79-5 | 2-methylamino-1-(3,4-methylenedioxyphenyl)propan-1-one | March 2005 |
4-HO-DET | 22204-89-3 | 3-(2-diethylaminoethyl)-1H-indol-4-ol | April 2005 |
DiPT | 14780-24-6 | 3-[2-(diisopropylamino)ethyl]indole | April 2005 |
MeOPP | 38212-30-5 | 1-(4-methoxyphenyl)piperazine | April 2005 |
MDHOET | 74698-43-4 | 3,4-methylenedioxy-N-(2-hydroxyethyl)amphetamine | May 2005 |
2C-P | 207740-22-5 | 2-(2,5-dimethoxy-4-(n)-propylphenyl)ethanamine | August 2005 |
5-MeO-AMT | 1137-04-8 | 1-(5-methoxy-1H-indol-3-yl)propan-2-amine | August 2005 |
5-MeO-DET | 2454-70-8 | N,N-diethyl-5-methoxy-1H-Indole-3-ethanamine | August 2005 |
MiPT | 96096-52-5 | N-[2-(1H-indol-3-yl)ethyl]-N-methylpropan-2-amine | August 2005 |
2C-T-4 | 207740-25-8 | 2-[4-(isopropylthio)-2,5-dimethoxyphenyl]ethanamine | August 2005 |
4-AcO-DiPT | 936015-60-0 | 3-[2-[bis(1-methylethyl)amino]ethyl]-1H-indol-4-ol acetate | September 2005 |
DPIA | 10509-86-1 | di-(beta-phenylisopropyl)amine | October 2005 |
pFPP | 64090-19-3 | 1-(4-fluorophenyl)piperazine | April 2006 |
pCPP | 38212-33-8 | 1-(4-chlorophenyl)piperazine | November 2006 |
DBZP | 2298-55-7 | 1,4-dibenzylpiperazine | November 2006 |
2,4-DMA | 52850-81-4 | 2,4-dimethoxyamphetamine | November 2006 |
2-AI | 2975-41-9 | 2,3-dihydro-1H-inden-2-amine | November 2006 |
Bromo-dragonfly | 502759-67-3 | 1-(4-bromofuro[2,3-f] [1]benzofuran-8-yl)propan-2-amine | November 2006 |
DOI | 82864-02-6 | 1-(2,5-dimethoxy-4-iodophenyl)-propan-2-amine | November 2006 |
2C-B-Fly | 178557-21-6 | 2-(8-bromo-2,3,6,7-tetrahydrofuro[2,3-f] [1]benzofuran-4-yl)ethanamine | February 2007 |
5-MeO-DALT | 928822-98-4 | 5-methoxy-N,N-di-2-propen-1-yl-1H-indole-3-ethanamine | February 2007 |
N-ethyl-2C-B | 155639-24-0 | 2-(4-bromo-2,5-dimethoxyphenyl)-N-ethylethanamine | February 2007 |
GBR-12909 | 67469-78-7 | 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine | May 2007 |
D2PM | 22348-32-9 | diphenyl(pyrrolidin-2-yl)methanol | May 2007 |
N-acetyl-DOB | 42203-75-8 | N-(1-(4-bromo-2,5-dimethoxyphenyl)propan-2-yl)acetamide | June 2007 |
1-PEA | 618-36-0 | 1-phenylethan-1-amine | June 2007 |
Phenazepam | 51753-57-2 | 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one | June 2007 |
Nimetazepam | 2011-67-8 | 7-nitro-5-phenyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one | June 2007 |
Bufotenine | 487-93-4 | 3-(2-dimethylaminoethyl)-1H-indol-5-ol | June 2007 |
Harmine | 442-51-3 | 7-methoxy-1-methyl-9H-pyrido[3,4-b]indole | June 2007 |
Salvinorin A | 83729-01-5 | methyl (2S,4aR,6aR,7R,9S,10aS,10bR)-9-(acetyloxy)-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxododecahydro-2H-benzo[f]isochromene-7-carboxylate | June 2007 |
Glaucine | 475-81-0 | (S)-5,6,6a,7-tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4H-dibenzo[de,g]quinoline | July 2007 |
Gelbes | 39577-43-0 | 1-(3-chlorophenyl)-4-(3-chloropropyl)piperazine | September 2007 |
NMPEA | 589-08-2 | N-methyl-2-phenylethanamine | December 2007 |
N-desmethylsibutramine | 168835-59-4 | 1-(1-(4-chlorophenyl)cyclobutyl)-N,3-dimethylbutan-1-amine | December 2007 |
Butylone | 17762-90-2 | 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one | January 2008 |
Ethcathinone | 51553-17-4 | 2-ethylamino-1-phenyl-propan-1-one | March 2008 |
Mephedrone | 1189726-22-4 | 2-methylamino-1-(4-methylphenyl)propan-1-one | March 2008 |
7-hydroxymitragynine | 174418-82-7 | (E)-methyl 2-((2S,3S,7aS,12bS)-3-ethyl-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate | March 2008 |
4-HO-MET | 77872-41-4 | 3-(2-(ethyl(methyl)amino)ethyl)-1H-indol-4-ol | June 2008 |
4-FMC | 7589-35-7 | 1-(4-fluorophenyl)-2-methylaminopropan-1-one | September 2008 |
3-FMC | 1049677-77-1 | 1-(3-fluorophenyl)-2-methylaminopropan-1-one | October 2008 |
LSA | 478-94-4 | (8β)-9,10-didehydro-6-methyl-ergoline-8-carboxamide | October 2008 |
pFBT | 172883-97-5 | (1R,5S)-(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)-4-fluorobenzoate | December 2008 |
MDPV | 24622-62-6 | 1-(benzo[d] [1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one | December 2008 |
4-Fluoroamphetamine | 459-02-9 | 1-(4-fluorophenyl)propan-2-amine | December 2008 |
JWH-018 | 209414-07-3 | 1-pentyl-3-(1-naphthoyl)indole | December 2008 |
2-Fluoroamphetamine | 1716-60-5 | 1-(2-fluorophenyl)propan-2-amine | January 2009 |
alpha-PPP | 19134-50-0 | 1-phenyl-2-(1-pyrrolidinyl)-1-propanone | January 2009 |
2-DPMP | 519-74-4 | 2-benzhydrylpiperidine | February 2009 |
CP 47,497 | 70434-82-1 | 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol | February 2009 |
(C6)-CP 47,497 | 132296-20-9 | 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methylheptan-2-yl)phenol | February 2009 |
(C8)-CP 47,497 | 70434-92-3 | 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol | February 2009 |
(C9)-CP 47,497 | 132296-12-9 | 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyldecan-2-yl)phenol | February 2009 |
JWH-073 | 208987-48-8 | 1-butyl-3-(1-naphthoyl)indole | March 2009 |
4-AcO-MET | 4-acetoxy-N-methyl-N-ethyltryptamine | April 2009 | |
TMA-6 | 15402-79-6 | 1-(2,4,6-trimethoxyphenyl)propan-2-amine | June 2009 |
HU-210 | 112830-95-2 | (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | June 2009 |
O-desmethyltramadol | 73986-53-5 | 3-[2-(1-amino-1-methylethyl)-1-hydroxycyclohexyl]phenol | June 2009 |
4-AcO-DMT | 92292-84-7 | 3-[2-(dimethylamino)ethyl]-1H-indol-4-yl acetate | August 2009 |
2-PEA | 64-04-0 | phenylethan-2-amine | October 2009 |
JWH-398 | 1292765-18-4 | 1-pentyl-3-(4-chloro-1-naphthoyl)indole | October 2009 |
JWH-250 | 864445-43-2 | 2-(2-methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone | October 2009 |
Methedrone | 530-54-1 | 1-(4-methoxyphenyl)-2-(methylamino)propan-1-one | October 2009 |
Etaqualone | 7432-25-9 | 3-(2-ethylphenyl)-2-methyl-quinazolin-4-one | November 2009 |
MDPPP | 24698-57-5 | 1-(3,4-methylenedioxyphenyl)-2-(1-pyrrolidinyl)-1-propanone | November 2009 |
Metamfepramone | 15351-09-4 | 2-dimethylamino-1-phenylpropan-1-one | November 2009 |
3-FMA | 1182818-14-9 | 1-(3-fluorophenyl)-N-methylpropan-2-amine | November 2009 |
JWH-200 | 103610-04-4 | (1-(2-morpholin-4-ylethyl)indol-3-yl)-naphthalen-1-ylmethanone | December 2009 |
4-MA | 22683-78-9 | 1-(4-methylphenyl)propan-2-amine | December 2009 |
Pregabalin | 148553-50-8 | (S)-3-(aminomethyl)-5-methylhexanoic acid | December 2009 |
2C-B-BZP | 1094424-37-9 | 1-(4-bromo-2,5-dimethoxybenzyl)piperazine | January 2010 |
MDAI | 132741-81-2 | 6,7-dihydro-5H-cyclopenta[f] [1,3]benzodioxol-6-amine | February 2010 |
BMPEA | 582-22-9 | 2-phenylpropan-1-amine | February 2010 |
N-benzyl-1-PEA | 3193-62-2 | N-benzyl-1-phenylethanamine | February 2010 |
N,N-dimethyl-2-PEA | 1126-71-2 | N,N-dimethyl-2-phenylethanamine | February 2010 |
4-FMA | 351-03-1 | 1-(4-fluorophenyl)-N-methylpropan-2-amine | March 2010 |
RCS-4 | 1345966-78-0 | (4-methoxyphenyl)(1-pentyl-indol-3-yl)methanone | May 2010 |
JWH-081 | 210179-46-7 | 4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone | June 2010 |
Naphyrone | 850352-53-3 | 1-naphthalen-2-yl-2-pyrrolidin-1-ylpentan-1-one | June 2010 |
Iso-ethcathinone | 65913-24-8 | 1-ethylamino-1-phenylpropan-2-one | June 2010 |
DMAA | 105-41-9 | 2-amino-4-methylhexane | June 2010 |
Dimethocaine | 94-15-5 | (3-diethylamino-2,2-dimethylpropyl)-4-aminobenzoate | June 2010 |
4'-methyl-JWH-073 | 1354631-21-2 | 4-methylnaphthalen-1-yl-(1-butylindol-3-yl)methanone | June 2010 |
Buphedrone | 166593-10-8 | 2-(methylamino)-1-phenylbutan-1-one | July 2010 |
4-MEC | 1266688-86-1 | 2-ethylamino-1-(4-methylphenyl)propan-1-one | July 2010 |
AM-694 | 335161-03-0 | 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone | July 2010 |
JWH-122 | 619294-47-2 | (4-methyl-1-naphthyl)-(1-pentylindol-3-yl)methanone | July 2010 |
MPBP | 59921-84-5 | 1-(4-methylphenyl)-2-(1-pyrrolidinyl)-1-butanone | July 2010 |
JWH-015 | 155471-08-2 | (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone | July 2010 |
4-MBC | 1225617-75-3 | 1-(4-methylphenyl)-2-(benzylamino)propan-1-one | August 2010 |
4-MePPP | 28117-80-8 | 1-(4-methylphenyl)-2-(1-pyrrolidinyl)-1-propanone | August 2010 |
alpha-Naphyrone | 1026650-76-9 | 1-naphthalen-1-yl-2-pyrrolidin-1-ylpentan-1-one | August 2010 |
Pentylone | 17763-01-8 | 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one | September 2010 |
M-alpha | 127292-43-7 | 1-methylamino-1-(3,4-methylenedioxyphenyl)propane | September 2010 |
5-MeO-DPT | 2427-80-7 | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-propylpropan-1-amine | September 2010 |
Pentedrone | 879669-95-1 | 1-phenyl-2-(methylamino)pentan-1-one | September 2010 |
JWH-210 | 824959-81-1 | 4-ethylnaphthalen-1-yl-(1-pentylindol-3-yl)methanone | September 2010 |
3,4-DMMC | 1081772-06-6 | 1-(3,4-dimethylphenyl)-2-(methylamino)propan-1-one | October 2010 |
JWH-203 | 864445-54-5 | 2-(2-chlorophenyl)-1-(1-pentylindol-3-yl)ethanone | October 2010 |
JWH-019 | 209414-08-4 | 1-hexyl-3-(naphthalen-1-oyl)indole | October 2010 |
Methoxetamine | 1239943-76-0 | 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone | November 2010 |
4'-HM-RCS-4 | 1391485-19-0 | 3-(4-Hydroxymethylbenzoyl)-1-pentylindole | November 2010 |
MDPBP | 24622-60-4 | 1-(3,4-methylenedioxyphenyl)-2-(1-pyrrolidinyl)-1-butanone | November 2010 |
3'-MeO-PCE | 1364933-80-1 | 1-(3-methoxyphenyl)-1-(ethylamino)cyclohexane | November 2010 |
Dibutylone | 17763-12-1 | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)butan-1-one | November 2010 |
Arecoline | 63-75-2 | methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate | November 2010 |
BMDP | 1387636-19-2 | 2-benzylamino-1-(3,4-methylenedioxyphenyl)propan-1-one | December 2010 |
BMDB | 2-benzylamino-1-(3,4-methylenedioxyphenyl)butan-1-one | December 2010 | |
5-APB | 286834-80-8 | 5-(2-aminopropyl)benzofuran | December 2010 |
Desoxy-D2PM | 119237-64-8 | 2-(diphenylmethyl)pyrrolidine | December 2010 |
CB-13 | 432047-72-8 | naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone | January 2011 |
4'-MeO-PCP | 2201-35-6 | 1-[1-(4-methoxyphenyl)cyclohexyl]-piperidine | January 2011 |
Methiopropamine | 7464-94-0 | 1-(thiophen-2-yl)-2-methylaminopropane | January 2011 |
AM-2201 | 335161-24-5 | 1-[(5-fluoropentyl)-1H-indol-3-yl]-(naphthalen-1-yl)methanone | January 2011 |
Dimethylamphetamine | 4075-96-1 | N,N-dimethyl-1-phenylpropan-2-amine | February 2011 |
JWH-251 | 864445-39-6 | 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone | February 2011 |
AB-001 | 1345973-49-0 | 1-pentyl-3-(adamant-1-oyl)-indole | February 2011 |
JWH-182 | 824960-02-3 | 4-propylnaphthalen-1-yl-(1-pentylindol-3-yl)methanone | March 2011 |
5-IAI | 132367-76-1 | 5-iodo-2,3-dihydro-1H-inden-2-amine | March 2011 |
Cannabipiperidiethanone | 1345970-43-5 | 2-(2-methoxyphenyl)-1-[1-([1-methylpiperidin-2-yl]methyl)indol-3-yl]ethanone | March 2011 |
DMMA | 33236-61-2 | 1-(3,4-dimethoxyphenyl)-N-methylpropan-2-amine | April 2011 |
alpha-PVP | 5485-65-4 | 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone | April 2011 |
ortho-RCS-4 | 1345966-76-8 | (2-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone) | April 2011 |
JWH-007 | 155471-10-6 | 1-pentyl-2-methyl-3-(1-naphthoyl)indole | May 2011 |
AM-1220 | 137642-54-7 | (1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | May 2011 |
AM-1220 azepane | 1348081-04-8 | (1-((1-methylazepan-3-yl)methyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | May 2011 |
5-HTP | 56-69-9 | 2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid | May 2011 |
Pravadoline | 92623-83-1 | (4-methoxyphenyl)-[2-methyl-1-(2-morpholin-4-ylethyl)indol-3-yl]methanone | May 2011 |
NBOMe-2C-C | 1227608-02-7 | 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine | June 2011 |
Ostarine | 841205-47-8 | ((2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide) | June 2011 |
MAM-2201 | 1354631-24-5 | 1-[(5-fluoropentyl)-1H-indol-3-yl]-(4-methylnaphthalen-1-yl)methanone | June 2011 |
6-APB | 286834-84-2 | 6-(2-aminopropyl)benzofuran | June 2011 |
4-APB | 286834-83-1 | 4-(2-aminopropyl)benzofuran | June 2011 |
(C4)-RCS-4 | 1345966-77-9 | (4-methoxyphenyl)(1-butyl-indol-3-yl)methanone | June 2011 |
JWH-387 | 1366067-59-5 | 1-pentyl-3-(4-bromo-1-naphthoyl)indole | July 2011 |
JWH-412 | 1364933-59-4 | 1-pentyl-3-(4-fluoro-1-naphthoyl)indole | July 2011 |
JWH-307 | 914458-26-7 | (5-(2-fluorophenyl)-1-pentylpyrrol-3-yl)-naphthalen-1-ylmethanone | August 2011 |
AM-2233 | 444912-75-8 | 1-[(N-methylpiperidin-2-yl)methyl]-3-(2-iodobenzoyl)indole | August 2011 |
Org 27569 | 868273-06-7 | 5-chloro-3-ethyl-1H-indole-2-carboxylic acid [2-(4-piperidin-1-yl-phenyl)ethyl]amide | August 2011 |
Org 27759 | 868273-09-0 | 5-fluoro-3-ethyl-1H-indole-2-carboxylic acid [2-(4-dimethylaminophenyl)ethyl]amide | August 2011 |
Org 29647 | 868273-11-4 | 5-chloro-3-ethyl-1H-indole-2-carboxylic acid (1-benzyl-pyrrolidin-3-yl)-amide | August 2011 |
N-ethylbuphedrone | 1354631-28-9 | 2-(ethylamino)-1-phenylbutan-1-one | August 2011 |
4-BMC | 486459-03-4 | 1-(4-bromophenyl)-2-methylaminopropan-1-one | September 2011 |
Iso-pentedrone | 1429402-11-8 | 1-methylamino-1-phenyl-pentan-2-one | September 2011 |
4-EMC | 1225622-14-9 | 2-methylamino-1-(4-ethylphenyl)propan-1-one | October 2011 |
4-BZPD | 31252-42-3 | 4-benzylpiperidine | October 2011 |
Dimethylone | 765231-58-1 | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)propan-1-one | October 2011 |
4-methylbuphedrone | 1337016-51-9 | 2-methylamino-1-(4-methylphenyl)butan-1-one | November 2011 |
Methoxyphenamine | 93-30-1 | 1-(2-methoxyphenyl)-N-methylpropan-2-amine | November 2011 |
Ethylphenidate | 57413-43-1 | ethyl 2-phenyl-2-piperidin-2-ylacetate | November 2011 |
Camfetamine | 92499-19-9 | N-methyl-3-phenylbicyclo[2.2.1]heptan-2-amine | November 2011 |
JWH-022 | 209414-16-4 | naphthalen-1-yl(2-(pent-4-enyl)-1H-indol-3-yl)methanone | November 2011 |
Etizolam | 40054-69-1 | 4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4]diazepine) | December 2011 |
AM-2232 | 335161-19-8 | 5-(3-(1-naphthoyl)-1H-indol-1-yl)pentanenitrile | December 2011 |
Homoamphetamine | 22374-89-6 | 3-amino-1-phenylbutane | December 2011 |
alpha-PBP | 13415-54-8 | 1-phenyl-2-(1-pyrrolidinyl)-1-butanone | December 2011 |
5"-Cl-AM-694 | 1391483-97-8 | 1-[(5-chloropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone | December 2011 |
1-PPA | 2941-20-0 | 1-phenyl-1-propanamine | December 2011 |
HU-331 | 137252-25-6 | 3-hydroxy-2-[(1R)-6-isopropenyl-3-methyl-cyclohex-2-en-1-yl]-5-pentyl-1,4-benzoquinone | January 2012 |
AM-679 | 335160-91-3 | 1-pentyl-3-(2-iodobenzoyl)indole | January 2012 |
WIN 55,212-2 | 131543-23-2 | (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-napthalenylmethanone | January 2012 |
UR-144 | 1199943-44-6 | (1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone | February 2012 |
JWH-370 | 914458-22-3 | (5-(2-methylphenyl)-1-pentylpyrrol-3-yl)-naphthalen-1-ylmethanone | February 2012 |
Propylamphetamine | 51799-32-7 | N-(1-methyl-2-phenylethyl)propan-1-amine | February 2012 |
(C1)-RCS-4 | (4-methoxyphenyl)(1-methyl-1H-indol-3-yl)methanone | February 2012 | |
trans-(C8)-CP 47,497 | 2-(3-hydroxycyclohexyl)-5-(2-methylnonan-2-yl)phenol (1:1 mix of (1S,3S) and (1R,3R) enantiomers) | February 2012 | |
Methoxyphenyl-cyclohexane | 1-(n-methoxyphenyl)cyclohexane (isomer not determined) | February 2012 | |
3-fluoro-isomethcathinone | 1445751-68-7 | 1-methylamino-1-(3-fluorophenyl)propan-2-one | February 2012 |
3-methyl-BZP | 5321-48-2 | 1-(3-methylbenzyl)piperazine | February 2012 |
Thienoamphetamine | 30433-93-3 | 1-(thiophen-2-yl)-2-aminopropane | February 2012 |
URB-754 | 86672-58-4 | 6-methyl-2-[(4-methylphenyl)amino]-4H-3,1-benzoxazin-4-one | February 2012 |
5-APDB | 152623-94-4 | 1-(2,3-dihydro-1-benzofuran-5-yl)propan-2-amine | March 2012 |
Phenibut | 1078-21-3 | 4-amino-3-phenyl-butyric acid | March 2012 |
6-APDB | 152623-93-3 | 1-(2,3-dihydro-1-benzofuran-6-yl)propan-2-amine | March 2012 |
2-FMA | 1017176-48-5 | 1-(2-fluorophenyl)-N-methylpropan-2-amine | March 2012 |
ECX | 78-27-3 | 1-ethynyl-1-cyclohexanol | March 2012 |
4-fluoroephedrine | 2711-62-8 | 1-(4-fluorophenyl)-2-(methylamino)propan-1-ol | March 2012 |
3'-MeO-PCP | 72242-03-6 | 1-[1-(3-methoxyphenyl)cyclohexyl]-piperidine | March 2012 |
5F-UR-144 | 1364933-54-9 | (1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | March 2012 |
NBOMe-2C-D | 1354632-02-2 | 2-(2,5-dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine | April 2012 |
A-796,260 | 895155-26-7 | [1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone) | April 2012 |
4-AcO-DALT | 1445751-71-2 | 3-(2-(diallylamino)ethyl)-1H-indol-4-yl acetate | April 2012 |
PPBO | 92728-83-1 | 1-Phenyl-2-(piperidin-1-yl)butan-1-one | May 2012 |
2,4,5-triMe-MC | 1368603-85-3 | 2-methylamino-1-(2,4,5-trimethylphenyl)propan-1-one | May 2012 |
APINACA | 1345973-536 | N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide | May 2012 |
5-IT | 3784-30-3 | 5-(2-aminopropyl)indole | June 2012 |
Zopiclone | 43200-80-2 | 6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate | June 2012 |
UR-144 pentenyl | 1445578-20-0 | [1-(pent-4-en-1-yl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone | June 2012 |
NBOMe-2C-I | 919797-19-6 | 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine | June 2012 |
4-HO-DPT | 63065-88-3 | 4-hydroxy-N,N-dipropyltryptamine | June 2012 |
5-MeO-MET | 16977-53-0 | 5-methoxy-N-ethyl-N-methyl-tryptamine | June 2012 |
5F-APICA | 1354631-26-7 | N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide | June 2012 |
MPHP | 34138-58-4 | 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)-hexan-1-one | June 2012 |
APICA | 1345973-50-3 | N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide | July 2012 |
NNE1 | 1338925-11-3 | 1-pentyl-N-(naphthalen-1-yl)-1H-indole-3-carboxamide | July 2012 |
MDDM | 74698-50-3 | 3,4-methylenedioxy-N,N-dimethylamphetamine | July 2012 |
5"-Cl-MAM-2201 | 1445578-25-5 | [1-(5-chloropentyl)-1H-indol-3-yl](4-methyl-1-naphthalenyl)methanone | July 2012 |
JWH-149 pentenyl | 1445578-24-4 | (4-methylnaphthalen-1-yl)[2-methyl-1-(pent-4-en-1-yl)-1H-indol-3-yl)]methanone | July 2012 |
JWH-122 pentenyl | 1445577-68-3 | (4-methylnaphthalen-1-yl)(1-(pent-4-en-1-yl)-1H-indol-3-yl)methanone | July 2012 |
AM-694 2'-methyl | 1445578-69-7 | 1-(5-fluoropentyl)-3-(2-methylbenzoyl)indole | July 2012 |
AM-694 2'-ethyl | 1445579-52-1 | 1-(5-fluoropentyl)-3-(2-ethylbenzoyl)indole | July 2012 |
5"-Cl-JWH-018 | 1445578-56-2 | [1-(5-chloropentyl)-1H-indol-3-yl](naphthalen-1-yl)methanone | July 2012 |
5"-Br-JWH-018 | 1445578-62-0 | [1-(5-bromopentyl)-1H-indol-3-yl](naphthalen-1-yl)methanone | July 2012 |
AH-7921 | 55154-30-8 | 3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide | August 2012 |
4-AcO-DPT | 1445751-75-6 | 4-acetoxy-N,N-dipropyltryptamine | August 2012 |
Bromo-alprazolam | 71368-80-4 | 8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3a] [1,4]benzodiazepine | August 2012 |
Pyrazolam | 39243-02-2 | 8-bromo-1-methyl-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3a] [1,4]benzodiazepine | August 2012 |
2-Methoxyketamine | 7063-51-6 | 2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone | August 2012 |
4-hydroxyamphetamine | 1518-86-1 | 4-(2-aminopropyl)phenol | September 2012 |
3-MMC | 1246816-62-5 | 1-(3-methylphenyl)-2-(methylamino)propan-1-one | September 2012 |
NENK | 1354634-10-8 | 2-(2-chlorophenyl)-2-(ethylamino)cyclohexanone | September 2012 |
IAP | 152624-02-7 | 1-(2,3-dihydro-1H-inden-5-yl)propan-2-amine | September 2012 |
AM-1248 | 335160-66-2 | 1-[(N-methylpiperidin-2-yl)methyl]-3-(adamant-1-oyl)indole | September 2012 |
5F-APINACA | 1400742-13-3 | N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | September 2012 |
5F-NNE1 indazole | 1445581-91-8 | N-1-naphthalenyl-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | October 2012 |
PB-22 | 1400742-17-7 | quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate | November 2012 |
AB-005 | 895155-25-6 | [1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone | November 2012 |
AB-005 azepane | 1445751-74-5 | (1-(1-methylazepan-3-yl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | November 2012 |
4-HTMPIPO | 1445751-38-1 | 4-hydroxy-3,3,4-trimethyl-1-(1-pentyl-1H-indol-3-yl)pentan-1-one | November 2012 |
p-fluorobutyrbenzylfentanyl | N-(1-benzylpiperidin-4-yl)-N-(4-fluorophenyl)butanamide | December 2012 | |
Isobutyrfentanyl | 119618-70-1 | N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide | December 2012 |
5"-Cl-UR-144 | 1445577-42-3 | (1-(5-chloropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | December 2012 |
4-chloroamphetamine | 64-12-0 | 1-(4-chlorophenyl)propan-2-amine) | December 2012 |
NBOMe-2C-B | 1026511-90-9 | 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine | December 2012 |
GANESHA | 207740-37-2 | 1-(2,5-dimethoxy-3,4-dimethylphenyl)propan-2-amine | December 2012 |
2C-N | 261789-00-8 | 2,5-dimethoxy-4-nitrophenethylamine | December 2012 |
NBOMe-2C-E | 1354632-14-6 | 2-(2,5-dimethoxy-4-ethylphenyl)-N-(2-methoxybenzyl)ethanamine | December 2012 |
NBOMe-2C-G | 1354632-65-7 | 2-(2,5-dimethoxyphenyl-3,4-dimethyl)-N-[(2-methoxyphenyl)methyl]ethanamine | December 2012 |
NBOMe-2C-N | 1354632-03-3 | 2-(2,5-dimethoxyphenyl-4-nitro)-N-[(2-methoxyphenyl)methyl]ethanamine | December 2012 |
4,4'-DMAR | 1445569-01-6 | 4-methyl-5-(p-tolyl)-4,5-dihydrooxazol-2-amine | December 2012 |
4'-methylphendimetrazine | 1445576-23-7 | 3,4-dimethyl-2-(p-tolyl)morpholine | December 2012 |
5-MAPB | 1354631-77-8 | 1-(benzofuran-5-yl)-N-methylpropan-2-amine | January 2013 |
4-fluorocathinone | 2-amino-1-(4-fluorophenyl)propan-1-one | January 2013 | |
BB-22 | 1400742-42-8 | Quinolin-8-yl 1-(cyclohexylmethyl)-1H-indole-3-carboxylate | January 2013 |
A-834,735 | 895155-57-4 | [1-(tetrahydropyran-4-ylmethyl)indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone | January 2013 |
JWH-368 | [5-(3-fluorophenyl)-1-pentyl-pyrrol-3-yl]-(1-naphthyl)methanone | February 2013 | |
Carfentanil | 59708-52-0 | methyl 1-(2-phenylethyl)-4-[phenyl(propionyl)amino]-4-piperidinecarboxylate | February 2013 |
EAM-2201 | 1364933-60-7 | (4-ethyl-1-naphthyl)-[1-(5-fluoropentyl)indol-3-yl]methanone | February 2013 |
Flubromazepam | 2647-50-9 | 7-bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one | March 2013 |
5F-PB-22 | 1400742-41-7 | quinolin-8-yl 1-(5-fluoropentyl)indole-3-carboxylate | March 2013 |
JWH-307 2'-bromo | (5-(2-bromophenyl)-1-pentyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone | March 2013 | |
JWH-030 | 162934-73-8 | naphthalen-1-yl(1-pentyl-1H-pyrrol-3-yl)methanone | April 2013 |
JWH-145 | naphthalen-1-yl(1-pentyl-5-phenyl-1H-pyrrol-3-yl)methanone | April 2013 | |
(C7)-UR-144 | (1-heptyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | April 2013 | |
3,4-CTMP | methyl (2R)-2-(3,4-dichlorophenyl)-2-[(2R)-piperidin-2-yl]acetate | April 2013 | |
NBOMe-2C-H | 2-(2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine | April 2013 | |
URB-597 | [3-(3-carbamoylphenyl)phenyl] N-cyclohexylcarbamate | April 2013 | |
N,α-DEPEA | 29805-52-5 | N-Ethyl-1-phenyl-2-butanamine | May 2013 |
AB-PINACA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide | May 2013 | |
alpha-PVT | 2-(pyrrolidin-1-yl)-1-(thiophen-2-yl)pentan-1-one | May 2013 | |
A-836,339 | N-[3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2-ylidene]-2,2,3,3-tetramethylcyclopropane-carboxamide | June 2013 | |
N-benzyl-4-methylbuphedrone | 2-(benzylamino)-1-(4-methylphenyl)butan-1-one | June 2013 | |
2,N,N-TMT | N,N-dimethyl-2-(2-methyl-1H-indol-3-yl)ethanamine | June 2013 | |
4-MeO-alpha-PVP | 1-(4-methoxyphenyl)-2-(pyrrolidin-1-yl)pentan-1-one | June 2013 | |
NMP | 1-methylpyrrolidin-2-one | June 2013 | |
Tropicamide | N-ethyl-3-hydroxy-2-phenyl-N-(pyridin-4-ylmethyl)propanamide | July 2013 | |
RH-34 | 3-[2-(2-methoxybenzylamino)ethyl]-1H-quinazoline-2,4-dione | July 2013 | |
NB345TM-34DMPEA | 2-(2,3-dimethoxyphenyl)-N-(3,4,5-trimethoxybenzyl)ethanamine | July 2013 | |
JTE-907 | N-(benzo[1,3]dioxol-5-ylmethyl)-7-methoxy-2-oxo-8-pentyloxy-1,2-dihydroquinolin-3-carboxamide | July 2013 | |
AB-FUBINACA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide | July 2013 | |
5F-AB-PINACA | N-(1-carbamoyl-2-methyl-propyl)-1-(5-fluoropentyl)indazole-3-carboxamide | July 2013 | |
Mebroqualone | 3-(2-bromophenyl)-2-methylquinazolin-4(3H)-one | July 2013 | |
Allylescaline | 4-allyloxy-3,5-dimethoxy-phenethylamine | July 2013 | |
alpha-PEP | 1-phenyl-2-(1-pyrrolidinyl)heptan-1-one | July 2013 | |
5-EAPB | 1-(1-benzofuran-5-yl)-N-ethylpropan-2-amine | July 2013 | |
Mephtetramine | 2-((methylamino)methyl)-3,4-dihydronaphthalen-1(2H)-one | July 2013 | |
Escaline | 3,5-dimethoxy-4-ethoxyphenethylamine | July 2013 | |
bk-PBDB | 1-(1,3-benzodioxol-5-yl)-2-(propylamino)butan-1-one | July 2013 | |
Proscaline | 2-(3,5-dimethoxy-4-propoxyphenyl)ethanamine | August 2013 | |
W-15 | (E)-4-chloro-N-(1-phenethylpiperidin-2-ylidene)benzenesulfonamide | August 2013 | |
Nitracaine | 3-(N,N-diethylamino)-2,2-dimethylpropyl-4-nitrobenzoate | August 2013 | |
Diclazepam | 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one | August 2013 | |
Bromo-methoxetamine | 2-(2-bromo-5-methoxy-phenyl)-2-(ethylamino)cyclohexanone | August 2013 | |
NBOMe-2C-iP | 2-[2,5-dimethoxy-4-(propan-2-yl)phenyl]-N-(2-methoxybenzyl)ethanamine | August 2013 | |
3C-P | 1-(3,5-dimethoxy-4-propoxyphenyl)propan-2-amine | September 2013 | |
3C-E | 1-(4-ethoxy-3,5-dimethoxyphenyl)propan-2-amine | September 2013 | |
NBMD-2C-I | N-(1,3-benzodioxol-4-ylmethyl)-2-(4-iodo-2,5-dimethoxy-phenyl)ethanamine | September 2013 | |
6-MAPB | 1-(benzofuran-6-yl)-N-methylpropan-2-amine | September 2013 | |
LY-2183240 | N,N-dimethyl-5-[(4-biphenyl)methyl]tetrazole-1-carboxamide | September 2013 | |
Methoxypiperamide | (4-methoxyphenyl)(4-methylpiperazine-1-yl)methanone | September 2013 | |
bk-MPA | 2-(methylamino)-1-(thiophenyl-2-yl)propan-1-one | September 2013 | |
AM-1248 azepane | (adamant-1-yl)[1-(1-methylazepan-3-yl)-1H-indol-3-yl]methanone | September 2013 | |
Methallylescaline | 2-[3,5-dimethoxy-4-[(2-methyl-prop-2-en-1-yl)oxy]phenyl]ethanamine | October 2013 | |
C30-NBOMe | 2-(4-chloro-2,5-dimethoxy-phenyl)-N-[(3,4,5-trimethoxyphenyl)methyl]ethanamine | October 2013 | |
ADBICA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indole-3-carboxamide | October 2013 | |
Gabapentin | 2-[1-(aminomethyl)cyclohexyl]acetic acid | October 2013 | |
Sibutramine | 1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethyl-1-butanamine | October 2013 | |
Venlafaxine | 1-[(2-dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol | October 2013 | |
2-FMC | 1-(2-fluorophenyl)-2-(methylamino)propan-1-one | October 2013 | |
bisNBOMe-2C-B | 2-(4-bromo-2,5-dimethoxyphenyl)-N,N-bis(2-methoxybenzyl)ethanamine | October 2013 | |
Diphenhydramine | 2-(diphenylmethoxy)-N,N-dimethylethanamine | October 2013 | |
Atomoxetine | (3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine | October 2013 | |
Ocfentanil | (N-(2-fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl)-4-piperidinyl]acetamide | October 2013 | |
6-EAPB | 1-(benzofuran-6-yl)-N-ethylpropan-2-amine | October 2013 | |
5F-NNE1 2-naphthyl | (1-(5-fluoropentyl)-N-(napthalen-2-yl)-1H-indole-3-carboxamide | November 2013 | |
4-MMA | N-methyl-1-(4-methylphenyl)propan-2-amine | November 2013 | |
AM-2201 indazole | [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone | November 2013 | |
N-methyl-2-AI | N-methylindan-2-amine | November 2013 | |
Embutramide | N-[2-ethyl-2-(3-methoxyphenyl)butyl]-4-hydroxy-butanamide | November 2013 | |
ADB-FUBINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide | November 2013 | |
ADB-PINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide | December 2013 | |
bk-2C-B | 2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethan-1-one | December 2013 | |
Butorphanol | 17-cyclobutylmethyl-morphinan-3,14-diol | December 2013 | |
MT-45 | 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine | December 2013 | |
LSZ | [(2S,4S)-2,4-dimethylazetidin-1-yl]-[(9R)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-yl]methanone | December 2013 | |
PTI-1 | 1400742-46-2 | N,N-diethyl-2-(1-pentyl-1H-indol-3-yl)-4-thiazole-methanamine | December 2013 |
PTI-2 | 1400742-45-1 | N-(2-methoxyethyl)-N-(1-methylethyl)-2-(1-pentyl-1H-indol-3-yl)-4-thiazolemethanamine | December 2013 |
1-(Cyclohexylmethyl)-2-[(4-ethoxyphenyl)methyl]-N,N-diethyl-1H-benzimidazole-5-carboxamide | December 2013 | ||
A-796,260 degradant | (E)-3,4,4-trimethyl-1-[1-(2-morpholinoethyl)indol-3-yl]pent-2-en-1-one | December 2013 | |
SDB-006 | N-benzyl-1-pentyl-1H-indole-3-carboxamide | December 2013 | |
5F-SDB-006 | N-benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide | December 2013 | |
FUB-PB-22 | 8-quinolyl 1-[(4-fluorophenyl)methyl]-3H-indole-3-carboxylate | December 2013 | |
6-Br-MDMA | 1-(6-bromo-1,3-benzodioxol-5-yl)-N-methylpropan-2-amine | January 2014 | |
Methoxphenidine | 1-(1-(2-methoxyphenyl)-2-phenylethyl)piperidine | January 2014 | |
Tramadol | (+)-cis-2-[(dimethylamino)methyl]-1-(m-methoxyphenyl)cyclohexanol | January 2014 | |
N-methyl-2C-B | 4-bromo-N-methyl-2,5-dimethoxyphenethylamine | January 2014 | |
Diphenidine | 1-(1,2-diphenylethyl)piperidine | January 2014 | |
PB-22 indazole | quinolin-8-yl 1-pentyl-1H-indazole-3-carboxylate | January 2014 | |
5F-PB-22 indazole | quinolin-8-yl 1-(5-fluoropentyl)-1H-indazole-3-carboxylate | January 2014 | |
MEP | 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one | January 2014 | |
4-F-alpha-PVP | 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one | February 2014 | |
2-APB | 1-(1-benzofuran-2-yl)propan-2-amine | February 2014 | |
2-MAPB | 2-(N-methyl-2-aminopropyl)-1-benzofuran | February 2014 | |
3,4-DMeO-alpha-PVP | 1-(3,4-dimethoxyphenyl)-2-(pyrrolidin-1-yl)pentan-1-one | February 2014 | |
4-BEC | 1-(4-bromophenyl)-2-(ethylamino)propan-1-one | February 2014 | |
FDU-PB-22 | 1-naphthyl 1-[(4-fluorophenyl)methyl]indole-3-carboxylate | February 2014 | |
JWH-018 indazole | 1-naphthalenyl(1-pentyl-1H- indazol-3-yl)-methanone | February 2014 | |
3,4-DMEC | (1-(3,4-dimethylphenyl)-2-(ethylamino)propan-1-one | February 2014 | |
Mepirapim | (4-methylpiperazin-1-yl)-(1-pentylindol-3-yl)methanone | February 2014 | |
Quetiapine | 2-[2-(4-dibenzo[b,f] [1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol | February 2014 | |
N-ethylnorpentedrone | (2-(ethylamino)-1-phenyl-pentan-1-one | March 2014 | |
Eutylone | 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one | March 2014 | |
Mesembrine | ((3aS,7aS)-3a-(3,4-dimethoxyphenyl)-1-methyl-2,3,4,5,7,7a-hexahydroindol-6-one | March 2014 | |
alpha-PHP | 2-(pyrrolidin-1-yl)-1-(phenyl)hexan-1-one | March 2014 | |
p-fluorobutyrfentanyl | N-(4-fluorophenyl)-N-[(1-(2-phenylethyl)-4-piperidinyl)]butanamide | March 2014 | |
Hexedrone | 2-(methylamine)-1-(phenyl)hexan-1-one | March 2014 | |
4-chloro-alpha-PPP | 1-(4-chlorophenyl)-2-(1-pyrrolidinyl)propan-1-one | March 2014 | |
2-methoxyamphetamine | 1-(2-methoxyphenyl)propan-2-amine | March 2014 | |
4-fluoro-N-isopropylnorpentedrone | 1-(4-fluorophenyl)-2-(1-methylethylamino)pentan-1-one | March 2014 | |
3-MeOMC | 1-(3-methoxyphenyl)-2-(methylamino)propan-1-one | March 2014 | |
Alprazolam triazolobenzophenone | (2-(3-(aminomethyl)-5-methyl-4-H-1,2,4-triazol-4-yl)-5-chlorophenyl)(phenyl)methanone | April 2014 | |
Fubimina | 1-(5-fluoropentyl)-1H-benzo[d]imidazol-2-yl)(naphthalen-1-yl)methanone | April 2014 | |
4-bromoamphetamine | 1-(4-bromophenyl)propan-2-amine | April 2014 | |
AB-CHMINACA | N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide | April 2014 | |
5F-AMBICA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide | April 2014 | |
2-MMC | 1-(2-methylphenyl)-2-(methylamino)propane-1-one | May 2014 | |
Orphenadrine | N,N-dimethyl-2-(2-methylbenzhydryloxy)ethylamine | May 2014 | |
DL-4662 | (1-(3,4-dimethoxyphenyl)-2-(ethylamino)pentan-1-one | May 2014 | |
4-F-PPVO | 1-(4-fluorophenyl)-2-(piperidin-1-yl)pentan-1-one | May 2014 | |
5-MeO-MALT | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methyl-prop-2-en-1-amine | May 2014 | |
4-methylpentedrone | 1-(4-methylphenyl)-2-methylamino-pentan-1-one | June 2014 | |
5F-AMB | methyl 2-({[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}amino)-3-methylbutanoate | June 2014 | |
JWH-071 | (1-ethyl-1H-indol-3-yl)-1-naphthalenyl-methanone | June 2014 | |
Ephenidine | N-ethyl-1,2-diphenyl-ethanamine | June 2014 | |
Isopropylphenidine | N-(1,2-diphenylethyl)propan-2-amine | June 2014 | |
EG-018 | naphthalen-1-yl(9-pentyl-9H-carbazol-3-yl)methanone | June 2014 | |
Dipentylone | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)-pentan-1-one | June 2014 | |
4-fluoropentedrone | 1-(4-fluorophenyl)-2-(methylamino)pentan-1-one | June 2014 | |
3-MEC | 2-(ethylamino)-1-(3-methylphenyl)propan-1-one | July 2014 | |
NNE1 indazole | N-(naphthalen-1-yl)-1-pentyl-1H-indazole-3-carboxamide | July 2014 | |
Bupropion | 1-(1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone | July 2014 | |
FUB-APINACA | N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide | July 2014 | |
AB-FUBINACA 2-fluorobenzyl | N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(2-fluorophenyl)methyl]-1H-indazole-3-carboxamide | August 2014 | |
Clephedrone | 1-(4-chlorophenyl)-2-(methylamino)propan-1-one | August 2014 | |
2-EAPB | 1-(1-benzofuran-2-yl)-N-ethylpropan-2-amine | August 2014 | |
5-MeO-NiPT | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-propan-2-amine | August 2014 | |
4-MeO-alpha-PBP | 1-(4-methoxyphenyl)-2-(pyrrolidin-1-yl)butan-1-one | August 2014 | |
Meclonazepam | 58662-84-3 | (S)-5-(2-chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one | August 2014 |
MET | N-methyl-N-ethyltryptamine | August 2014 | |
NM-2201 | naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate | September 2014 | |
Deschloroetizolam | 40054-73-7 | 2-ethyl-4-phenyl-9-methyl-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | September 2014 |
Butyrfentanyl | 1169-70-6 | N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]butanamide | September 2014 |
NM-2201 indazole | naphthalen-1-yl-1-(5-fluoropentyl)-1H-indazole-3-carboxylate | September 2014 | |
W-18 | 93101-02-1 | 4-chloro-N-(1-[2-(4-nitrophenyl)ethyl]-piperidin-2-ylidene)benzenesulfonamide | September 2014 |
alpha-PBT | 2-(pyrrolidin-1-yl)-1-(thiophen-2-yl)butan-1-one | September 2014 | |
4-F-alpha-PEP | 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)heptan-1-one | September 2014 | |
ADB-CHMINACA | N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide | September 2014 | |
MDMB-CHMICA | N-[[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl]-3-methyl-valine methyl ester | September 2014 | |
3-F-phenmetrazine | 2-(3-fluorophenyl)-3-methylmorpholine | September 2014 | |
Dimephedrone | 2-dimethylamino-1-(4-methylphenyl)propan-1-one | September 2014 | |
EFLEA | N-(1-(2,3-dihydrobenzo[b] [1,4]dioxin-6-yl)propan-2-yl)-N-methylhydroxylamine | September 2014 | |
Acetylfentanyl | N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide | September 2014 | |
MDPR | 74698-36-5 | α-methyl-N-propyl-1,3-benzodioxole-5-ethanamine | September 2014 |
alpha-POP | 1-phenyl-2-(pyrrolidin-1-yl)octan-1-one | September 2014 | |
CUMYL-BICA | 1-butyl-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide | September 2014 | |
CUMYL-PINACA | 1-pentyl-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide | September 2014 | |
ADB-CHMICA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indole-3-carboxamide | September 2014 | |
CUMYL-5F-PICA | 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide | September 2014 | |
CUMYL-THPINACA | N-(2-phenylpropan-2-yl)-1-((tetrahydro-2H-pyran-4-yl)methyl)-1H-indazole-3-carboxamide | September 2014 | |
CUMYL-PICA | 1-pentyl-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide | September 2014 | |
Adrafinil | 2-[(diphenylmethyl]sulfinyl]-N-hydroxyacetamide | September 2014 | |
4-F-alpha-POP | 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)octan-1-one | October 2014 | |
DALT | N-allyl-N-[2-(1H-indol-3-yl)ethyl]prop-2-en-1-amine | October 2014 | |
5-MeO-EiPT | N-ethyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]propan-2-amine | October 2014 | |
CUMYL-5F-PINACA | 1-(5-fluoropentyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide | October 2014 | |
Clophedrone | 1-(3-chlorophenyl)-2-(methylamino)propan-1-one | October 2014 | |
NBOMe-5-APB | 1-(benzofuran-5-yl)-N-[(2-methoxyphenyl)methyl]propan-2-amine | October 2014 | |
NBOMe-4-MMA | N-[(2-methoxyphenyl)methyl]-N-methyl-1-(p-tolyl)propan-2-amine | October 2014 | |
NBOMe-4-EA | 1-(4-ethylphenyl)-N-[(2-methoxyphenyl)methyl]propan-2-amine | October 2014 | |
NBOMe-3,4-DMA | 1-(3,4-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]propan-2-amine | October 2014 | |
4-MDEC | 2-diethylamino-1-(4-methylphenyl)propan-1-one | October 2014 | |
Afloqualone | 56287-74-2 | 6-amino-2-(fluoromethyl)-3-(2-methylphenyl)-3H-quinazolin-4-one | October 2014 |
Flubromazolam | 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo-[4,3a] [1,4]benzodiazepine | October 2014 | |
Modafiendz | 2-{[bis(4-fluorophenyl)methyl]sulfinyl}-N-methylacetamide | October 2014 | |
Methylmethaqualone | 3-(2,4-dimethylphenyl)-2-methylquinazolin-4(3H)-one | October 2014 | |
5F-APP-PINACA | N-(2-amino-1-benzyl-2-oxo-ethyl)-1-(5-fluoropentyl)indazole-3-carboxamide | November 2014 | |
APP-FUBINACA | N-(2-amino-1-benzyl-2-oxo-ethyl)-1-[(4-fluorophenyl)methyl]indazole-3-carboxamide | November 2014 | |
MDPHP | 1-(1,3-benzodioxol-5-yl)-2-pyrrolidin-1-yl-hexan-1-one | November 2014 | |
4-MeO-alpha-PEP | 1-(4-methoxyphenyl)-2-pyrrolidin-1-yl-heptan-1-one | November 2014 | |
5F-APP-PICA | N-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide | November 2014 | |
5F-AMB-PICA | methyl (1-(5-fluoropentyl)-1H-indole-3-carbonyl)-L-valinate | December 2014 | |
Flibanserin | 167933-07-5 | 1-(2-(4-[3-(trifluormethyl)phenyl]piperazine-1-yl)ethyl)-1,3-dihydro-2H-benzimidazole-2-one | December 2014 |
AMB-FUBINACA | methyl-2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)-3-methylbutanoate | December 2014 | |
5F-MDMB-PINACA | methyl-[2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate | January 2015 | |
Nifoxipam | 5-(2-fluorophenyl)-3-hydroxy-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one | January 2015 | |
NSI-189 | (4-benzylpiperazin-1-yl)-[2-(3-methylbutylamino)pyridin-3-yl]methanone | January 2015 | |
Clonazolam | 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | January 2015 | |
U-47700 | 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide | January 2015 | |
bk-IVP | 1-(2,3-dihydro-1H-inden-5-yl)-2-(ethylamino)pentan-1-one | January 2015 | |
bk-MMDMA-2 | 1-(6-methoxy-1,3-benzodioxol-5-yl)-2-(methylamino)propan-1-one | January 2015 | |
ADAMANTYL-THPINACA | N-(1-adamantyl)-1-(tetrahydropyran-4-ylmethyl)indazole-3-carboxamide | January 2015 | |
2-Chloro-4,5-MDMA | 1-(6-chloro-1,3-benzodioxol-5-yl)-N-methyl-propan-2-amine | January 2015 | |
IPPV | 1-(2,3-dihydro-1H-inden-5-yl)-2-phenyl-2-(pyrrolidinyl-1-yl)ethan-1-one | January 2015 | |
4-FEC | 2-(ethylamino)-1-(4-fluorophenyl)propan-1-one | February 2015 | |
5-DBFPV | 1-(2,3-dihydrobenzofuran-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one | February 2015 | |
25I-NB34MD | 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(3,4-methylenedioxyphenyl)methyl]ethanamine | February 2015 | |
FUB-144 | [1-[(4-fluorophenyl)methyl]indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone | February 2015 | |
4F-PBP | 1-(4-fluorophenyl)-2-(1-pyrrolidinyl)-1-butanone | February 2015 | |
25I-NBF | 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-fluorophenyl)methyl]ethanamine | February 2015 | |
CUMYL-5F-P7AICA | 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-7-azaindole-3-carboxamide | February 2015 | |
alpha-PNP | alpha-pyrrolidinononaphenone | February 2015 | |
DMBA | 4-methylpentan-2-amine | February 2015 | |
Methylnaphthidate | methyl 2-(2-naphthyl)-2-(2-piperidyl)acetate | March 2015 | |
Isopropylphenidate | isopropyl 2-phenyl-2-(2-piperidyl)acetate | March 2015 | |
1P-LSD | N,N-diethyl-7-methyl-4-propanoyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide | March 2015 | |
M-CHMIC | 1-(cyclohexylmethyl)-2-methyl-indole-3-carboxylate | March 2015 | |
Deschloroketamine | 2-(methylamino)-2-phenyl-cyclohexanone | March 2015 | |
Modafinil sulfone | 2-benzhydrylsulfonylacetamide | March 2015 | |
4Br-alpha-PVP | 1-(4-bromophenyl)-2-pyrrolidin-1-yl-pentan-1-one | March 2015 | |
DB-MDBP | 1-((2,2-difluorobenzo[D][1,3]dioxol-5-yl)methyl)piperazine | March 2015 | |
AL-LAD | (6aR,9R)-7-allyl-N,N-diethyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide | March 2015 | |
SDB-005 | Naphthalen-1-yl-1-pentyl-1H-indazole-3-carboxylate | March 2015 | |
5F-ADB-PINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | March 2015 | |
AB-PINACA N-(2-fluoropentyl) isomer | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(2-fluoropentyl)-1H-indazole-3-carboxamide | April 2015 | |
APP-CHMINACA | N-(2-amino-1-benzyl-2-oxo-ethyl)-1-(cyclohexylmethyl)indazole-3-carboxamide | April 2015 | |
2C-TFM | 2-[2,5-dimethoxy-4-(trifluoromethyl)phenyl]ethanamine | April 2015 | |
5-BPDI | 1-indan-5-yl-2-pyrrolidin-1-yl-hexan-1-one | April 2015 | |
MDMB-FUBICA | methyl 2-(1-(4-fluorobenzyl)-1H-indol-3-carboxamide)-3,3-dimethylbutanoate | May 2015 | |
4-methylmethylphenidate | methyl 2-(2-piperidyl)-2-(p-tolyl)acetate | May 2015 | |
4-EEC | 2-(ethylamino)-1-(4-ethylphenyl)propan-1-one | May 2015 | |
DOIP | 1-(4-isopropyl-2,5-dimethoxy-phenyl)propan-2-amine | May 2015 | |
AMB-CHMINACA | methyl 2-(1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)-3-methylbutanoate | May 2015 | |
4-MeO-alpha-PV9 | 1-(4-methoxyphenyl)-2-(pyrrolidin-1-yl)octan-1-one | May 2015 | |
3,4-DMeO-alpha-PHP | 1-(3,4-dimethoxyphenyl)-2-(pyrrolidin-1-yl)hexan-1-one | May 2015 | |
Propylphenidate | propyl-2-phenyl-2-(piperidin-2-yl)acetate | June 2015 | |
5F-AB-FUPPYCA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-5-(4-fluorophenyl)-1H-pyrazole-3-carboxamide | June 2015 | |
5F-PY-PICA | 1-(5-fluoropentyl)-3-(pyrrolidine-1-carbonyl)-1-H-indole | June 2015 | |
FUB-018 | 1-(4-fluorobenzyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | June 2015 | |
Normephedrone | 2-amino-1-(4-methylphenyl)-1-propanone | June 2015 | |
Despropionyl-2-fluoro fentanyl | N-(2-fluorophenyl)-1-(2-phenylethyl)piperidin-4-amine | June 2015 | |
5C-AKB48 | N-(2-adamantyl)-1-(5-chloropentyl)indazole-3-carboxamide | June 2015 | |
5F-EMB-PINACA | ethyl 2-[[1-(5-fluoropentyl)indazole-3-carbonyl]amino]-3-methyl-butanoate | June 2015 | |
5F-PY-PINACA | [1-(5-fluoropentyl)indazol-3-yl]-pyrrolidin-1-yl-methanone | June 2015 | |
EMB-FUBINACA | ethyl 2-[[1-[(4-fluorophenyl)methyl]indazole-3-carbonyl]amino]-3-methyl-butanoate | June 2015 | |
Ethylnaphthidate | ethyl 2-(2-naphthyl)-2-(2-piperidyl)acetate | June 2015 | |
CBL-018 | naphthalen-1-yl 1-pentyl-1H-indole-3-carboxylate | July 2015 | |
N-methyl aminorex | 5-phenyl-2-amino-N-methyl-oxazoline | July 2015 | |
5-Fluoropentyl-3-pyridinoylindole | [1-(5-fluoropentyl)-1H-indol-3-yl](pyridin-3-yl)methanone | July 2015 | |
Methamnetamine | N-methyl-1-(naphthalen-2-yl)propan-2-amine | August 2015 | |
AB-CHMFUPPYCA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide | August 2015 | |
3-MeO-PCMo | 4-[1-(3-methoxyphenyl)cyclohexyl]morpholine | August 2015 | |
McPT | N-(2-(1H-indol-3-yl)ethyl-N-methylcyclopropanamine | August 2015 | |
TH-PVP | 2-pyrrolidin-1-yl-1-tetralin-6-yl-pentan-1-one | August 2015 | |
2,3-XP | 1-(2,3-dichlorophenyl)piperazine | August 2015 | |
4-MeO-BF | N-(4-methoxyphenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide | August 2015 | |
DOPR | 1-(2,5-dimethoxy-4-propylphenyl)propan-2-amine | September 2015 | |
DOF | 1-(4-fluoro-2,5-dimethoxyphenyl)propan-2-amine | September 2015 | |
Mexedrone | 3-methoxy-2-(methylamino)-1-(4-methylphenyl)propan-1-one | September 2015 | |
4-CMA | 1-(4-chlorophenyl)-N-methylpropan-2-amine | September 2015 | |
Propylcathinone | 1-phenyl-2-(propylamino)propan-1-one | September 2015 | |
2,4-DMMC | 1-(2,4-dimethylphenyl)-2-(methylamino)propan-1-one | September 2015 | |
2,4-DMEC | 1-(2,4-dimethylphenyl)-2-(ethylamino)propan-1-one | September 2015 | |
3,4-DMAR | 3,4-dimethyl-5-phenyl-1,3-oxazolidin-2-imine | September 2015 | |
4-CDMC | 1-(4-chlorophenyl)-2-(N,N-dimethylamino)propan-1-one | September 2015 | |
2-MEC | 2-(ethylamino)-1-(2-methylphenyl)propan-1-one | October 2015 | |
AMB-CHMICA | methyl 2-{[1-(cyclohexylmethyl)indole-3-carbonyl]amino}-3-methyl-butanoate | October 2015 | |
MDMB-CHMCZCA | methyl 2-(9-(cyclohexylmethyl)-9H-carbazole-3-carboxamido)-3,3-dimethylbutanoate | October 2015 | |
25C-NBF | 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-fluorophenyl)methyl]ethanamine | October 2015 | |
4-MPH | 3-methyl-2-(p-tolyl)morpholine | October 2015 | |
5-PPDI | 1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)butan-1-one | October 2015 | |
Furanylfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide | November 2015 | |
4-Cl-alpha-PVP | 1-(4-chlorophenyl)-2-pyrrolidin-1-yl-pentan-1-one | November 2015 | |
4-F-alpha-PHP | 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)hexan-1-one | November 2015 | |
Phenetrazine | 3-ethyl-2-phenyl-morpholine | November 2015 | |
bk-IBP | 1-(2,3-dihydro-1H-inden-5-yl)-2-(ethylamino)butan-1-one | November 2015 | |
4-fluoromethylphenidate | methyl 2-(4-fluorophenyl)-2-(piperidin-2-yl)acetate | December 2015 | |
tBuONE | 1-(1,3-Benzodioxol-5-yl)-2-(tert-butylamino)propan-1-one | December 2015 | |
Epirocaine | [2-methyl-2-(propylamino)propyl] benzoate | December 2015 | |
Modafinil | 2-[(diphenylmethyl)sulfinyl]acetamide | December 2015 | |
Adinazolam | 1-(8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,5-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine | December 2015 | |
CHM-018 | [1-(cyclohexylmethyl)-1H-indol-3-yl](naphthalen-1-yl)methanone | December 2015 | |
5-MAPDB | 1-(2,3-dihydrobenzofuran-5-yl)-N-methylpropan-2-amine | December 2015 | |
Iso-phenmetrazine | 5-methyl-2-phenylmorpholine | December 2015 | |
5-MBPB | 1-(benzofuran-5-yl)-N-methylbutan-2-amine | December 2015 | |
5F-PCN | 1-(5-fluoropentyl)-N-(naphthalen-1-yl)-1H-pyrrolo[3,2-c]pyridine-3-carboxamide | December 2015 | |
alpha-TMT | 2-(1H-indol-3-yl)-1-methyl-ethyl)dimethylamine | December 2015 | |
Phenmetetrazine | 4-ethyl-3-methyl-2-phenyl-morpholine | December 2015 | |
3F-Phenetrazine | 3-ethyl-2-(3-fluorophenyl)morpholine | December 2015 | |
Metizolam | 4-(2-chloro-phenyl)-2-ethyl-6H-thieno[3, 2-f][1,2,4]triazolo[4,3-a][1,4]diazepine | December 2015 | |
Nitrazolam | 1-methyl-8-nitro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | December 2015 | |
Bromantane | N-(4-bromophenyl)adamantan-2-amine | December 2015 | |
NiPP | 2-(isopropylamino)-1-phenylpentan-1-one | December 2015 | |
5-MeO-DIBF | 2-(5-methoxy-1-benzofuran-3-yl)ethyl]bis(propan-2-yl)amine | December 2015 | |
MDMB-FUBINACA | methyl 2-[[1-[(4-fluorophenyl) methyl]indazole-3-carbonyl]amino]-3,3-dimethyl-butanoate | January 2016 | |
Viloxazine | 2-[(2-ethoxyphenoxy)methyl]morpholine | January 2016 | |
Fladrafinil | 2-[bis(4-fluorophenyl)methylsulfinyl]-N-hydroxyacetamide | January 2016 | |
Cloniprazepam | 5-(2-chlorophenyl)-1-(cyclopropylmethyl)-7-nitro-1,3-dihydro-2H-[1,4]-benzodiazepin-2-one | January 2016 | |
25C-NBOH | 2-[[2-(4-chloro-2,5-dimethoxy-phenyl)ethylamino]methyl]phenol | January 2016 | |
Ephylone | 1-(2H-1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one | January 2016 | |
2,4-DMPPP | 1-(2,4-dimethylphenyl)-2-pyrrolidin-1-yl-propan-1-one | January 2016 | |
4-CEC | 1-(4-chlorophenyl)-2-(ethylamino)propan-1-one | January 2016 | |
N-ethylhexedrone | 2-(ethylamino)-1-1phenylhexan-1-one | February 2016 | |
PDM-35 | 3,5-dimethyl-2-phenylmorpholine | February 2016 | |
3,6-DMPM | 3,6-dimethyl-2-phenylmorpholine | February 2016 | |
EG-2201 | (9-(5-fluoropentyl)-9H-carbazol-3-yl)(1-naphthalenyl)methanone | February 2016 | |
AKB-57 | 1-adamantyl 1-pentylindazole-3-carboxylate | February 2016 | |
LTI-701 | 1-(5-fluoropentyl)-N-phenyl-indole-3-carboxamide | February 2016 | |
4Br-α-PPP | 1-(4-bromophenyl)-2-pyrrolidin-1-yl-propan-1-one | February 2016 | |
25I-NBOH | 2-[[2-(4-iodo-2,5-dimethoxy-phenyl)ethylamino]methyl]phenol | February 2016 | |
4-CIC | 1-(4-chlorophenyl)-2-(isopropylamino)propan-1-one | March 2016 | |
CUMYL-4CN-BINACA | 1-(4-cyanobutyl)-N-(1-methyl-1-phenyl-ethyl)indazole-3-carboxamide | March 2016 | |
3-CEC | 1-(3-chlorophenyl)-2-(ethylamino)propan-1-one | March 2016 | |
TH-PHP | 2-pyrrolidin-1-yl-1-tetralin-6-yl-hexan-1-one | March 2016 | |
Cinazepam | 4-[[7-bromo-5-(2-chlorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]oxy]-4-oxo-butanoic acid) | March 2016 | |
Valerylfentanyl | N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]pentanamide | March 2016 | |
4-Fluoroethylphenidate | ethyl 2-(4-fluorophenyl)-2-(2-piperidyl)acetate | March 2016 | |
Propylone | 1-(1,3-benzodioxol-5-yl)-2-(propylamino)propan-1-one | March 2016 | |
ALD-52 | (8β)-1-acetyl-N,N-diethyl-6-methyl-9,10-didehydroergoline-8-carboxamide | April 2016 | |
Memantine | 3,5-dimethyladamantan-1-amine | April 2016 | |
3-Hydroxyphenazepam | 7-bromo-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-one | May 2016 | |
Benocyclidine | 1-[1-(1-benzothiophen-2-yl)cyclohexyl]piperidine | May 2016 | |
Fonazepam | 5-(2-fluorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one | June 2016 | |
Tiletamine | 2-ethylamino-2-(2-thienyl)cyclohexanone | June 2016 | |
25B-NBF | 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-fluorophenyl)methyl]ethanamine | June 2016 | |
25B-NBOH | 2-[[2-(4-bromo-2,5-dimethoxy-phenyl)ethylamino]methyl]phenol | June 2016 | |
2-MABB | 1-(1-benzofuran-2-yl)-N-methylbutan-2-amine | June 2016 | |
4F-NEB | 2-(ethylamino)-1-(4-fluorophenyl)butan-1-one | June 2016 | |
6-IT | 2-(1H-indol-6-yl)-1-methyl-ethylamine | July 2016 | |
3-Methylphenmetrazine | 3-methyl-2-(3-methylphenyl)morpholine | July 2016 | |
Acryloylfentanyl | N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide | July 2016 | |
G-130 | 5,5-dimethyl-2-phenyl-morpholine | July 2016 | |
Methylmorphenate | 2-(morpholin-3-yl)-2-phenylacetate | July 2016 | |
PRE-084 | 2-(morpholin-4-yl)ethyl 1-phenylcyclohexane-1-carboxylate | July 2016 | |
2-Fluorofentanyl | N-(2-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propanamide | August 2016 | |
Deschloro-N-ethyl-ketamine | 2-(ethylamino)-2-phenyl-cyclohexanone | August 2016 | |
ETH-LAD | (6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo-[4,3-fg]quinoline-9-carboxamide | August 2016 | |
4Cl-iBF | N-(4-chlorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4-piperidyl] propanamide | August 2016 | |
N-methyl-bk-MMDA-5 | 1-(7-methoxybenzo[d][1,3]dioxol-5-yl)-2-(methylamino)propan-1-one | August 2016 | |
4F-iBF | N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide | August 2016 | |
4-Chlorodiazepam | 7-chloro-5-(4-chlorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-one | September 2016 | |
FUB-NPB-22 | quinolin-8-yl-(4-fluorobenzyl)-1H-indazole-3-carboxylate | September 2016 | |
5F-EDMB-PINACA | ethyl-2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate | September 2016 | |
5-MAPDI | 1-(2,3-dihydro-1H-inden-5-yl)-N-methylpropan-2-amine | September 2016 | |
5F-MDMB-PICA | methyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate | September 2016 | |
AMB-FUBICA | methyl 2-[[1-[(4-fluorophenyl)methyl]indole-3-carbonyl]amino]-3-methyl-butanoate | October 2016 | |
3-Fluorofentanyl | N-(3-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidyl]propanamide | October 2016 | |
2-Fluorodeschloroketamine | 2-(2-fluorophenyl)-2-methylamino-cyclohexanone | October 2016 | |
1-Phenethyl-4-hydroxypiperidine | 1-(2-phenylethyl)piperidin-4-ol | October 2016 | |
Flunitrazolam | 6-(2-fluorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | October 2016 | |
N-Methylbenzedrone | 2-[benzyl(methyl)amino]-1-(4-methylphenyl)-1-propanone | October 2016 | |
MDA-19 | N-[(Z)-(1-hexyl-2-oxoindol-3-ylidene)amino]benzamide | October 2016 | |
3-MeO-PCMMo | 4-[[1-(3-methoxyphenyl)cyclohexyl]methyl]morpholine | November 2016 | |
3-MeO-α-PPP | 3-methoxy-1-phenyl-2-(pyrrolidin-1-yl)propan-1-one | November 2016 | |
α-PHiP | 4-methyl-1-phenyl-2-pyrrolidin-1-yl-pentan-1-one | December 2016 | |
Methoxyacetylfentanyl | 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide | December 2016 | |
U-49,900 | 3,4-dichloro-N-[2-(diethylamino)cyclohexyl]-N-methylbenzamide | December 2016 | |
Dichloropane (RTI-111) | methyl 3-(3,4-dichlorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate | December 2016 | |
MO-CHMINACA | 1-methoxy-3,3-dimethyl-1-oxobutan-2-yl 1-(cyclohexylmethyl)-1Hindazole-3-carboxylate | December 2016 | |
Tetrahydrofuranylfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]tetrahydrofuran-2-carboxamide | December 2016 |
Compounds banned in Alabama from March 2014
[edit]Note that this law also includes broad analogue provisions covering many homologues and analogues of the substances specifically listed.[3]
- The list includes some precursors, as well as some compounds structurally or pharmacologically similar to known designer drugs, but which have not yet been reported as NPS.
- Several compounds are specifically listed more than once in the original text, but have been given only one entry below.
- Many synthetic cannabinoid compounds are "triple banned", being both specifically listed, included within the scope of a broad analogue provision due to their chemical structure, and also banned due to being capable of producing a cannabinoid-like pharmacological effect.
- Some entries are ambiguous, having a code name that does not clearly indicate possible isomeric designations, and no formal chemical name. For instance, "N-ethyl-methamphetamine" seems like it should refer to N-ethyl-N-methylamphetamine, but it could alternatively have been intended to refer to N-ethyl-4-methylamphetamine (which might make more sense, as both 4-MA and 4-MMA are listed, while N,N-dimethylamphetamine and N,N-diethylamphetamine are not).
- Similarly, "4-methyl-phencyclidine" could potentially refer to any of three isomeric compounds 4-methyl-PCP, 4'-methyl-PCP or 4"-methyl-PCP (i.e. substituted on the cyclohexyl, phenyl or piperidine rings respectively), all three of which are known compounds. Given that it is listed alongside various other arylcyclohexylamine derivatives which are substituted on the phenyl ring, it might be assumed that this entry refers to 4'-Me-PCP, but alternatively it could be argued that given the all-inclusive aspirations of this law, the legislature may have left this entry deliberately ambiguous, so that it covers all three isomers.
- Some entries have a code number that does not correspond with the chemical name that accompanies it, for instance "2,5-DMA" which commonly refers to 2,5-dimethoxyamphetamine, is here specified to mean 2,5-dimethylamphetamine instead.
Common name | CAS number | Chemical name |
---|---|---|
Methylone | ||
MDPV | ||
Mephedrone | ||
Methedrone | ||
3-FMC | ||
4-FMC | ||
AM-694 | ||
AM-2201 | ||
HU-210 | ||
HU-211 | ||
JWH-007 | ||
JWH-015 | ||
JWH-018 | ||
JWH-019 | ||
JWH-073 | ||
JWH-081 | ||
JWH-098 | ||
JWH-122 | ||
JWH-200 | ||
JWH-203 | ||
JWH-210 | ||
JWH-250 | ||
JWH-307 | ||
JWH-398 | ||
CP 47,497 (and homologues) | ||
RCS-8 | ||
RCS-4 | ||
WIN 55,212-2 | ||
Pravadoline | ||
AM-2233 | ||
AB-001 | ||
AM-1220 | ||
XLR-11 (5F-UR-144) | ||
UR-144 | ||
URB-754 | ||
URB-602 | ||
URB-597 | ||
MAM-2201 | ||
CB-13 | ||
5"-Cl-UR-144 | ||
STS-135 (5F-APICA) | ||
AM-1248 | ||
APICA | ||
APINACA | ||
3-naphthoylindole | ||
A-796,260 | ||
A-834,735 | ||
JWH-122 4-pentenyl analog | ||
AB-FUBINACA | ||
5"-Br-UR-144 | ||
(C8)-CP 47,497 | ||
5F-APINACA | ||
JWH-022 | ||
5"-Cl-JWH-018 | ||
5"-HO-JWH-018 | ||
A-836,339 | ||
AM-679 | ||
JWH-251 | ||
PB-22 | ||
5F-PB-22 | ||
NNE1 | ||
BB-22 | ||
AB-PINACA | ||
MN-25 (UR-12) | 501926-82-5 | 7-methoxy-1-(2-morpholinoethyl)-N-((1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl)-1H-indole-3-carboxamide |
ADB-PINACA | ||
FUB-AKB48 (FUB-APINACA) | N-(adamantan-1-yl)-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide | |
FUB-PB-22 | ||
(C7)-UR-144 | ||
THJ-018 | ||
THJ-2201 | ||
JWH-020 | ||
JWH-072 | ||
JWH-133 | 259869-55-1 | (6aR,10aR)-3-(1,1-Dimethylbutyl)-6a,7,10,10a-tetrahydro -6,6,9-trimethyl-6H-dibenzo[b,d]pyran |
JWH-175 | ||
JWH-201 | ||
JWH-302 | ||
HU-308 | ||
HU-331 | ||
CB-25 | N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-undecanamide | |
CB-52 | N-cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-undecanamide | |
CP 55,940 | ||
4-MEC | ||
4-MePPP | ||
Naphyrone | ||
Pipradrol | ||
Pyrovalerone | ||
3,4-DMMC | ||
4-FA | ||
4-FMA | ||
Butylone | ||
alpha-PVP | ||
Dibutylone | ||
Buphedrone | ||
Ethcathinone | ||
2-FA | ||
Methoxetamine | ||
Pentedrone | ||
MDC | 2-amino-1-(3,4-methylenedioxyphenyl)propan-1-one | |
2-FMA | ||
4-MMA | ||
4-FIC | 4-fluoroisocathinone | |
3-FMA | ||
MPA | 801156-47-8 | 1-(thiophen-2-yl)-2-methylaminopropane |
alpha-PBP | ||
Methedrone | ||
alpha-PPP | ||
2-DPMP | ||
Ethylone | ||
MDPBP | ||
Pentylone | ||
3-FA | ||
3-FMC | ||
2-FMC | ||
Dimethylone | ||
Amfepramone | ||
DMAA | ||
N,N-Dimethylcathinone | ||
Ethamphetamine | ||
2-EEC | ||
4-EEC | ||
Dimemebfe | ||
5-MeO-NET benzofuran | 2-(5-Methoxy-1-benzofuran-3-yl)N-ethylethanamine | |
PMMA | ||
PMEA | ||
4-MeO-EC | ||
3-MMC | ||
MPBP | ||
2-MEC | ||
3-MEC | ||
3-EEC | ||
3-EMC | ||
MDPPP | ||
alpha-PVT | ||
3-MeO-MC | ||
MBDB | ||
Diethylone | ||
3,4-methylenedioxy-propiophenone | ||
2-bromo-3,4-methylenedioxypropiophenone | ||
3,4-methylenedioxy-propiophenone-2-oxime | ||
N-acetyl-3,4-methylenedioxycathinone | ||
N-acetyl-methylone | ||
N-acetyl-ethylone | ||
4-BMC | 486459-03-4 | 1-(4-bromophenyl)-2-methylaminopropan-1-one |
3-BMC | 1-(3-bromophenyl)-2-methylaminopropan-1-one | |
Eutylone | ||
MOPPP | ||
MPHP | ||
BTCP | 112726-66-6 | 1-[1-(1-benzothiophen-2-yl)cyclohexyl]piperidine |
4-fluorobuphedrone | ||
3-Me-4-MeO-MC | ||
4-methyl-NEB | 2-(ethylamino)-1-(4-methylphenyl)-1-butanone | |
4-EMC | ||
3-FC | ||
4-FC | ||
4-methylbuphedrone | ||
BMDP | 1-(1,3-benzodioxol-5-yl)-2-(benzylamino)propan-1-one | |
BMDB | 1-(1,3-benzodioxol-5-yl)-2-(benzylamino)butan-1-one | |
N-hydroxy-methylone | ||
N-ethylbuphedrone | ||
MOPBP | ||
4-Et-PBP | ||
5-IT | ||
PPBO | 1-phenyl-2-(piperidin-1-yl)butan-1-one | |
2,4,5-TMMC | 1-(2,4,5-trimethylphenyl)-2-(methylamino)propan-1-one | |
alpha-PHP | ||
4-MA | ||
N-ethyl-methamphetamine | ||
4-APB | ||
5-APDI | 13396-94-6 | 1-(2,3-dihydro-1H-inden-5-yl)propan-2-amine |
MDAT | ||
4-MTA | ||
4-CA | 4-chloroamphetamine | |
TMA-6 | ||
TMA-2 | ||
2,5-diMe-A | 2,5-dimethylamphetamine | |
3,4-diMe-A | 3,4-dimethylamphetamine | |
N-propylamphetamine | ||
4-hydroxyamphetamine | ||
3-hydroxyamphetamine | ||
MDDM | ||
2-AI | ||
MDMAI | ||
2C-T-21 | ||
2C-B-Fly | ||
2C-G | ||
NBOMe-2C-D | ||
NBOMe-2C-G | ||
NBOMe-2C-N | ||
Bromo-dragonfly | ||
DOB-Fly | ||
Aleph-2 | 2,5-dimethoxy-4-ethylthioamphetamine | |
MEM | 2,5-dimethoxy-4-ethoxyamphetamine | |
Aleph-7 | 2,5-dimethoxy-4-propylthioamphetamine | |
N-benzyl-PEA | ||
N,N-dimethyl-PEA | ||
6-CAT | 6-chloro-2-aminotetralin | |
beta-methyl-PEA | ||
PEA | 2-phenylethylamine | |
M-ALPHA | ||
Camfetamine | ||
Methoxyphenamine | ||
4-methylaminorex | ||
Thienoamphetamine | (1-thiophen-2-yl)propan-2-amine | |
Dimethocaine | ||
4-fluoroephedrine | ||
4,4'-DMAR | ||
AM-1221 | 335160-53-7 | 1-[(N-methylpiperidin-2-yl)methyl]-2-methyl-3-(naphthalen-1-oyl)-6-nitroindole |
(C4)-RCS-4 | ||
AM-2232 | ||
JWH-387 | ||
JWH-412 | ||
5"-Cl-AM-694 | ||
AM-1241 | 444912-48-5 | (2-iodo-5-nitrophenyl)-[1-[(1-methylpiperidin-2-yl)methyl]indol-3-yl]methanone |
JWH-182 | ||
JWH-267 | ||
meta-RCS-4 | ||
EAM-2201 | ||
ADB-FUBINACA | ||
ADBICA | ||
AM-279 | ?? | |
JWH-370 | ||
5"-Cl-MAM-2201 | ||
AM-694 2'-methyl analogue | ||
AM-694 2'-ethyl analogue | ||
AB-005 | ||
AB-005 azepane | ||
4-HTMPIPO | ||
5F-ADBICA | ||
Bay 38-7271 | ||
JTE-907 | ||
Org 27569 | ||
Org 27759 | ||
Org 29647 | ||
LY-2183240 | ||
JTE 7-31 | 194358-72-0 | 2-[2-(4-hydroxyphenyl)ethyl]-5-methoxy-4-(pentylamino)-2,3-dihydro-1H-isoindol-1-one |
URB-937 | ||
3'-MeO-PCE | ||
PCA | 1-phenylcyclohexylamine | |
4'-Me-PCP | ||
4'-MeO-PCE | ||
4'-MeO-PCP | ||
3'-MeO-PCP | ||
PCPr | ||
PCMEA | N-(2-methoxyethyl)-1-phenylcyclohexanamine | |
PCEEA | N-(2-ethoxyethyl)-1-phenylcyclohexanamine | |
PCMPA | N-(3-methoxypropyl)-1-phenylcyclohexanamine | |
3'-OH-PCP | ||
Methoxyketamine | ||
Tiletamine | ||
NENK | ||
N-methyltryptamine | ||
MiPT | ||
4-HO-MiPT | ||
4-AcO-DiPT | ||
4-MeO-DMT | ||
Serotonin | ||
5-AcO-DMT | ||
5-MeO-DPT | ||
LSA | ||
DOC | ||
NBOMe-2C-I | ||
2C-E | ||
2C-I | ||
6-APDB | ||
6-APB | ||
5-APDB | ||
5-APB | ||
2C-T-7 | ||
2C-P | ||
DOB | ||
2C-B-BZP | ||
2C-B | ||
2C-C | ||
2C-T-2 | ||
DOI | ||
DOM | ||
2C-H | ||
NBOMe-2C-B | ||
NBOMe-2C-C | ||
NBOMe-2C-E | ||
2-EMC | ||
NBOMe-2C-H | ||
BZP | ||
pFPP | ||
pMePP | ||
mCPP | ||
pMeOPP | ||
DBZP | ||
TFMPP | ||
2C-T-4 | ||
2C-T | ||
2C-D | ||
2C-N | ||
5-MeO-DALT | ||
5-MeO-DiPT | ||
5-MeO-AMT | ||
4-AcO-DMT | ||
4-HO-DET | ||
4-HO-DiPT | ||
4-HO-MET | ||
5-MeO-DET | ||
5-MeO-MiPT | ||
4-AcO-DET | ||
4-AcO-MiPT | ||
DPT | ||
DiPT | ||
4-MeO-MiPT | ||
Tyramine | ||
5-HO-AMT | ||
5-HO-N-methyltryptamine | ||
5-MeO-DMT | ||
5,N,N-TMT | ||
Diphenylprolinol | ||
3,4-CTMP | ||
4-methyl-methylphenidate | ||
4-fluoro-methylphenidate | ||
Ethylphenidate | ||
Etizolam | ||
Phenazepam | ||
Pyrazolam | ||
CL-218,872 | ||
Zopiclone | ||
Salvinorin A | ||
AH-7921 | ||
O-desmethyltramadol | ||
Desomorphine | ||
Acetylfentanyl | ||
MT-45 | ||
oMeOPP | ||
pCPP | ||
Methylmethaqualone | ||
Etaqualone | ||
5-IAI | ||
5,6-MDAI | ||
4,5-MDAI | ||
MMAI | ||
W-15 | ||
W-18 |
Compounds banned in Latvia from November 2014
[edit]Unlike the Alabama list which is riddled with spelling mistakes, repeated entries and ambiguity, the Latvian list of controlled NPS is generally highly accurate (although again some compounds are listed twice), and has all the compounds neatly grouped by structural family.[4] This list does not include a number of atypical compounds that do not fall into any of the common structural classes, but it should be noted that this is not a complete list of the NPS banned in Latvia, as for instance there are no fentanyl analogues listed, despite these compounds being major drugs of abuse in Latvia. So these most likely had already been banned in a previous law, and are not included in this more recent update. See here for a more complete and updated list, though it does not include some compounds from the 2014 list so again is presumably only a subset of the total group of compounds covered.
Common name | CAS number | Chemical name |
---|---|---|
2C-B | 66142-81-2 | |
2C-C | 88441-14-9 | |
2C-I | 69587-11-7 | |
2C-D | 24333-19-5 | |
2C-E | 71539-34-9 | |
2C-P | 207740-22-5 | |
2C-F | 207740-15-6 | |
2C-N | 261789-00-8 | |
2C-T-2 | 207740-24-7 | |
2C-T-4 | 207740-25-8 | |
2C-T-7 | 207740-26-9 | |
2C-T-8 | 207740-27-0 | |
2C-T-19 | 207740-28-1 | |
2C-T-21 | 207740-33-8 | |
HOT-2 | 207740-38-3 | |
HOT-7 | 207740-39-4 | |
HOT-17 | 207740-40-7 | |
NBOMe-2C-I | 919797-19-6 | |
NBOMe-2C-C | 1227608-02-7 | |
NBOMe-2C-B | 1026511-90-9 | |
NBMD-2C-I | 919797-25-4 | |
DOM | 26011-50-7 | |
DOET | 15588-95-1 | |
DOB | 64638-07-9 | |
DOF | 125903-69-7 | |
2,5-DMA | 2801-68-5 | |
NBOMe-2C-TFM | 1027161-33-6 | |
NBOH-2C-I | 919797-20-9 | |
NBF-2C-I | 919797-21-0 | |
MDMPEA | 451-77-4 | |
MDA | 4764-17-4 | |
MMDPEA | 23693-38-1 | |
MMDA | 13674-05-0 | |
MDEA | 82801-81-8 | |
MBDB | 103818-46-8 | |
BDB | 42542-07-4 | |
EBDB | 167394-39-0 | |
MBDP | 952016-78-3 | |
EBDP | 952016-47-6 | |
MDMA | 42542-10-9 | |
MDIP | 74698-37-6 | |
MDBU | 74698-38-7 | |
MDMP | 81262-69-3 | |
MDAL | 74698-45-6 | |
MDPR | 74698-36-5 | |
MDBZ | 65033-29-6 | |
MDCPM | 22698-08-4 | |
MDOH | 74698-47-8 | |
MDHOET | 74698-43-4 | |
MDMEO | 74698-48-9 | |
MDMEOET | 74698-44-5 | |
2-methyl-MDA | 691876-73-0 | |
5-methyl-MDA | 749191-14-8 | |
MDDM | 74698-50-3 | |
MDHMA | 214414-88-7 | |
DMMDA | 15183-13-8 | |
MDPH | 39235-63-7 | |
Amphetamine | 405-41-4 | |
Dexamphetamine | 51-64-9 | |
Levoamphetamine | 156-34-3 | |
Methamphetamine | 4298-16-2 | |
Dexmethamphetamine | 537-46-2 ? | |
Levomethamphetamine | 537-46-2 ? | |
PMA | 64-13-1 | |
PMMA | 3398-68-3 | |
2-FMA | 1017176-48-5 | |
4-FMA | 351-03-1 | |
3-FA | 1626-71-7 | |
4-FA | 459-02-9 | |
3-MA | 77083-25-1 | |
4-MA | 64-11-9 | |
MMA | 87179-33-7 | |
4-MTA | 14116-06-4 | |
3,4-DMA | 120-26-3 | |
TMA | 1082-88-8 | |
TMA-2 | 1083-09-6 | |
TMA-6 | 15402-79-6 | |
5-APDI | 152624-02-7 | |
2,4-DMA | 23690-13-3 | |
Ethamphetamine | 457-87-4 | |
5-IT | 3784-30-3 | |
MDAI | 132741-81-2 | |
MDMAI | 132741-82-3 | |
5,6-DEAI | 312753-70-1 | |
5-BAI | 181477-28-1 | |
MMAI | 132980-16-6 | |
5-FAI | 2340-06-9 | |
5-IAI | 132367-76-1 | |
4-MeOAI | 76413-92-8 | |
5-MeOAI | 73305-09-6 | |
2C-B-Fly | 178557-21-6 | |
TFMFly | 780744-19-6 | |
Bromo-dragonfly | 502759-67-3 | |
2C-B-2-dragonfly | 2-(4-brom-7,8-dihidro-6H-furo[2,3-g]hromen-9-il)etānamīns | |
2C-B-butterfly | 502659-24-7 | 2-(10-brom-2,3,4,7,8,9-heksahidropirano[2,3-g]hromen-5-il)-etānamīns |
NBOMe-2C-B-Fly | 1335331-42-4 | |
Cathinone | 71031-15-7 | |
Methcathinone | 66514-93-0 | |
Ethcathinone | 51553-17-4 | |
Buphedrone | 166593-10-8 | |
Pentedrone | 879669-95-1 | |
Dimethylcathinone | 15351-09-4 | |
Diethylcathinone | 134-80-5 | |
Mephedrone | 1189805-46-6 | |
4-MEC | 1225617-18-4 | |
3,4-DMMC | 1081772-06-6 | |
Methedrone | 530-54-1 | |
3-FMC | 1049677-77-1 | |
4-FMC | 7589-35-7 | |
Methylone | 186028-79-5 | |
Butylone | 17762-90-2 | |
Eutylone | 17764-18-0 | |
Pentylone | 698963-77-8 | |
alpha-PPP | 19134-50-0 | |
4-MePPP | 1313393-58-6 | |
Naphyrone | 850352-53-3 | |
MDPPP | 24698-57-5 | |
MOPPP | 478243-09-3 | |
MDPV | 687603-66-3 | |
Ethylone | 1112937-64-0 | |
MPHP | 34138-58-4 | |
Pyrovalerone | 3563-49-3 | |
alpha-PVP | 14530-33-7 | |
4-BMC | 486459-03-4 | |
Benzedrone | 17762-90-2 | |
alpha-PBP | 13415-54-8 | |
MDPBP | 24622-60-4 | |
2C-B-BZP | 1094424-37-9 | |
BZP | 2759-28-6 | |
MBZP | 374898-00-7 | |
mCPP | 51639-49-7 | |
TFMPP | 15532-75-9 | |
MDBZP | 32231-06-4 | |
pFPP | 2252-63-3 | |
MeOPP | 38212-30-5 | |
mCPCPP ("Gelbes", cf. EMCDDA 2007) | 52605-52-4 | |
oMeOPP | 35386-24-4 | |
pCPP | 38212-33-8 | |
mMPP | 41186-03-2 | |
pMPP | 39593-08-3 | |
MT-45 | 52694-55-0 | |
5-HO-DMT | 487-93-4 | |
DMT | 61-50-7 | |
5-MeO-DMT | 1019-45-0 | |
4-MeO-DMT | 3965-97-7 | |
5-EtO-DMT | 855245-09-9 | |
NMT | 61-49-4 | |
NET | 61-53-0 | |
AET | 2235-90-7 | |
AMT | 299-26-3 | |
4-Me-AMT | 3569-29-7 | |
4-Me-AET | 28289-30-7 | |
7-Me-AET | 13712-80-6 | |
5-F-AMT | 712-08-3 | |
5-MeO-AMT | 1137-04-8 | |
5-MeO-DPT | 2427-80-7 | |
5-MeO-DiPT | 4021-34-5 | |
MiPT | 96096-52-5 | |
DiPT | 14780-24-6 | |
5-MeO-MiPT | 96096-55-8 | |
DET | 7558-72-7 | |
4-AcO-DMT | 92292-84-7 | |
3'-MeO-PCP | 72242-03-6 | |
4'-MeO-PCP | 2201-35-6 | |
Esketamine | 33643-46-8 | |
Ketamine | 6740-88-1 | |
PCE | 2201-15-2 | |
Methoxetamine | 1239943-76-0 | |
Methoxyketamine | 7063-51-6 | |
PCPr | 18949-81-0 | |
PCP | 77-10-1 | |
PCMEA | 2201-57-2 | |
PCEEA | 1072895-05-6 | |
PCPEA | 2201-58-3 | |
PCPy | 2201-39-0 | |
Tiletamine | 14176-50-2 | |
PCA | 2201-24-3 | |
PCM | 2201-16-3 | |
PCiP | 1195-42-2 | |
PCBu | 73166-29-7 | |
PCEOH | 2201-22-1 | |
PCDM | 1934-69-6 | |
2-OH-PCP | 94852-58-1 | |
2-MeO-PCP | 78636-34-7 | |
2-Me-PCP | 59397-29-4 | |
2-Keto-PCP | 101688-16-8 | |
2-Keto-PCE | 6740-82-5 | |
4-Me-PCP | 19420-52-1 | |
4-Keto-PCP | 65620-13-5 | |
2'-Cl-PCP | 2201-31-2 | |
2'-MeO-PCP | 2201-34-5 | |
3'-F-PCP | 89156-99-0 | |
3'-Me-PCP | 2201-30-1 | |
3'-NH2-PCP | 72242-00-3 | |
3'-OH-PCP | 79787-43-2 | |
3'-MeO-PCE | 1364933-80-1 | |
3'-MeO-PCPr | 1364933-81-2 | |
3'-MeO-PCPy | 1364933-79-8 | |
4'-OH-PCP | 66568-88-5 | |
4'-F-PCP | 22904-99-0 | |
Arketamine | 6740-88-1 | |
Deschloroketamine | 7063-30-1 | |
Fluoroketamine | 111982-50-4 | |
Bromoketamine | 120807-70-7 | |
3"-Me-PCP (PC3MP) | 2201-41-4 | |
4"-Me-PCP (PC4MP) | 2201-42-5 | |
PCDMPy | 3,3-dimetil-1-(1-fenilcikloheksil)pirolidīns | |
PCMo | 2201-40-3 | |
2'-MeO-PCMo | 1314323-88-0 | |
4'-Me-PCMo | 120803-52-3 | |
2'-Me-4'-OH-PCMo | 1314323-89-1 | |
TCM | 139401-07-3 | |
TCE | 101589-62-2 | |
TCPy | 22912-13-6 | |
Dimetamine | 65619-06-9 | |
Gacyclidine | 68134-81-6 | |
TCP | 21500-98-1 | |
Δ9-THC | 1972-08-3 | |
O-acetyl-Δ9-THC | 23132-17-4 | |
AM-087 | (6aR,10aR)-3-(2-metil-6-bromheks-2-il)-6,6,9-trimetil-6a,7,10,10a-tetrahidrobenzo[c]hromen-1-ols | |
Cannabinol | 521-35-7 | |
Parahexyl | 117-51-1 | |
HU-210 | 112830-95-2 | |
HU-243 | 56689-43-1 | |
Nabilone | 51022-71-0 | |
DMHP | 32904-22-6 | |
CP 47,497 | 70434-82-1 | |
CP 55,940 | 83002-04-4 | |
(C8)-CP 47,497 | 70434-92-3 | |
JWH-171 | 619294-62-1 | |
JWH-175 | 619294-35-8 | |
JWH-184 | 619294-37-0 | |
JWH-185 | 619294-39-2 | |
JWH-192 | 619294-55-2 | |
JWH-194 | 619294-43-8 | |
JWH-195 | 619294-53-0 | |
JWH-196 | 619294-41-6 | |
JWH-197 | 619294-45-0 | |
JWH-199 | 619294-57-4 | |
JWH-030 | 162934-73-8 | |
JWH-145 | 914458-19-8 | |
JWH-147 | 914458-20-1 | |
JWH-368 | 914458-31-4 | |
JWH-370 | 914458-22-3 | |
JWH-307 | 914458-26-7 | |
AM-679 | 335160-91-3 | |
AM-2233 | 444912-75-8 | |
AM-630 | 164178-33-0 | |
AM-694 | 335161-03-0 | |
RCS-4 | 1345966-78-0 | |
Pravadoline | 92623-83-1 | |
WIN 54,461 | 166599-63-9 | |
5"-Cl-AM-694 | 1391483-97-8 | |
ortho-RCS-4 | 1345966-76-8 | |
(C4)-RCS-4 | 1345966-77-9 | |
AM-661 | 444912-75-8 | |
AM-1241 | 444912-48-5 | |
AB-001 | 1345973-49-0 | |
AM-1248 | 335160-66-2 | |
UR-144 | 1199943-44-6 | |
5F-UR-144 | 1364933-54-9 | |
A-834,735 | 895155-57-4 | |
TFB-AB-001 | 1-[1-(4,4,4-trifluorbutil)-1H-indol-3-il]-(triciklo[3.3.1.13,7]dec-1-il)metanons | |
AB-034 | 895155-25-6 | |
A-796,260 | 895155-26-7 | |
5"-Br-UR-144 | [1-(5-brompentil)-1H-indol-3-il](2,2,3,3-tetrametilciklopropil)metanons | |
5"-Cl-UR-144 | 1445577-42-3 | |
JWH-249 | 864445-60-3 | |
JWH-250 | 864445-43-2 | |
JWH-251 | 864445-39-6 | |
JWH-203 | 864445-54-5 | |
Cannabipiperidiethanone | 1345970-43-5 | |
JWH-201 | 86445-47-6 | |
JWH-302 | 86445-45-4 | |
RCS-8 | 1345970-42-4 | |
JWH-167 | 864445-37-4 | |
JWH-004 | [2-metil-1-heksil-1H-indol-3-il](naft-1-il)metanons | |
JWH-007 | 155471-10-6 | |
JWH-011 | 155471-13-9 | |
JWH-015 | 155471-08-2 | |
JWH-016 | 155471-09-3 | |
JWH-018 | 209414-07-3 | |
5"-Cl-JWH-018 | 1445578-56-2 | |
JWH-019 | 209414-08-4 | |
JWH-020 | 209414-09-5 | |
JWH-071 | 209414-05-1 | |
JWH-072 | 209414-06-2 | |
JWH-073 | 208987-48-8 | |
JWH-080 | 210179-44-5 | |
JWH-081 | 210179-46-7 | |
JWH-098 | 316189-74-9 | |
JWH-122 | 619294-47-2 | |
JWH-164 | 824961-61-7 | |
JWH-180 | 824959-87-7 | |
JWH-181 | 824960-03-4 | |
JWH-182 | 824960-02-3 | |
JWH-193 | 133438-58-1 | |
JWH-198 | 166599-76-4 | |
JWH-200 | 103610-04-4 | |
JWH-210 | 824959-81-1 | |
JWH-213 | 824959-83-3 | |
JWH-234 | 824960-64-7 | |
JWH-258 | 210179-46-7 | |
JWH-387 | 207227-49-4 | |
JWH-398 | 1292765-18-4 | |
AM-1220 | 134959-64-1 | |
AM-1235 | 335161-27-8 | |
AM-2201 | 335161-24-5 | |
MAM-2201 | 1354631-24-5 | |
JWH-412 | 1364933-59-4 | |
4'-Me-JWH-073 | (1-butil-1H-indol-3-il)(4-metilnaft-1-il)metanons | |
AM-1221 | 335160-53-7 | |
JWH-116 | 619294-64-3 | |
JWH-149 | 548461-82-1 | |
JWH-424 | 1366068-04-3 | |
WIN 55,212-2 | 131543-23-2 | |
AM-1220 azepane | 1348081-04-8 | |
JWH-022 | 209414-16-4 | |
AM-2232 | 335161-19-8 | |
PB-22 | 1400742-17-7 | |
5F-PB-22 | 1400742-41-7 | |
FDU-PB-22 | ||
FUB-PB-22 | ||
BB-22 | 1400742-42-8 | |
ADBICA | 1445583-48-1 | |
STS-135 (5F-APICA) | 1354631-26-7 | |
APICA (2NE1, SDB-001) | 1345973-50-3 | |
Mepirapim | (4-metilpiperazin-1-il)(1-pentil-1H-indol-3-il)metanons | |
SDB-006 | 695213-59-3 | |
UR-12 (MN-25) | 501926-82-5 | |
2-Me-UR-12 | 501927-29-3 | |
Org 28611 | 639068-99-8 | |
Org 28312 | 1244028-73-6 | |
SGT-55 (CUMYL-BICA) | 1400742-22-4 | |
SGT-56 (CUMYL-PICA) | 1400742-32-6 | |
NNE1 (MN-24) | 1338925-11-3 | |
AB-FUBINACA | 1185282-01-2 | |
AB-PINACA | 1445752-09-9 | |
5F-AB-PINACA | N-[(1S)-amino-3-metil-1-oksobutan-2-il]-1-(5-fluorpentil)-1H-indazol-3-karboksamīds | |
ADB-FUBINACA | 1445583-51-6 | |
THJ-018 | 1364933-55-0 | |
5F-AKB-48 (5F-APINACA) | 1400742-13-3 | |
APINACA | 1345973-53-6 | |
5F-MN-18 | 763954-93-9 | |
MN-18 (NNE1 indazole) | 1391484-80-2 | |
AKB-N1 | 1400742-62-2 | |
Granisetron | 109889-09-0 | |
JWH-018 benzimidazole | (Naft-1-il)(1-pentil-1H-benz[d]imidazol-2-il)metanons | |
FUBIMINA | (1-(5-fluorpentil)-1H-benz[d]imidazol-2-il)(naft-1-il)metanons | |
Diphenidine | 36794-52-2 | |
Methoxphenidine | 127529-46-8 | |
2-Cl-diphenidine | 1-[1-(2-hlorfenil)-2-feniletil]piperidīns | |
Diphenidine pyrrolidine homologue | 1939-35-1 | |
Lefetamine | 7262-75-1 | |
Lanicemine | 153322-05-5 | |
Norlefetamine | 53663-25-5 | |
Bisnorlefetamine | 25611-78-3 |
Compounds banned in China from October 2015
[edit]Note that several individual compounds such as mephedrone and JWH-018 were banned in China several years earlier, from January 2012, but this is the first time that a large list of this kind of compounds has been banned at one time.[5]
Common name | CAS number | Chemical name |
---|---|---|
2C-B-NBOMe | 1026511-90-9 | 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine |
2C-C | 88441-14-9 | 4-Chloro-2,5-dimethoxyphenethylamine |
2C-C-NBOMe | 1227608-02-7 | 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine |
2C-D | 24333-19-5 | 4-Methyl-2,5-dimethoxyphenethylamine |
2C-D-NBOMe | 1354632-02-2 | 2-(4-Methyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine |
2C-E | 71539-34-9 | 4-Ethyl-2,5-dimethoxyphenethylamine |
2C-I-NBOMe | 919797-19-6 | 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine |
2C-P | 207740-22-5 | 4-Propyl-2,5-dimethoxyphenethylamine |
2C-T-2 | 207740-24-7 | 4-Ethylthio-2,5-dimethoxyphenethylamine |
2C-T-4 | 207740-25-8 | 4-Isopropylthio-2,5-dimethoxyphenethylamine |
2C-T-7 | 207740-26-9 | 4-Propylthio-2,5-dimethoxyphenethylamine |
2-FA | 1716-60-5 | 1-(2-Fluorophenyl)propan-2-amine |
2-FMA | 1017176-48-5 | N-Methyl-1-(2-fluorophenyl)propan-2-amine |
2-MAPB | 806596-15-6 | N-Methyl-1-(benzofuran-2-yl)propan-2-amine |
3-FA | 1626-71-7 | 1-(3-Fluorophenyl)propan-2-amine |
3-FMA | 1182818-14-9 | N-Methyl-1-(3-fluorophenyl)propan-2-amine |
4-CA | 64-12-0 | 1-(4-Chlorophenyl)propan-2-amine |
4-FA | 459-02-9 | 1-(4-Fluorophenyl)propan-2-amine |
4-FMA | 351-03-1 | N-Methyl-1-(4-fluorophenyl)propan-2-amine |
5-APDB | 152624-03-8 | 1-(2,3-Dihydro-1-benzofuran-5-yl)propan-2-amine |
5-MAPB | 1354631-77-8 | N-Methyl-1-(benzofuran-5-yl)propan-2-amine |
6-Br-MDMA | N-Methyl-(6-bromo-3,4-methylenedioxyphenyl)propan-2-amine | |
6-Cl-MDMA | 319920-71-3 | N-Methyl-(6-chloro-3,4-methylenedioxyphenyl)propan-2-amine |
DOC | 123431-31-2 | 1-(4-Chloro-2,5-dimethoxyphenyl)propan-2-amine |
MPA | 801156-47-8 | N-Methyl-1-(thiophen-2-yl)propan-2-amine |
5F-ABICA | 1801338-26-0 | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide |
5F-AB-PINACA | 1800101-60-3 | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide |
5F-ADBICA | 1801338-27-1 | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide |
5F-AMB | 1715016-74-2 | 1-Methoxy-3-methyl-1-oxobutan-2-yl-1-(5-fluoropentyl)-1H-indazole-3-carboxamide |
5F-APINACA | 1400742-13-3 | N-(1-Adamantyl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide |
5F-PB-22 | 1400742-41-7 | Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate |
5F-UR-144 | 1364933-54-9 | (1-(5-Fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone |
A-796,260 | 895155-26-7 | (1-(2-Morpholin-4-ylethyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone |
A-834,735 | 895155-57-4 | (1-(Tetrahydropyran-4-ylmethyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone |
AB-CHMINACA | 1185887-21-1 | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide |
AB-FUBINACA | 1629062-56-1 | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide |
AB-PINACA | 1445583-20-9 | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pe-ntyl-1H-indazole-3-carboxamide |
ADBICA | 1445583-48-1 | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indole-3-carboxamide |
ADB-PINACA | 1633766-73-0 | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide |
AM-1220 | 137642-54-7 | (1-((1-Methylpiperidin-2-yl)methyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone |
AM-1248 | 335160-66-2 | (1-((1-Methylpiperidin-2-yl)methyl)-1H-indol-3-yl)(adamantan-1-yl)methanone |
AM-2233 | 444912-75-8 | (1-((1-Methylpiperidin-2-yl)methyl)-1H-indol-3-yl)(2-iodophenyl)methanone |
APICA | 1345973-50-3 | N-(1-Adamantyl)-1-pentyl-1H-indole-3-carboxamide |
APINACA | 1345973-53-6 | N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide |
CB-13 | 432047-72-8 | (4-Pentyloxynaphthalen-1-yl)(naphthalen-1-yl)methanone |
CUMYL-THPINACA | 1400742-50-8 | N-(2-Phenylpropan-2-yl)-1-(tetrahydropyran-4-ylmethyl)-1H-indazole-3-carboxamide |
EAM-2201 | 1364933-60-7 | (1-(5-Fluoropentyl)-1H-indol-3-yl)(4-ethylnaphthalen-1-yl)methanone |
FUB-JWH-018 | (1-(4-Fluorobenzyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | |
FUB-PB-22 | 1800098-36-5 | Quinolin-8-yl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate |
JWH-007 | 155471-10-6 | (2-Methyl-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone |
JWH-015 | 155471-08-2 | (2-Methyl-1-propyl-1H-indol-3-yl)(naphthalen-1-yl)methanone |
JWH-019 | 209414-08-4 | (1-Hexyl-1H-indol-3-yl)(naphthalen-1-yl)methanone |
JWH-081 | 210179-46-7 | (1-Pentyl-1H-indol-3-yl)(4-methoxynaphthalen-1-yl)methanone |
JWH-122 | 619294-47-2 | (1-Pentyl-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone |
JWH-203 | 864445-54-5 | 2-(2-Chlorophenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone |
JWH-210 | 824959-81-1 | (1-Pentyl-1H-indol-3-yl)(4-ethylnaphthalen-1-yl)methanone |
JWH-370 | 914458-22-3 | (5-(2-Methylphenyl)-1-pentyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone |
MAM-2201 | 1354631-24-5 | (1-(5-Fluoropentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone |
MDMB-CHMICA | 1715016-78-6 | N-(1-Methoxy-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indole-3-carboxamide |
MDMB-FUBINACA | 1715016-77-5 | N-(1-Methoxy-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide |
PB-22 | 1400742-17-7 | Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate |
PX-2 | N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | |
RCS-4 | 1345966-78-0 | (1-Pentyl-1H-indol-3-yl)(4-methoxyphenyl)methanone |
STS-135 | 1354631-26-7 | N-(1-Adamantyl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide |
UR-144 | 1199943-44-6 | (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone |
2-FMC | 1186137-35-8 | 1-(2-Fluorophenyl)-2-methylaminopropan-1-one |
2-MMC | 1246911-71-6 | 1-(2-Methylphenyl)-2-methylaminopropan-1-one |
3,4-DMMC | 1082110-00-6 | 1-(3,4-Dimethylphenyl)-2-methylaminopropan-1-one |
3-CMC | 1049677-59-9 | 1-(3-Chlorophenyl)-2-methylaminopropan-1-one |
3-MeOMC | 882302-56-9 | 1-(3-Methoxyphenyl)-2-methylaminopropan-1-one |
3-MMC | 1246911-86-3 | 1-(3-Methylphenyl)-2-methylaminopropan-1-one |
4-BMC | 486459-03-4 | 1-(4-Bromophenyl)-2-methylaminopropan-1-one |
4-CMC | 1225843-86-6 | 1-(4-Chlorophenyl)-2-methylaminopropan-1-one |
4-FMC | 447-40-5 | 1-(4-Fluorophenyl)-2-methylaminopropan-1-one |
4-F-α-PVP | 850352-62-4 | 1-(4-Fluorophenyl)-2-(1-pyrrolidinyl)pentan-1-one |
4-MeBP | 1337016-51-9 | 1-(4-Methylphenyl)-2-methylaminobutan-1-one |
4-MeO-α-PVP | 14979-97-6 | 1-(4-Methoxyphenyl)-2-(1-pyrrolidinyl)pentan-1-one |
Buphedrone | 408332-79-6 | 1-Phenyl-2-methylaminobutan-1-one |
Butylone | 802575-11-7 | 1-(3,4-Methylenedioxyphenyl)-2-methylaminobutan-1-one |
Dimethylone | 765231-58-1 | 1-(3,4-Methylenedioxyphenyl)-2-dimethylaminopropan-1-one |
Ethcathinone | 18259-37-5 | 1-Phenyl-2-ethylaminopropan-1-one |
Ethylone | 1112937-64-0 | 1-(3,4-Methylenedioxyphenyl)-2-ethylaminopropan-1-one |
MDPBP | 784985-33-7 | 1-(3,4-Methylenedioxyphenyl)-2-(1-pyrrolidinyl)butan-1-one |
MDPPP | 783241-66-7 | 1-(3,4-Methylenedioxyphenyl)-2-(1-pyrrolidinyl)propan-1-one |
Methedrone | 530-54-1 | 1-(4-Methoxyphenyl)-2-methylaminopropan-1-one |
NEB | 1354631-28-9 | 1-Phenyl-2-ethylaminobutan-1-one |
Pentedrone | 879722-57-3 | 1-Phenyl-2-methylaminopentan-1-one |
α-PBP | 13415-82-2 | 1-Phenyl-2-(1-pyrrolidinyl)butan-1-one |
α-PHP | 13415-86-6 | 1-Phenyl-2-(1-pyrrolidinyl)hexan-1-one |
α-PHPP | 13415-83-3 | 1-Phenyl-2-(1-pyrrolidinyl)heptan-1-one |
α-PVP | 14530-33-7 | 1-Phenyl-2-(1-pyrrolidinyl)pentan-1-one |
α-PVT | 1400742-66-6 | 1-(Thiophen-2-yl)-2-(1-pyrrolidinyl)pentan-1-one |
MXE | 1239943-76-0 | 2-(3-Methoxyphenyl)-2-(ethylamino)cyclohexanone |
NENK | 1354634-10-8 | 2-(2-Chlorophenyl)-2-(ethylamino)cyclohexanone |
5-MeO-DALT | 928822-98-4 | 5-Methoxy-N,N-diallyltryptamine |
5-MeO-DiPT | 4021-34-5 | 5-Methoxy-N,N-diisopropyltryptamine |
5-MeO-DMT | 1019-45-0 | 5-Methoxy-N,N-dimethyltryptamine |
5-MeO-MiPT | 96096-55-8 | 5-Methoxy-N-isopropyl-N-methyltryptamine |
AMT | 299-26-3 | alpha-Methyltryptamine |
DBZP | 1034-11-3 | 1,4-Dibenzylpiperazine |
mCPP | 6640-24-0 | 1-(3-Chlorophenyl)piperazine |
TFMPP | 15532-75-9 | 1-(3-Trifluoromethylphenyl)piperazine |
2-AI | 2975-41-9 | 2-Aminoindane |
MDAI | 132741-81-2 | 5,6-Methylenedioxy-2-aminoindane |
2-DPMP | 519-74-4 | 2-Diphenylmethylpiperidine |
3,4-CTMP | 1400742-68-8 | Methyl 2-(3,4-dichlorophenyl)-2-(piperidin-2-yl)acetate |
Acetylfentanyl | 3258-84-2 | N-(1-Phenethylpiperidin-4-yl)-N-phenylacetamide |
AH-7921 | 55154-30-8 | 3,4-Dichloro-N-((1-(dimethylamino)cyclohexyl)methyl)benzamide |
Butyrylfentanyl | 1169-70-6 | N-(1-Phenethylpiperidin-4-yl)-N-phenylbutyramide |
Ethylphenidate | 57413-43-1 | Ethyl 2-phenyl-2-(piperidin-2-yl)acetate |
Methoxphenidine | 127529-46-8 | 1-(1-(2-Methoxyphenyl)-2-phenylethyl)piperidine |
Phenazepam | 51753-57-2 | 7-Bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one |
β-Hydroxythiofentanyl | 1474-34-6 | N-(1-(2-Hydroxy-2-(thiophen-2-yl)ethyl)piperidin-4-yl)-N-phenylpropanamide |
4-Fluorobutyrfentanyl | 244195-31-1 | N-(4-Fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide |
Isobutyrfentanyl | 119618-70-1 | N-(1-Phenethylpiperidin-4-yl)-N-phenylisobutyramide |
Ocfentanyl | 101343-69-5 |
Compounds banned in Japan as of September 2015
[edit]As well as the long list of specifically listed compounds, this also includes analogue provisions covering many additional compounds. Again several older designer drugs such as mephedrone and JWH-018 are not listed here as they were already banned, but they fall within the scope of the analogue provisions defined here.[6] Updated 2016
Common name | CAS number | Chemical name |
---|---|---|
isobutyl nitrite | ||
isopropyl nitrite | ||
amyl nitrite | ||
t-butyl nitrite | ||
cyclohexyl nitrite | ||
n-butyl nitrite | ||
4-AcO-MiPT | ||
4-AcO-MET | ||
4-AcO-DALT | ||
4-AcO-DiPT | ||
4-AcO-DET | ||
4-AcO-DMT | ||
FUB-APINACA | ||
5F-APINACA | ||
5F-APICA | ||
APINACA | ||
AB-001 | ||
APICA (2NE1) | ||
AM-1248 | ||
FU-PX-2 | ||
PX-2 | ||
PX-1 | ||
ADB-CHMINACA | ||
ADB-FUBINACA | ||
5F-ADB-PINACA | ||
5F-ADBICA | ||
ADB-PINACA | ||
ADBICA | ||
bk-2C-B | ||
5"-Cl-AB-PINACA | ||
AB-CHMINACA | ||
AB-FUBINACA | ||
5F-AB-PINACA | ||
5F-ABICA | ||
AB-PINACA | ||
Allylescaline | ||
Aleph-4 | ||
MiPT | ||
5-MeO-MiPT | ||
2-AI | ||
5-PPDI (3,4-trimethylene-alpha-PBP) | ||
5-BPDI (3,4-trimethylene-alpha-PVP) | ||
despentyl-UR-144 | ||
5-IT | ||
bk-IBP (3,4-trimethylene-NEB) | ||
bk-IVP (3,4-trimethylene-NEP) | ||
Methoxetamine | ||
5-MeO-EiPT | ||
2C-E | ||
NBOMe-2C-E | ||
Aleph-2 | ||
4-HO-MET | ||
5-MeO-EPT | ||
PMEA | ||
3C-E | ||
Phthalimidopropiophenone | ||
BB-22 | ||
FUB-NPB-22 (FUB-PB-22 indazole) | ||
FUB-PB-22 | ||
5F-NPB-22 | ||
PB-22 | ||
Org 27569 | ||
2C-C | ||
C30-NBOMe | ||
NBF-2C-C | ||
DOC | ||
NBOMe-2C-C | ||
NBOH-2C-C | ||
4-chloroamphetamine | ||
JWH-203 | ||
Salvinorin A | ||
DiPT | ||
Dimethocaine | ||
4-HO-DET | ||
5-MeO-DET | ||
MT-45 | ||
CHMINACA-BA (O-desmethyl-MMB-CHMINACA) | ||
AH-7921 | ||
2,3-DCPP | 1-(2,3-dichlorophenyl)piperazine | |
3,4-CTMP | ||
Diclofensine | ||
5-DBFPV (dihydrobenzofuran-5-yl-alpha-PVP) | ||
5-APDB | ||
6-APDB | ||
Diphenidine | ||
Diphenylprolinol | ||
Desoxy-D2PM | ||
DPT | ||
3,4-dimethyl-NEB | ||
3,4-dimethyl-NEP | ||
3,4-dimethyl-alpha-PVP | ||
2C-N | ||
DON | ||
2C-H | ||
DL-4662 (3,4-dimethoxy-NEP) | ||
3,4-dimethoxy-alpha-PHP | ||
3,4-dimethoxy-alpha-PVP | ||
NBOMe-2C-H | ||
2C-P | ||
A-834,735 | ||
XLR-12 (TFB-UR-144) | ||
UR-144 | ||
2C-C-3 | 2,5-dimethoxy-3,4,6-trichlorophenethylamine | |
TMA-6 | ||
Naphyrone | ||
FDU-PB-22 | naphthalen-1-yl 1-(4-fluorobenzyl)indole-3-carboxylate | |
5F-SDB-005 | naphthalen-1-yl 1-(5-fluoropentyl)indazole-3-carboxylate | |
5F-NNE1 | N-(naphthalen-1-yl)-1-(5-fluoropentyl)indole-3-carboxamide | |
NM-2201 | naphthalen-1-yl 1-(5-fluoropentyl)indole-3-carboxylate | |
THJ-018 | ||
MN-18 (NNE1 indazole) | ||
SDB-005 | naphthalen-1-yl 1-pentylindazole-3-carboxylate | |
NNE1 | ||
CB-13 | ||
EG-018 | naphthalen-1-yl(9-pentyl-9H-carbazol-3-yl)methanone | |
JWH-030 | ||
JWH-145 | ||
BiPICANA | bis(1-pentylindol-3-ylmethanoyl)-1-naphthylamine | |
4-HO-MiPT | ||
4-HO-DiPT | ||
CP 47,497 | ||
alpha-PBT | ||
alpha-PVT | ||
Ethylphenidate | ||
PPBO (alpha-PBP piperidine homologue) | ||
Prolintane | ||
Acetylfentanyl | ||
4-F-IVP (4-fluoro-N-isopropylpentedrone) | ||
pFPP | ||
4-F-alpha-PVP piperidine homologue | ||
2-FA | ||
3-FA | ||
4-FA | ||
JWH-307 | ||
JWH-368 | ||
2-FMA | ||
3-FMA | ||
4-FMA | ||
FUB-UR-144 | ||
FDU-NNE1 | N-(naphthalen-1-yl)-1-(4-fluorobenzyl)indole-3-carboxamide | |
NBF-2C-I | ||
THJ-2201 | ||
5-fluoropentyl-3-pyridinoylindole | ||
AM-694 | ||
5F-MN-18 (5F-NNE1 indazole) | ||
CUMYL-5F-PINACA | ||
CUMYL-5F-PICA | ||
FUBIMINA | ||
NBF-2C-B | ||
NBOMe-2C-B | ||
Bromo-dragonfly | ||
BMDP (Benzylone) | ||
4-benzylpiperidine | ||
5F-SDB-006 | ||
SDB-006 | ||
MBZP | ||
2-EAPB | ||
5-EAPB | ||
2-APB | ||
5-APB | ||
6-APB | ||
2-MAPB | ||
5-MAPB | ||
CUMYL-PINACA | ||
CUMYL-PICA | ||
AM-1220 azepane | ||
3,4-DMMC | ||
Methiopropamine | ||
Mephtetramine | ||
N-methyl-2-AI | ||
MDMB-CHMINACA | ||
MMB-CHMINACA (MA-CHMINACA) | ||
MDMB-CHMICA | ||
Methamnetamine | N-methyl-1-(naphthalen-2-yl)propan-2-amine | |
MEPIRAPIM | ||
AM-1220 | ||
4-MA | ||
JWH-251 | ||
3-Me-BZP | 1-(3-methylbenzyl)piperazine | |
MDMB-FUBINACA (FUB-ADB) | ||
FUB-AMB | ||
5F-ADB | ||
5F-AMB | ||
MMB-2201 (5F-AMB indole) | ||
4,4'-DMAR | ||
AMB | ||
HMDMA | N-methyl-1-(3,4-methylenedioxyphenyl)-3-methylpropan-3-amine | |
MDAI | ||
BDB | ||
MDBZP | ||
5-MeO-AMT | ||
A-836,339 | ||
5-MeO-DPT | ||
5-MeO-DMT | ||
3'-MeO-PCP | ||
4'-MeO-PCP | ||
MeOPP | ||
Methoxphenidine | ||
JWH-250 | ||
ortho-RCS-4 | ||
RCS-4 | ||
Cannabipiperidiethanone | ||
RH-34 | ||
NBOMe-2C-D | ||
5-MeO-2,N,N-TMT | ||
MMDA-2 | ||
N-methyl-bk-MMDA-2 | ||
JWH-200 | ||
5-IAI | ||
DOI | ||
NB34MD-2C-I | ||
NBOMe-2C-I | ||
AM-1241 | ||
AM-679 | ||
AM-2233 | ||
AM-2233 azepane | ||
JWH-210 | ||
JWH-213 | ||
JWH-398 | ||
JWH-022 | ||
AM-2232 | ||
JWH-019 | ||
JWH-182 | ||
JWH-122 pentenyl | ||
JWH-015 | ||
JWH-007 | ||
JWH-081 | ||
N-ethylbuphedrone (NEB) | ||
4-MEC | ||
4-EMC | ||
4-methyldibuphedrone | ||
Dimethylone | ||
alpha-PBP | ||
3-FMC | ||
4-FMC | ||
4-BMC | ||
Buphedrone | ||
Pentedrone | ||
4-methylbuphedrone | ||
Butylone | ||
Pentylone | ||
4-MePPP | ||
MDPBP | ||
MDPPP | ||
Dimethedrone | ||
4-MeO-alpha-PVP | ||
Methedrone | ||
4-methyl-N-ethylhexedrone | ||
alpha-POP | 1-phenyl-2-(pyrrolidin-1-yl)octan-1-one | |
alpha-PNP | 1-phenyl-2-(pyrrolidin-1-yl)nonan-1-one | |
alpha-PHP | 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one | |
alpha-PHPP | 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one | |
4-F-alpha-POP | ||
4-F-alpha-PHPP | ||
4-F-octedrone | N-methyl-1-(4-fluorophenyl)-2-aminooctan-1-one | |
4-F-hexedrone | ||
MPHP | ||
MDPHP | ||
4-MeO-alpha-POP | ||
4-MeO-alpha-PHPP |
Vermont Regulated Drugs Rule effective January 2016
[edit]Most recent update here.[7] Note some entries are for analogue provisions and have been omitted from this list. Plant products and mixtures have also been omitted. This list includes many classical illegal drugs as well as a wide range of NPS. Newer update [2]
Common name | CAS number | Chemical name |
---|---|---|
2-AI | 2-Aminoindane | |
2-DPMPy | 2-diphenylmethylpyrrolidine | |
2-DPMP | 2-diphenylmethylpiperidine | |
2-FMA | 2-fluoromethamphetamine | |
2-FMC | 2-fluoromethcathinone | |
2-MMC | 2-methylmethcathinone | |
3-FMC | 3-fluoromethcathinone | |
3,4-DMMC | 3,4-dimethylmethcathinone | |
MDMA | 3,4-methylenedioxy-methamphetamine | |
Methylone | 3,4-methylenedioxy-N-methylcathinone | |
MDPV | 3,4-methylenedioxypyrovalerone | |
4-BMC | 4-bromomethcathinone | |
Clephedrone | 4-chloromethcathinone | |
4-EMC | 4-ethylmethcathinone | |
4-FA | 4-fluoroamphetamine | |
4-FMA | 4-fluoromethamphetamine | |
4-FMC | 4-fluoromethcathinone | |
pFPP | 4-fluorophenylpiperazine | |
Benzedrone | (±)-1-(4-methylphenyl)-2-(benzylamino)propan-1-one | |
4-MEC | 4-methyl-N-ethylcathinone | |
4-MPD | 4-Methyl-Pentedrone | |
5-IAI | 5-Iodo-2-Aminoindane | |
5-ME | 5-methyl-ethylone | |
a-ethylaminopentiophenone | N-ethylpentedrone | |
a-PBP | (RS)1-phenyl-2-(1-pyrrolidinyl)-1-pentanone | |
a-PPP | alpha-pyrrolidinopropiophenone | |
a-PVP | 1- phenyl-2-(1-pyrrolidinyl)-1-pentanone | |
Amphetamine | ||
Benzphetamine | ||
bk-2C-B | bk-4 Bromo-2,5-dimethoxyphenethylamine | |
BZP | N-benzylpiperazine | |
Buphedrone | 2-(methylamino)-1-phenylbutan-1-one | |
Butylone | beta-Keto-N-methyl-3,4-benzodioxyolybutanamine | |
Cathine | ||
Cathinone | ||
Chlorphentermine | ||
Clortermine | ||
D2PM | diphenyl-2-pyrrolidinyl-methanol | |
DBZP | 1,4-dibenzylpiperazine | |
Diethylpropion | N,N-diethylcathinone | |
Dimethocaine | (3-diethylamino-2,2-dimethylpropyl)-4-aminobenzoate | |
Ethcathinone | 2-ethylamino-1-phenyl-propan-1-one | |
Ethylone | 3,4-methylenedioxy-N-ethylcathinone | |
Eutylone | beta-Keto-Ethylbenziodioxolylbutanamine | |
3-MeOMC | 3-methoxymethcathinone | |
Gamma butyrolactone | ||
Gamma hydroxybutyric acid | ||
Dimethylone | ||
4-MePPP | 4-methyl-alpha-pyrrolidinopropiophenone | |
MBPV (5-DBFPN) | 1-(2,3-dihydrobenzofuran-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one | |
MBZP | 1-methyl-4-benzylpiperazine | |
mCPP | 1-(3-chlorophenyl)piperazine | |
MDAI | 5,6-methylenedioxy-2-aminoindane | |
MDAT | 6,7-methylenedioxy-2-aminotetralin | |
MDPBP | 3,4-methylenedioxy-alpha-pyrrolidinobutiophenone | |
MDPPP | (RS)-1-(3,4- methylenedioxyphenyl)-2-(1-pyrrolidinyl)-1-propanone | |
Methiopropamine (MPA) | ||
MeOPP | 1-(4-methoxyphenyl)piperazine | |
Mitragynine | ||
MOPPP | 4-methoxy-alpha-pyrrolidinopropiophenone | |
MPBP | 4-methyl-alpha-pyrrolidinobutyrophenone | |
Mazindol | ||
Mephedrone | ||
Mephtetramine | ||
Methamphetamine | ||
Methcathinone | ||
Metamfepramone | N,N-dimethylcathinone | |
Methedrone | (RS)-1-(4-methoxyphenyl)-2-(methylamino)propan-1-one | |
Methylphenidate | ||
MT-45 | 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine | |
Naphyrone | naphthylpyrovalerone | |
NRG-2 | ?? | |
NM2AI | N-Methyl-2-Aminoindane | |
Pemoline (including organometallic complexes and chelates thereof) | ||
Pentedrone | 2-(methylamino)-1-phenyl-1-pentanone | |
Pentylone | beta-Keto-N-methylbenzodioxolylpentanamine | |
Phendimetrazine | ||
Phenmetrazine | ||
Phentermine | ||
Pyrovalerone | ||
TFMPP | 1-[3-(trifluoromethyl)phenyl]piperazine | |
Alprazolam | ||
Barbituric acid and its derivatives | ||
Chloral betaine | ||
Chloral Hydrate | ||
Chlorexadol | ||
Clonazepam | ||
Clorazepate | ||
Clordiazepoxide | ||
Diazepam | ||
Ethchlorvynol | ||
Ethinamate | ||
Fenfluramine | ||
Flurazepam | ||
Glutethimide | ||
Ketamine | ||
Lorazepam | ||
Lysergic acid | ||
Lysergic acid amide | ||
Mebutamate | ||
Mecloqualone | ||
Meprobamate | ||
Methaqualone | ||
Methyprylon | ||
Oxazepam | ||
Paraldehyde | ||
Petrichloral | ||
Phenazepam | ||
Phencyclidine | ||
Sulfondiethylmethane | ||
Sulfonethylmethane | ||
Sulfonmethane | ||
Temazepam | ||
Triazolam | ||
Acetorphine | ||
Acetyldihydrocodeine | ||
Acetyl-fentanyl | ||
Acetylmethadol | ||
Allylprodine | ||
Alphacetylmethadol | ||
Alphameprodine | ||
Alphamethadol | ||
Alphaprodine | ||
Anileridine | ||
Benzethidine | ||
Benzylmorphine | ||
Betacetylmethadol | ||
Betameprodine | ||
Betamethadol | ||
Betaprodine | ||
Bezitramide | ||
Buprenorphine | ||
Clonitazene | ||
Cocaine | ||
Codeine | ||
Codeine methylbromide | ||
Codeine-N-Oxide | ||
Cyprenorphine | ||
Desomorphine | ||
Dextromoramide | ||
Diampromide | ||
RTI-111 | methyl (1R,2S,3S,5S)-3-(3,4-dichloropheny;)-8-azabicyclo[3.2.1]octane-2-carboxylate | |
Diethylthiambutene | ||
Difenoxin | ||
Dihydrocodeine | ||
Dihydromorphine | ||
Dimenoxadol | ||
Dimepheptanol | ||
Dimethylthiambutene | ||
Dioxaphetyl butyrate | ||
Diphenoxylate | ||
Dipipanone | ||
Drotebanol | ||
Ethylmethylthiambutene | ||
Ethylmorphine | ||
Etonitazene | ||
Etorphine | ||
Etoxeridine | ||
Fentanyl | ||
Furethidine | ||
Heroin | ||
Hydrocodone | ||
Hydromorphinol | ||
Hydromorphone | ||
Hydroxypethidine | ||
Isomethadone | ||
Ketobemidone | ||
Levomethorphan | ||
Levomoramide | ||
Levophenacylmorphan | ||
Levorphanol | ||
Metazocine | ||
Methadone | ||
Methadone-Intermediate | 4-cyano-2-dimethylamino-4, 4-diphenyl butane | |
Methyldesorphine | ||
Methyldihydromorphine | ||
Methopholine | 1-[2-(4-chlorophenyl)ethyl]-6,7-dimethoxy-2-methyl-1,2,3,4 tetrahydroisoquinoline | |
Metopon | ||
Moramide-Intermediate | 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid | |
Morpheridine | ||
Morphine | ||
Morphine methylbromide | ||
Morphine methylsulfonate | ||
Morphine-N-Oxide | ||
Myrophine | ||
Nicocodeine | ||
Nicomorphine | ||
Noracymethadol | ||
Norlevorphanol | ||
Normethadone | ||
Normorphine | ||
Norpipanone | ||
o-desmethyltramadol | 3-[2-(1-Amino-1-methylethyl)-1-hydroxycyclohexyl]phenol | |
Oxycodone | ||
Oxymorphone | ||
Pentazocine | ||
Pethidine | ||
Pethidine-Intermediate- A | 4-cyano-1-methyl-4-phenylpiperdine | |
Pethidine-Intermediate-B | ethyl-4-phenylpiperidine-4-carboxylate | |
Pethidine-Intermediate-C | 1-methyl-4-phenylpiperidine-4-carboxylic acid | |
Phenadoxone | ||
Phenampromide | ||
Phenazocine | ||
Phenomorphan | ||
Phenoperidine | ||
Pholcodine | ||
Piminodine | ||
Piritramide | ||
Proheptazine | ||
Properidine | ||
Propiram | ||
Propoxyphene | ||
Racemethorphan | ||
Racemoramide | ||
Racemorphan | ||
Thebacon | ||
Thebaine | ||
Tilidine | ||
Tramadol | ||
Trimeperidine | ||
Methoxypiperamide | 1-(4-methoxybenzoyl)-4-methylpiperazine | |
2,5-DMA | 2,5-dimethoxyamphetamine | |
Methoxyketamine | ||
2C-B | 4-bromo-2,5-dimethoxy-benzeneethanamine | |
2C-C | 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine | |
2C-D | 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine | |
2C-E | 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine | |
2C-H | 2-(2,5-Dimethoxyphenyl)ethanamine | |
2C-I | 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine | |
2C-N | 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine | |
2C-P | 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine | |
2C-T-2 | 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine | |
2C-T-4 | 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine | |
2C-T-7 | 2,5-dimethoxy-4-(propylthio)-benzeneethanamine, monohydrochloride | |
2C-TFM-NBOMe | 2-(4-trifluoromethyl-2,5-dimethoxyphenyl)-N-[(2- methoxyphenyl)methyl]ethanamine | |
2CBCB-NBOMe | N-(2-methoxybenzyl)-1-[(7R)-3-bromo-2,5-dimethoxybicyclo[4.2.0]octa- 1,3,5-trien-7-yl]methanamine | |
2CBFly-NBOMe | N-(2-Methoxybenzyl)-1-(8-bromo-2,3,6,7-tetrahydrobenzo[1,2-b:4,5- b’]difuran-4-yl)-2-aminoethane | |
3,4,5-trimethoxy amphetamine | ||
MDA | 3,4-methylenedioxy amphetamine | |
3'-HO-PCE | 3-[1-(ethylamino)cyclohexyl]phenol | |
3'-HO-PCP | ||
3'-MeO-PCP | 1-[1-(3-methoxyphenyl)cyclohexyl]-piperidine | |
4-AcO-DET | 3-(2-Diethylaminoethyl)-1H-indol-4-yl acetate | |
4-AcO-DMT | 3-[2-(Dimethylamino)ethyl]-1H-indol-4-yl acetate | |
4-AcO-DPT | ||
4-AcO-MET | 3-(2-Ethyl(methyl)aminoethyl)-1H-indol-4-yl acetate | |
DOB | 4-bromo-2, 5-dimethoxyamphetamine | |
4-HO-MET | 3-(2-(ethyl(methyl)amino)ethyl)-1H-indol-4-ol | |
4-HO-MIPT | 3-(2-[Isopropyl(methyl)amino]ethyl)-1H-indol-4-ol | |
4-HO-MPMI | (R)-3-(N-methylpyrrolidin-2-ylmethyl)-4-hydoxyindole | |
4-HO-MPT | 3-{2-[methyl(propyl)amino]ethyl}-1H-indol-4-ol | |
4-MeO-AET | ||
4-MeO-MIPT | ||
4'-MeO-PCP | 1-[1-(4-methoxyphenyl)cyclohexyl]-piperidine | |
PMA | 4-methoxyamphetamine | |
DOM | 4-methyl-2, 5-dimethoxyamphetamine | |
4-methyl-AET | ||
5-APB | 5-(2-aminopropyl)benzofuran | |
5-EAPB | 5-(2-Ethylaminopropyl)Benzofuran | |
5F-AMB | ||
5F-ADBICA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide | |
5F-AKB48 (5F-APINACA) | N-((3s,5s,7s)-adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | |
5F-MN-018 | N-1-naphthalenyl-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | |
5F-MN24 (5F-NNE1) | 1-(5-fluoropentyl)-N-(naphthalen-1-yl)-1H-indole-3-carboxamide | |
5F-SDB-005 | naphthalen-1-yl 1-(5-fluoropentyl)-1H-indazole-3-carboxylate | |
5F-THJ-2201 | (1-(5-fluoropentyl)-1H-indazol-3-yl)(naphthalen-1-yl)methanone | |
AB-FUBINACA | ||
5F-AB-PINACA | (S)-N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | |
5F-PB-22 | 1-(5-fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid | |
5F-SDB-006 | N-benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide | |
5-IT | 5-(2-aminopropyl)indole | |
5-MAPB | 5-(2-Methylaminopropyl) Benzofuran | |
5-MeO-AMT | 1-(5-methoxy-1H-indol-3-yl)propan-2-amine | |
5-MeO-DALT | N-ally1-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-en-1-amine | |
5-MeO-DET | N,N-Diethyl-5-Methoxytryptamine | |
5-MeO-DIPT | 3-[2-(Diisopropylamino)ethyl]-5-methoxyindole | |
5-MeO-DMT | 2-(5-methoxy-1H-indol-3-yl)-N,N-dimethylethanamine | |
5-MeO-DPT | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-propylpropan-1-amine | |
5-MeO-MDA | 5-methoxy-3, 4-methylenedioxy amphetamine | |
5-MeO-MIPT | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amine | |
5-MeO-MPMI | (R)-3-(N-methylpyrrolidin-2-ylmethyl)-5-methoxyindole | |
5F-UR-144 (XLR-11) | (5-fluoropentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone | |
6-APB | 6-(2-aminopropyl)benzofuran | |
7-hydroxymitragynine | (αE,2S,3S,7aS,12bS)-3-Ethyl-1,2,3,4,6,7,7a,12b-octahydro-7a- hydroxy-8-methoxy-α-(methoxymethylene)indolo[2,3-a]quinolizine-2-acetic acid methyl ester | |
NBOMe-2C-B | 2-(4-bromo-2,5-dimethoxyphenyl)-N- [(2-methoxyphenyl)methyl]ethanamine | |
NBOMe-2C-C | 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine | |
25I-NBF | 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-fluorophenyl)methyl]ethanamine | |
NBMD-2C-I | 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2,3-methylenedioxyphenyl)methyl]ethanamine | |
25I-NBOH | 2-((2-(4-iodo-2,5-dimethoxyphenyl)ethylamino)methyl)phenol | |
25I-NBOMe | 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine | |
A1 dodeca-2E, 4E, 8Z, 10Z – tetraenoic acid isobutyl amide | ?? | |
A2 dodeca-2E, 4E, dienoic acid idobutylamide | ?? | |
A-796,260 | 1-(2-morpholin-4-ylethyl)-1H-indol-3-yl]-(2,2,3,3 tetramethylcyclopropyl) methanone | |
A-834,735 | 1-(tetrahydropyran-4-ylmethyl)-1H-indol-3-yl]-(2,2,3,3- tetramethylcyclopropyl)methanone | |
A-836,339 | N-[3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2-ylidene]-2,2,3,3- tetramethylcyclopropane-1-carboxamide | |
AB-001 | 1-pentyl-3-(1-adamantoyl) indole | |
AB-034 | [1-[(N-methylpiperidin-2-yl)methyl]-1H-indole-3-yl]-(2,2,3,3- tetramethylcyclopropyl)methanone | |
AB-CHMINACA | N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide | |
AB-PINACA | (S)-N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide | |
ACEA | N-(2-chloroethyl)-5Z,8Z,11Z,14Z-eicosatetraenamide | |
ACPA | N-cyclopropyl-5Z,8Z,11Z,14Z-eicosatetraenamide | |
ADBICA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indole-3-carboxamide | |
AH-7921 | 3,4-dichloro-N-[(1dimethylamino)cyclohexylmethyl]benzamide | |
AKB-48 (APINACA) | N-adamantyl-1-pentylindazole-3-carboxamide | |
AL-LAD | 6-Allyl-6-nor-lysergic acid diethylamide | |
AM-630 | [6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl)-methanone | |
AM-679 | 1-pentyl-3-(2-iodobenzoyl)indole | |
AM-694 | 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole | |
AM-1220 | (R)-(1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)(naphthalen-1- yl)methanone | |
AM-1241 | 1-(methylpiperidin-2-ylmethyl)-3-(2-iodo-5-nitrobenzoyl)indole | |
AM-1248 | 1-[(N-methylpiperidin-2-yl)methyl]-3-(adamant-1-oyl)indole | |
AM-2201 | 1-(5-fluoropentyl)-3-(1-naphthoyl)indole | |
AM-2233 | 1-[(N-methylpiperidin-2-yl)methyl]-3-(2-iodobenzoyl)indole | |
AM-4113 | ||
AMT | a-methyltryptamine | |
ASDB-FUB-187 | ||
BAY 38-7271 | (-)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluorobutyl-1- sulfonate | |
Bufotenine | 3-(N,N-dimethylaminoethyl) 5-hydroxyindole | |
CB-13 | Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone | |
CP 47,497 | ||
(C6)-CP 47,497 | ||
(C9)-CP 47,497 | ||
CP 50,556-1 (Levonantradol) | 9-hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy- 5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl]acetate | |
CP 55,940 | 2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl]-5-(2- methyloctan-2-yl)phenol | |
(C8)-CP 47,497 | ||
DET | N,N-Diethyltryptamine | |
Dextrorphan | ||
DIPT | Diisopropyltryptamine | |
DMT | Dimethyltryptamine | |
DPT | N,N,-dipropyltryptamine | |
EAM-2201 | (4-ethyl-1-naphthalenyl)[1-(5-fluoropentyl)-1H-indol-3-yl]-methanone | |
EG-018 | naphthalen-1-yl(9-pentyl-9H-carbazol-3-yl)methanone | |
Ethyl-ketamine | 2-(2-chlorophenyl)-2-(ethylamino)cyclohexanone | |
FDU-PB-22 | naphthalen-1-yl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate | |
FAB-144 | (1-(5-fluoropentyl)-1H-indazol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | |
F-UPB-22 | ?? | |
FUB-AKB48 | N-((3s,5s,7s)-adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide | |
FUB-PB22 | quinolin-8-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate | |
FUBIMINA | (1-(5-fluoropentyl)-1H-benzo[d]imidazol-2-yl)(naphthalen-1-yl)methanone | |
HDMP-28 | Methylnaphthidate | |
HU-210 | (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | |
HU-211 | (6aS, 10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | |
HU-243 | 3-dimethylheptyl-11-hydroxyhexahydrocannabinol | |
HU-308 | [(91R,2R,5R)-2-[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-7,7-dimethyl-4- bicyclo[3.1.1]hept-3-enyl]methanol | |
HU-331 | 3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl- 2,5-cyclohexadiene-1,4-dione | |
Ibogaine | 7-Ethyl-6,6a,7,8,9,10,12,3-octahydro-2-methoxy-6,9-methano-5H-pyrido([1’,2’:1,2]azepine[4,5-b])indole | |
JTE-907 | N-(benzol[1,3]dioxol-5-ylmethyl)-7-methoxy-2-oxo-8-pentyloxy-1,2-dihydroquinoline-3-carboxamide | |
JWH-007 | 1-pentyl-2-methyl-3-(1-naphthoyl)indole | |
JWH-015 | (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone | |
JWH-016 | (1-butyl-2-methyl-1H-indol-3-yl)-1-naphthalenyl-methanone) | |
JWH-018 | Naphthalen-1-yl-(1-pentylindol-3-yl)methanone | |
JWH-019 | napthanlen-1-yl-(1-pentylindol-3-yl)methanone | |
JWH-022 | 1-naphthalenyl[1-(4-penten-1-yl)-1H-indol-3-yl]-methanone | |
JWH-030 | naphthalen-1-yl-(1-pentylpyrrol- 3-yl)methanone | |
JWH-073 | naphthalen-1-yl-(1-butylindol-3-yl)methanone | |
JWH-081 | 4-methoxynapthalen-1-yl-(1-pentylindol-3-yl)methanone | |
JWH-098 | 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole | |
JWH-122 | 1-pentyl-3-(4-methyl-1-naphthoyl)indole | |
JWH-147 | (1-hexyl-5-phenyl-1H-pyrrol-3-yl)-1-naphthalenyl-methanone | |
JWH-164 | 1-pentyl-3-(7-methoxy-1-naphthoyl)indole | |
JWH-167 | 1-pentyl-3-(phenylacetyl)indole | |
JWH-175 | 3-(napthalen-1-ylmethyl)-1-pentyl-1H-indole | |
JWH-176 | E-1-[1-(1-Naphthalenylmethylene)-1H-inden-3-yl]pentane | |
JWH-184 | 1-Pentyl-1H-indol-3-yl-(4-methyl-1-naphthyl)methane | |
JWH-199 | ||
JWH-200 (WIN 55,225) | (1-(2-morpholin-4-ylethyl)indol-3-yl)-naphthalen-1-ylmethanone | |
JWH-201 | 1-pentyl-3-(4-methoxyphenylacetyl)indole | |
JWH-203 | 1-pentyl-3-(2-chlorophenylacetyl)indole | |
JWH-210 | 1-pentyl-3-(4-ethyl-1-naphthoyl)indole | |
JWH-250 | 1-pentyl-3-(2-methoxyphenylacetyl)indole | |
JWH-251 | 1-pentyl-3-(2-methylphenylacetyl)indole | |
JWH-302 | 2-(3-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)-ethanone | |
JWH-307 | (5-(2-fluorophenyl)-1-pent ylpyrrol-3-yl)-naphthalen-1-ylmethanone | |
JWH-370 | [5-(2-methylphenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naphthalenyl-methanone | |
JWH-398 | 1-pentyl-3-(4-chloro-1-naphthoyl)indole | |
L-759,633 | 3-(1,1-dimethylheptyl)-6aR,7,10,10aR-tetrahydro-1-methoxy-6,6,9-trimethyl-6H-dibenzo[b,d]pyran | |
L-759,656 | ||
Lysergic acid dimethylamide | ||
LSZ | Lysergic acid 2,4-dimethylazetidide | |
MAM-2201 | 4-methyl-1-naphthalenyl(1-fluoropentyl-1H-indol-3-yl)methanone | |
MIPT | N-isopropyl-N-methyltryptamine | |
MMB-CHMINACA | methyl (1-(cyclohexylmethyl)-1H-indazole-3-carbonyl)-L-valinate | |
MDMB-CHMINACA | N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl-L-valine, methyl ester | |
Mepirapim | (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone, monohydrochloride | |
Mescaline | 3,4,5-trimethoxyphenethylamine | |
Methoxetamine (MXE) | (RS)2-(3-methoxyphenyl)-2- (ethylamino)cyclohexanone | |
MMB-2201 | methyl (1-(5-fluoropentyl)-1H-indole-3-carbonyl)-L-valinate | |
MDMB-CHMICA | (2S)-methyl-2-(1-(cyclohexylmethyl)-1H-indol-3-ylcarbonylamino)-3,3-dimethylbutanoate | |
MN-18 | N-1-naphthalenyl-1-pentyl-1H-indazole-3-carboxamide | |
MN-24 (NNE1) | N-1-naphthalenyl-1-pentyl-1H-indole-3-carboxamide | |
N-ethyl-3 piperidyl benzilate | ||
N-methyl-3-piperidyl benzilate | ||
NM-2201 | ||
Psilocybin | ||
Psilocin | 4-OH-DMT | |
RCS-4 | [(4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone] | |
RCS-8 | 1-(2-(2-cyclohexylethyl)-1H-indol-3-yl)-2-(2-methyoxyphenylethanone) | |
STS-135 | N-adamantyl-1-pentylindazole-3-carboxamide | |
Salvinorin A | ||
SDB-005 | naphthalen-1-yl 1-pentyl-1H-indazole-3-carboxylate | |
SR 144528 | 5-(4-chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-pyrazole-3-carboxamide | |
STS-144 | (1-(5-fluoropentyl)-1H-indol-3-yl)(pyridin-3-yl)methanone | |
THJ-018 | 1-naphthalenyl(1-pentyl-1H-indazol-3-yl)-methanone | |
THJ-2201 | 1-naphthalenyl[1-(5-fluoropentyl)-1H-indazol-3-yl]-methanone | |
Tetrahydrocannabinols (all isomers) | tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol | |
TCP | 1-[1-(2-thienyl)cyclohexyl]piperidine | |
UR-144 | (1-Pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone | |
URB-597 | [3-(3-carbamoylphenyl)phenyl]-N-cyclohexylcarbamate | |
URB-602 | Cyclohexyl [1,1’-biphenyl]-3-ylcarbamate | |
URB-754 | 6-methyl-2-[(4-methylphenyl)amino]-4H-3,1-benzoxazin-4-one | |
URB-937 | 3’-carbamoyl-6-hydroxy-[1,1’-biphenyl]-3-yl cyclohexylcarbamate | |
Viminol | 1-[1-(2-chlorobenzyl)- 1H-pyrrol-2-yl]- 2-(di-sec-butylamino) ethanol | |
W-15 | (E)-4-chloro-N-(1-phenethylpiperidin-2-ylidene)benzenesulfonamide | |
Pravadoline (WIN 48,098) | (4-methoxyphenyl)-[2-methyl-1-(2-morpholin-4-ylethyl)indol-3-yl]methanone | |
WIN 55,212-2 | (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-napthalenylmethanone |
Hungary from September 2015
[edit]Common name | CAS number | Chemical name | Jurisdictions controlled |
---|---|---|---|
alpha-naphyrone | 1-(naphthalen-1-yl)-2-(pyrrolidin-1-yl)pentan-1-one | Hungary | |
bis-NBOMe-2C-B | N,N-bis(2-methoxybenzyl)-1-(2,5-dimethoxy-4-bromophenyl)-2-ethanamine | Hungary | |
NBOMe-2C-B | 1026511-90-9 | 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine | Alabama, China, Germany, Hungary, Japan, Latvia, Sweden, UK, Vermont |
NBOMe-2C-C | Hungary | ||
NBF-2C-I | Hungary, Japan, Latvia, Vermont | ||
NBOMe-2C-I | Hungary | ||
2C-C | 88441-14-9 | 4-Chloro-2,5-dimethoxyphenethylamine | Alabama, China, Germany, Hungary, Japan, Latvia, Sweden, UK, Vermont |
2C-D | Hungary | ||
2C-E | Hungary | ||
2C-I | Hungary | ||
2C-P | Hungary | ||
2C-TFM | Hungary | ||
2-DPMP | Hungary | ||
2-FMC | Hungary | ||
2-MPA | Hungary | ||
2-PEA | 2-phenethylamine | Hungary | |
3,4-CTMP | Hungary | ||
3,4-DMEC | Hungary | ||
3,4-DMMC | Hungary | ||
Homoamphetamine | 3-amino-1-phenylbutane | Hungary | |
Clophedrone (3-CMC) | 1049677-59-9 | 1-(3-Chlorophenyl)-2-methylaminopropan-1-one | China, Hungary, Sweden, UK |
3-FA | Hungary | ||
3-F-phenmetrazine | Hungary | ||
3-MMC | Hungary | ||
4-APB | Hungary | ||
4-BZPD | 4-benzylpiperidine | Hungary, Japan | |
Brephedrone (4-BMC) | Hungary | ||
4-CA | Hungary | ||
Clephedrone (4-CMC) | 1225843-86-6 | 1-(4-Chlorophenyl)-2-methylaminopropan-1-one | China, Hungary, Vermont |
4-EMC | Hungary | ||
4-FA | Hungary | ||
4-FMA | Hungary | ||
4F-PEP (4F-PV8) | 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)heptan-1-one | Hungary, Japan | |
4-MA | Hungary | ||
4-MEC | Hungary | ||
4-MeO-alpha-PVP | Hungary | ||
4'-MeO-PCP | Hungary | ||
4-methylbuphedrone | Hungary | ||
5-APDB | Hungary | ||
5-BPDI | Hungary | ||
5"-Cl-UR-144 | Alabama, Hungary, Latvia | ||
5F-AB-PINACA | Hungary | ||
5F-AMB | Hungary | ||
5F-AMBICA | Hungary | ||
5F-APP-PINACA | Hungary | ||
5F-ADB (5F-MDMB-PINACA) | Hungary | ||
5F-MN-24 | Hungary | ||
5F-PB-22 | Hungary | ||
5F-PB-22 indazole | Hungary | ||
5F-UR-144 | Hungary | ||
5-IAI | Hungary | ||
5-IT | Hungary | ||
5-MeO-AMT | Hungary | ||
5-MeO-DALT | Hungary | ||
5-MeO-MiPT | Hungary | ||
6-APB | Hungary | ||
6-APDB | Hungary | ||
A-796,260 | Hungary | ||
A-834,735 | Hungary | ||
A-836,339 | Hungary | ||
AB-CHMINACA | Hungary | ||
AB-FUBINACA | Hungary | ||
AB-PINACA | Hungary | ||
ADB-CHMINACA | Hungary | ||
ADB-FUBINACA | Hungary | ||
ADB-PINACA | Hungary | ||
AKB-48 (APINACA) | Hungary | ||
5F-AKB-48 | Hungary | ||
alpha-PBP | Hungary | ||
alpha-PBT | Hungary | ||
alpha-PEP | Hungary | ||
alpha-PHP | Hungary | ||
alpha-PVP | Hungary | ||
alpha-PVT | Hungary | ||
AM-1220 | Hungary | ||
AM-1248 | Hungary | ||
AM-1248 azepane | Hungary | ||
AM-2201 | Hungary | ||
AM-2233 | Hungary | ||
AM-6527 | Hungary | ||
AM-694 | Hungary | ||
5"-CL-AM-694 | Hungary | ||
AMB-FUBINACA | Hungary | ||
AMT | Hungary | ||
BB-22 | Hungary | ||
bk-2C-B | Hungary | ||
bk-MPA | Hungary | ||
BMDP | Hungary | ||
Bn-4-Me-MAPB | Hungary | ||
Buphedrone | Hungary | ||
Butylone | Hungary | ||
(C8)-CP 47,497 | Hungary | ||
Desoxy-D2PM | Hungary | ||
Diclazepam | Hungary | ||
Dimethocaine | Hungary | ||
Diphenidine | Hungary | ||
DMAA | 4-methylhexan-2-amine | Hungary | |
DMMA | 3,4-dimethoxy-N-methylamphetamine | Hungary | |
EAM-2201 | Hungary | ||
EG-018 | Hungary | ||
Ethylphenidate | Hungary | ||
Ethcathinone | Hungary | ||
Ethylone | Hungary | ||
FUB-PB-22 | Hungary | ||
GBL | Hungary | ||
JWH-018 | Hungary | ||
AB-001 | Hungary | ||
2NE1 (APICA) | Hungary | ||
JWH-019 | Hungary | ||
JWH-022 | Hungary | ||
JWH-073 | Hungary | ||
JWH-081 | Hungary | ||
JWH-122 | Hungary | ||
JWH-200 | Hungary | ||
JWH-203 | Hungary | ||
JWH-210 | Hungary | ||
JWH-250 | Hungary | ||
MAM-2201 | Hungary | ||
mCPP | Hungary | ||
MDAI | Hungary | ||
MDMB-CHMICA | Hungary | ||
MDMB-FUBICA | Hungary | ||
MDPBP | Hungary | ||
MDPV | Hungary | ||
Mephedrone | Hungary | ||
Methoxypiperamide | Hungary | ||
Mephtetramine | Hungary | ||
Mepirapim | Hungary | ||
Methedrone | Hungary | ||
Methylone | Hungary | ||
Methoxetamine | Hungary | ||
MPBP | Hungary | ||
MPHP | Hungary | ||
4-MePPP | Hungary | ||
Methoxphenidine | Hungary | ||
PTI-2 | 1400742-45-1 | N-(2-methoxyethyl)-N-([2-(1-pentyl-1H-indol-3-yl)thiazol-4-yl]methyl)propan-2-amine | Hungary |
PTI-1 | 1400742-46-2 | N,N-diethyl-N-([2-(1-pentyl-1H-indol-3-yl)thiazol-4-yl]methyl)ethanamine | Hungary |
N-ethylpentedrone | Hungary | ||
Ethamphetamine | Hungary | ||
N-ethylbuphedrone | Hungary | ||
Nitracaine | Hungary | ||
NM-2201 | Hungary | ||
O-desmethyltramadol | Hungary | ||
4-methyl-N-ethylpentedrone | Hungary | ||
4,4'-DMAR | Hungary | ||
PB-22 | Hungary | ||
PB-22 indazole | Hungary | ||
PCP | Hungary | ||
Pentedrone | Hungary | ||
Pentylone | Hungary | ||
pFPP | Hungary | ||
RCS-4 | Hungary | ||
(C4)-RCS-4 | Hungary | ||
RH-34 | 1028307-48-3 | 3-[2-(2-methoxybenzylamino)ethyl]-1H-quinazoline-2,4-dione | Hungary |
STS-135 | Hungary | ||
Salvinorin A | Hungary | ||
THJ-2201 (AM-2201 indazole) | Hungary | ||
UR-144 | Hungary | ||
(C7)-UR-144 | Hungary | ||
URB-754 | Hungary | ||
Pravadoline (WIN 48,098) | Hungary | ||
2,4-DMA | Hungary | ||
2-AI | Hungary | ||
bk-MMDMA-2 (2-A1MP) | Hungary | ||
6-Chloro-MDMA | Hungary | ||
2C-B-BZP | Hungary | ||
2C-B-Fly | Hungary | ||
2-EAPB | Hungary | ||
2-FMA | Hungary | ||
2-methoxyamphetamine | Hungary | ||
2-MMC | Hungary | ||
Naphyrone | Hungary | ||
NBOH-2C-CN | Hungary | ||
NB34MD-2C-I | Hungary | ||
NBOMe-2C-iP | Hungary | ||
NBOMe-2C-N | Hungary | ||
NBOMe-2C-TFM | Hungary | ||
3,4-dimethoxy-alpha-PHP | Hungary | ||
3,4-dimethoxy-alpha-PVP | Hungary | ||
3-CBP (Bupropion) | Hungary | ||
3C-E | Hungary | ||
3C-P | Hungary | ||
3-FMC | Hungary | ||
3-MeO-MC | Hungary | ||
3'-MeO-PCE | Hungary | ||
3'-MeO-PCP | Hungary | ||
30B-NBOMe | Hungary | ||
30C-NBOMe | 1445574-98-0 | N-(3,4,5-trimethoxybenzyl)-1-(2,5-dimethoxy-4-chlorophenyl)-2-ethanamine | Hungary |
30I-NBOMe | Hungary | ||
4-AcO-DMT | Hungary | ||
4-bromoamphetamine | Hungary | ||
4-CMC | Hungary | ||
4-FEC | Hungary | ||
4-fluoropentedrone | Hungary | ||
4F-PVP | Hungary | ||
4-MDMC | ?? | Hungary | |
4-MeO-alpha-PBP | Hungary | ||
4'-MeO-PCP | Hungary | ||
4-methylhexedrone | Hungary | ||
Dimephedrone | Hungary | ||
4-MMA | Hungary | ||
4-methylpentedrone | Hungary | ||
5-APB | Hungary | ||
5"-Br-UR-144 | Hungary | ||
5"-Cl-AKB-48 | Hungary | ||
5-EAPB | Hungary | ||
5F-AKB-48 | Hungary | ||
5F-MN-18 | Hungary | ||
5F-NPB-22 | Hungary | ||
5F-SDB-005 | Hungary | ||
5F-SDB-006 | Hungary | ||
5-MAPB | Hungary | ||
5-MAPDI | Hungary | ||
5-MeO-DiPT | Hungary | ||
5-MeO-DMT | Hungary | ||
5-MeO-MALT | Hungary | ||
5-MeO-NiPT | Hungary | ||
5-MeO-T | Hungary | ||
5-PPDi | Hungary | ||
6-bromo-MDMA | Hungary | ||
6-EAPB | Hungary | ||
6-MAPB | Hungary | ||
A-834,735 | Hungary | ||
AB-001 | Hungary | ||
AB-005 | Hungary | ||
adamantyl-THPINACA | Hungary | ||
AH-7921 | Hungary | ||
AM-1221 | Hungary | ||
AM-1235 | Hungary | ||
AM-1241 | Hungary | ||
5F-PB-22 | Hungary | ||
5F-AB-001 | Hungary | ||
AM-2202 | Hungary | ||
AM-630 | Hungary | ||
NNE1 | Hungary | ||
5F-NNE1 | Hungary | ||
AM-661 | Hungary | ||
AM-679 | Hungary | ||
benzedrone | Hungary | ||
beta-methyl-PEA | Hungary | ||
bk-IVP | Hungary | ||
Dimethylone | Hungary | ||
BMDB | Hungary | ||
Bromodragonfly | Hungary | ||
Cannabipiperidiethanone | Hungary | ||
CBL-018 (PB-22 naphthyl) | Hungary | ||
Cl-2201 | Hungary | ||
(C8)-CP 47,497 | Hungary | ||
CPCPP (Gelbes) | Hungary | ||
CB-13 | Hungary | ||
CUMYL-5F-PICA | Hungary | ||
CUMYL-5F-PINACA | Hungary | ||
CUMYL-BICA | Hungary | ||
CUMYL-PICA | Hungary | ||
CUMYL-PINACA | Hungary | ||
CUMYL-THPINACA | Hungary | ||
Diphenylprolinol | Hungary | ||
DBZP | Hungary | ||
Diclazepam | Hungary | ||
Diphenidine | Hungary | ||
Dibutylone | Hungary | ||
2,3-DCPP | Hungary | ||
Dimethylamphetamine | Hungary | ||
Dimethocaine | Hungary | ||
Dipentylone | Hungary | ||
DL-4662 | Hungary | ||
DMAA | Hungary | ||
ED-pyr-A | 1-(3,4-ethylenedioxyphenyl)-2-(pyrrolidin-1-yl)propane | Hungary | |
EFLEA | Hungary | ||
Etaqualone | Hungary | ||
Ethylphenidate | Hungary | ||
F-2201 | Hungary | ||
FAB-144 | Hungary | ||
FDU-PB-22 | Hungary | ||
Phenazepam | Hungary | ||
Phenylpropylamine | Hungary | ||
FUB-AKB48 | Hungary | ||
FUB-NPB-22 | Hungary | ||
FUB-PB-22 (MN-27) | Hungary | ||
Furfenorex | Hungary | ||
GBL | Hungary | ||
Harmine | Hungary | ||
Homoamphetamine | Hungary | ||
HOT-7 | Hungary | ||
HU-210 | Hungary | ||
Ibogaine | Hungary | ||
JWH-007 | Hungary | ||
JWH-015 | Hungary | ||
JWH-016 | Hungary | ||
PB-22 amide | Hungary | ||
JWH-020 | Hungary | ||
JWH-030 | Hungary | ||
JWH-071 | Hungary | ||
JWH-080 | Hungary | ||
JWH-116 | Hungary | ||
JWH-182 | Hungary | ||
JWH-193 | Hungary | ||
JWH-201 | Hungary | ||
JWH-204 | Hungary | ||
JWH-249 | Hungary | ||
JWH-251 | Hungary | ||
JWH-307 | Hungary | ||
JWH-370 | Hungary | ||
JWH-387 | Hungary | ||
JWH-398 | Hungary | ||
JWH-412 | Hungary | ||
JWH-424 | Hungary | ||
Camfetamine | Hungary | ||
M5FPIC | Hungary | ||
M5FNIN | Hungary | ||
MAL | Hungary | ||
MBZP | Hungary | ||
MDAI | Hungary | ||
MDHOET | Hungary | ||
MDPHP | Hungary | ||
MDPPP | Hungary | ||
Methoxypiperamide | Hungary | ||
MET | Hungary | ||
Metamfepramone | Hungary | ||
MN-18 | Hungary | ||
MOPPP | Hungary | ||
Methiopropamine | Hungary | ||
MT-45 | Hungary | ||
Methoxetamine | Hungary | ||
N-benzyl-1-PEA | Hungary | ||
bk-MMDMA-2 | Hungary | ||
N-ethylbuphedrone | Hungary | ||
NPB-22 | Hungary | ||
NPP | Hungary | ||
NTBT | Hungary | ||
PB-22 | Hungary | ||
pCPP | Hungary | ||
pFBT | Hungary | ||
pMeOPP | Hungary | ||
SDB-005 | Hungary | ||
SDB-006 | Hungary | ||
TFMPP | Hungary | ||
bk-methiopropamine | Hungary | ||
THJ-018 | Hungary | ||
THJ-2201 | Hungary | ||
Mephtetramine | Hungary | ||
UR-12 | Hungary | ||
6-Bromopravadoline (WIN 54,461) | Hungary | ||
XLR-12 | Hungary |
WADA Prohibited list 2016
[edit]Performance enhancing drugs represent a separate and overlapping category with many similarities to designer drugs used as new psychoactive substances. The WADA prohibited list relies heavily on drug classes sorted by pharmacological mechanism of action as well as by structure, but also includes many specific examples in each section, as well as the general provision "and other substances with a similar chemical structure or similar biological effect(s)." There is also an even more general provision for Non-Approved Substances; "Any pharmacological substance which is not addressed by any of the subsequent sections of the List and with no current approval by any governmental regulatory health authority for human therapeutic use (e.g. drugs under pre-clinical or clinical development or discontinued, designer drugs, substances approved only for veterinary use) is prohibited at all times."[8]
Common name | CAS number | Chemical name |
---|---|---|
Anabolic androgenic steroids (drug class) | N/A | N/A |
1-Androstenediol | 5α-androst-1-ene-3β,17β-diol | |
1-Androstenedione | 5α-androst-1-ene-3,17-dione | |
1-Testosterone | 17β-hydroxy-5α-androst-1-en-3-one | |
4-Hydroxytestosterone | 4,17β-dihydroxyandrost-4-en-3-one | |
19-Norandrostenedione | estr-4-ene-3,17-dione | |
Bolandiol | estr-4-ene-3β,17β-diol | |
Bolasterone | ||
Boldenone | ||
Boldione | androsta-1,4-diene-3,17-dione | |
Calusterone | ||
Clostebol | ||
Danazol | [1,2]oxazolo[4',5':2,3]pregna-4-en-20-yn-17α-ol | |
Dehydrochlormethyltestosterone | 4-chloro-17β-hydroxy-17α-methylandrosta-1,4-dien-3-one | |
Desoxymethyltestosterone | 17α-methyl-5α-androst-2-en-17β-ol | |
Drostanolone | ||
Ethylestrenol | 19-norpregna-4-en-17α-ol | |
Fluoxymesterone | ||
Formebolone | ||
Furazabol | 17α-methyl [1,2,5]oxadiazolo[3',4':2,3]-5α-androstan-17β-ol | |
Gestrinone | ||
Mestanolone | ||
Mesterolone | ||
Metandienone | 17β-hydroxy-17α-methylandrosta-1,4-dien-3-one | |
Metenolone | ||
Methandriol | ||
Methasterone | 17β-hydroxy-2α,17α-dimethyl-5α-androstan-3-one | |
Methyldienolone | 17β-hydroxy-17α-methylestra-4,9-dien-3-one | |
Methyl-1-testosterone | 17β-hydroxy-17α-methyl-5α-androst-1-en-3-one | |
Methylnortestosterone | 17β-hydroxy-17α-methylestr-4-en-3-one | |
Methyltestosterone | ||
Metribolone | 17β-hydroxy-17α-methylestra-4,9,11-trien-3-one | |
Mibolerone | ||
Nandrolone | ||
Norboletone | ||
Norclostebol | ||
Norethandrolone | ||
Oxabolone | ||
Oxandrolone | ||
Oxymesterone | ||
Oxymetholone | ||
Prostanozol | 17β-[(tetrahydropyran-2-yl)oxy]-1'Hpyrazolo[3,4:2,3]-5α-androstane | |
Quinbolone | ||
Stanozolol | ||
Stenbolone | ||
Tetrahydrogestrinone | 17-hydroxy-18a-homo-19-nor-17α-pregna-4,9,11-trien-3-one | |
Trenbolone | 17β-hydroxyestr-4,9,11-trien-3-one | |
Androstenediol | androst-5-ene-3β,17β-diol | |
Androstenedione | androst-4-ene-3,17-dione | |
Dihydrotestosterone | 17β-hydroxy-5α-androstan-3-one | |
Dehydroepiandrosterone | 3β-hydroxyandrost-5-en-17-one | |
Testosterone | ||
3β-Hydroxy-5α-androstan-17-one | ||
5α-Androstane-3α,17α-diol | ||
5α-Androstane-3α,17β-diol | ||
5α-Androstane-3β,17α-diol | ||
5α-Androstane-3β,17β-diol | ||
5β-Androstane-3α,17β-diol | ||
7α-Hydroxy-DHEA | ||
7β-Hydroxy-DHEA | ||
4-Androstenediol | androst-4-ene-3β, 17β-diol | |
5-Androstenedione | androst-5-ene-3,17-dione | |
7-Keto-DHEA | ||
19-Norandrosterone | ||
19-Noretiocholanolone | ||
Androst-4-ene-3α,17α-diol | ||
Androst-4-ene-3α,17β-diol | ||
Androst-4-ene-3β,17α-diol | ||
Androst-5-ene-3α,17α-diol | ||
Androst-5-ene-3α,17β-diol | ||
Androst-5-ene-3β,17α-diol | ||
Androsterone | ||
Epi-dihydrotestosterone | ||
Epitestosterone | ||
Etiocholanolone | ||
Selective androgen receptor modulators (drug class) | N/A | N/A |
Andarine | ||
Ostrarine | ||
Clenbuterol | ||
Tibolone | ||
Zeranol | ||
Zilpaterol | ||
Erythropoietin receptor agonists (drug class) | N/A | N/A |
Darbepoietin | ||
Erythropoietin | ||
EPO-Fc | ||
EPO-mimetic peptides (drug class) | N/A | N/A |
CNTO 530 | ||
Peginesatide | ||
Methoxy polyethylene glycol-Epoetin beta | ||
Non-erythropoietic EPO-Receptor agonists (drug class) | N/A | N/A |
ARA-290 | ||
Asialo EPO | ||
Carbamylated EPO | ||
Hypoxia-inducible factor (HIF) stabilizers (drug class) | N/A | N/A |
Cobalt | ||
FG-4592 | ||
HIF activators (drug class) | N/A | N/A |
Argon | ||
Xenon | ||
Chorionic Gonadotrophin (CG) | ||
Luteinizing Hormone (LH) | ||
Buserelin | ||
Gonadorelin | ||
Leuprorelin | ||
Corticotrophins and their releasing factors (drug class) | N/A | N/A |
Corticorelin | ||
Growth Hormone (GH) and its releasing factors and its analogues | ||
Growth Hormone Releasing Hormone (GHRH) | ||
CJC-1295 | ||
Sermorelin | ||
Tesamorelin | ||
Growth Hormone Secretagogues (GHS) (drug class) | N/A | N/A |
Ghrelin | ||
Ghrelin mimetics (drug class) | N/A | N/A |
Anamorelin | ||
Ipamorelin | ||
GH-Releasing Peptides (GHRPs) (drug class) | N/A | N/A |
Alexamorelin | ||
GHRP-6 | ||
Hexarelin | ||
Pralmorelin (GHRP-2) | ||
Fibroblast Growth Factors (FGFs) | ||
Hepatocyte Growth Factor (HGF) | ||
Insulin-like Growth Factor-1 (IGF-1) and its analogues | ||
Mechano Growth Factors (MGFs) | ||
Platelet-Derived Growth Factor (PDGF) | ||
Vascular-Endothelial Growth Factor (VEGF) | ||
All beta-2 agonists, including all optical isomers (drug class) | N/A | N/A |
Aromatase inhibitors (drug class) | N/A | N/A |
4-Androstene-3,6,17 trione (6-oxo) | ||
Aminoglutethimide | ||
Anastrozole | ||
Androsta-1,4,6-triene-3,17-dione (androstatrienedione) | ||
Exemestane | ||
Formestane | ||
Letrozole | ||
Testolactone | ||
Selective estrogen receptor modulators (SERMs) (drug class) | N/A | N/A |
Raloxifene | ||
Tamoxifen | ||
Toremifene | ||
Anti-estrogenic substances (drug class) | N/A | N/A |
Clomiphene | ||
Cyclofenil | ||
Fulvestrant | ||
Agents modifying myostatin function (drug class) | N/A | N/A |
Activators of the AMP-activated protein kinase (AMPK) (drug class) | N/A | N/A |
AICAR | ||
Peroxisome Proliferator Activated Receptor δ (PPARδ) agonists (drug class) | N/A | N/A |
GW 1516 | ||
Insulins and insulin-mimetics (drug class) | N/A | N/A |
Meldonium | ||
Trimetazidine | ||
Proposed under US Synthetic Drug Control Act of 2015
[edit]Note this list has been substantially reduced in subsequent versions of this bill (still not passed as of 2016), but the original draft is quite comprehensive and includes a number of compounds not listed elsewhere. All compounds are listed under chemical names with no common code names given (and many typos - corrected here where it seems obvious what compound they meant, but left as is where the chemical name is technically correct, even if it refers to a novel compound not previously reported), and there are a few repeated entries under different versions of the chemical name for the same compound. Some common RCs such as methylone and mephedrone are not listed due to being covered by existing laws.
Common name | CAS number | Chemical name |
---|---|---|
4-MEC | 2–(ethylamino)–1–(4-methylphenyl)–1-propanone | |
4-EMC | 1–(4-ethylphenyl)–2–(methylamino)–1-propanone | |
3-FMC | 1–(3-fluorophenyl)–2–(methylamino)–1-propanone | |
Flephedrone | 1–(4-fluorophenyl)–2–(methylamino)–1-propanone | |
Methedrone | 1–(4-methoxyphenyl)–2–(methylamino)–1-propanone | |
Ethedrone | 2–(ethylamino)–1–(4-methoxyphenyl)–1-propanone | |
Naphyrone | 1–(2-naphthalenyl)–2–(1-pyrrolidinyl)–1-pentanone | |
Ethylone | 1–(1,3-benzodioxol-5-yl)–2–(ethylamino)–1-propanone | |
Butylone | 1–(1,3-benzodioxol-5-yl)–2–(methylamino)–1-butanone | |
Pentylone | 1–(1,3-benzodioxol-5-yl)–2–(methylamino)–1-pentanone | |
Ethcathinone | 2–(ethylamino)–1-phenyl-1-propanone | |
alpha-PPP | 1-phenyl-2–(1-pyrrolidinyl)–1-propanone | |
4-Me-PPP | 1–(4-methylphenyl)–2–(1-pyrrolidinyl)–1-propanone | |
4-MeO-PPP | 1–(4-methoxyphenyl)–2–(1-pyrrolidinyl)–1-propanone | |
MDPPP | 1–(1,3-benzodioxol-5-yl)–2–(1-pyrrolidinyl)–1-propanone | |
alpha-PVP | 1-phenyl-2–(1-pyrrolidinyl)–1-pentanone | |
4-fluorocathinone | 2-amino-1–(4-fluorophenyl)–1-propanone | |
Pentedrone | 2–(methylamino)–1-phenyl-1-pentanone | |
4-EEC | 2–(ethylamino)–1–(4-ethylphenyl)–1-propanone | |
Dimethylcathinone | 2–(dimethylamino)–1-phenyl-1-propanone | |
MDPBP | 1–(1,3-benzodioxol-5-yl)–2–(1-pyrrolidinyl)–1-butanone | |
MPHP | 1–(4-methylphenyl)–2–(1-pyrrolidinyl)–1-hexanone | |
Buphedrone | 2–(methylamino)–1-phenyl-1-butanone | |
4-Me-buphedrone | 2–(methylamino)–1-p-tolyl-1-butanone | |
MPBP | 1–(4-methylphenyl)–2–(1-pyrrolidinyl)–1-butanone | |
3,4-DMMC | 1–(3,4-dimethylphenyl)–2–(methylamino)–1-propanone | |
alpha-PBP | 1-phenyl-2–(1-pyrrolidinyl)–1-butanone | |
Dimephedrone | 1–(1,3-benzodioxol-5-yl)–2–(dimethylamino)–1-propanone | |
Benzedrone | 1–(4-methylphenyl)–2–(benzylamino)–1-propanone | |
1-naphyrone | 1–(1-naphthyl)–2–(1-pyrrolidinyl)–1-pentanone | |
BMDP | 1–(1,3-benzodioxol-5-yl)–2–(benzylamino)–1-propanone | |
BMDB | 1–(1,3-benzodioxol-5-yl)–2–(benzylamino)–1-butanone | |
N-hydroxymethylone | 1–(1,3-benzodioxol)–2-[hydroxy(methyl)-amino]-1-propanone | |
Dibutylone | 1–(1,3-benzodioxol-5-yl)–2–(dimethylamino)–1-butanone | |
N-ethyl-N-methylbuphedrone | 2–(ethyl(methyl)amino)–1-phenyl-butanone | |
4-BMC | 1–(4-bromophenyl)–2–(methylamino)–1-propanone | |
N-ethyl-N-methylcathinone | 2–(ethyl(methyl)amino-1-phenyl-1-propanone | |
3-MMC | 2–(methylamino)–1-m-tolyl-1-propanone | |
alpha-PVT | 2–(pyrrolidin-1-yl)–1–(thiophen-2-yl)–1-pentanone | |
4-F-buphedrone | 1–(4-fluorophenyl)–2–(methylamino)–1-butanone | |
MOPBP | 1–(4-methoxyphenyl)–2–(pyrrolidin-1-yl)–1-butanone | |
4-Et-PBP | 1–(4-ethylphenyl)–2–(pyrrolidin-1-yl)–1-butanone | |
3-Me-4-MeO-MC | 1–(4-methoxy-3-methylphenyl)–2–(methylamino)–1-propanone | |
3-MEC | 2–(ethylamino)–1–(3-methylphenyl)–1-propanone | |
bk-5-IT | 2-amino-(1H-indol-5-yl)propan-1-one | |
PPBO | 1-phenyl-2–(piperidin-1-yl)butan-1-one | |
2,4,5-TMMC | 2-methylamino-1–(2,4,5-trimethylphenyl)-propan-1-one | |
alpha-PEP | 1-phenyl-2–(pyrrolidin-1-yl)heptan-1-one | |
alpha-PHP | 1-phenyl-2–(pyrrolidin-1-yl)hexan-1-one | |
4-F-PPP | 1–(4-fluorophenyl)–2–(pyrrolidin-1-yl)pentan-1-one | |
Dipentylone | 1–(benzo[d][1,3]dioxol-5-yl)–2–(dimethylamino)pentan-1-one | |
2-FMA | 1–(2-fluorophenyl)–N-methyl-propan-2-amine | |
2-FA | 1–(2-fluorophenyl)-propan-2-amine | |
3-FA | 1–(3-fluorophenyl)-propan-2-amine | |
3-FMA | 1–(3-fluorophenyl)–N-methyl-propan-2-amine | |
4-FA | 1–(4-fluorophenyl)-propan-2-amine | |
4-FMA | 1–(4-fluorophenyl)–N-methyl-propan-2-amine | |
4-MA | 1–(4-methylphenyl)propan-2-amine | |
Ethylmethylamphetamine | N-ethyl-N-methyl-1-phenylpropan-2-amine | |
4-APB | 1–(benzofuran-4-yl)propan-2-amine | |
5-APB | 1–(benzofuran-5-yl) propan-2-amine | |
5-APDB | 1–(2,3-dihydrobenzofuran-5-yl)propan-2-amine | |
6-APB | 1–(benzofuran-6-yl)-propan-2-amine | |
6-APDB | 1–(2,3-dihydrobenzofuran-6-yl)propan-2-amine | |
PMMA | 1–(4-methoxyphenyl)–N-methyl-propan-2-amine | |
Dimethamphetamine | N,N-dimethyl-1-phenylpropan-2-amine | |
5-APDI | 1–(2,3-dihydro-1H-inden-5-yl)propan-2-amine | |
MDAT | 5,6,7,8-tetrahydrobenzo[1,3]-benzodioxol-7-amine | |
4-MTA | a-methyl-4–(methylthio)-benzene-ethanamine | |
4-CA | 1–(4-chlorophenyl)-propan-2-amine | |
2,4,6-TMA | 1–(2,4,6-trimethoxyphenyl)-propan-2-amine | |
2,4,5-TMA | 1–(2,4,5-trimethoxyphenyl)-propan-2-amine | |
2,5-dimethylamphetamine | 1–(2,5-dimethylphenyl)-propan-2-amine | |
3,4-dimethylamphetamine | 1–(3,4-dimethylphenyl)-propan-2-amine | |
Propylamphetamine | N–(1-phenylpropan-2-yl)propan-1-amine | |
4-HO-amphetamine | 4–(2-aminopropyl)phenol | |
MDDM | 3,4-methylenedioxy-N,N-dimethyl-amphetamine | |
PMEA | N-ethyl-1–(4-methoxyphenyl)propan-2-amine | |
5-MAPB | 1–(benzofuran-5-yl)–N-methylpropan-2-amine | |
MDAI | 6,7-dihydro-5H-inden[5,6-d][1,3]dioxol-6-amine | |
5-IAI | 5-iodo-2,3-dihydro-1H-inden-2-amine | |
2-AI | 2,3-dihydro-1H-inden-2-amine | |
MMAI | 5-methoxy-6-methyl-2,3-dihydro-1H-inden-2-amine | |
MDMAI | N-methyl-6,7-dihydro-5H-cyclopenta[1,3]-benzodioxol-6-amine | |
NM-2-AI | N-methyl-2,3-dihydro-1H-inden-2-amine | |
2C-T-21 | 2-[4–(2-fluoroethylthio)–2,5-dimethoxyphenyl]ethanamine | |
2C-B-FLY | 8-bromo-2,3,6,7-tetrahydro-benzo[1,2-b;4,5-b’]difuran-4-ethanamine | |
NBOMe-2C-I | 4-iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)-methyl-benzene-ethamine | |
NBOMe-2C-C | 2–(4-chloro-2,5-dimethoxyphenyl)–N–(2-methoxybenzyl)-ethanamine | |
2C-G | 2–(2,5-dimethoxy-3,4-dimethylphenyl)-ethanamine | |
NBOMe-2C-D | 2–(4-methyl-2,5-dimethoxyphenyl)–N–(2-methoxybenzyl)-ethanamine | |
NBOMe-2C-E | 2–(4-ethyl-2,5-dimethoxyphenyl)–N–(2-methoxybenzyl)-ethanamine | |
NBOMe-2C-G | 2–(2,5-dimethoxy-3,4-dimethylphenyl)–N–(2-methoxybenzyl)-ethanamine | |
NBOMe-2C-H | 2–(2,5-dimethoxyphenyl)–N–(2-methoxybenzyl)-ethanamine | |
NBOMe-2C-B | 2–(4-bromo-2,5-dimethoxyphenyl)–N–(2-methoxybenzyl)-ethanamine | |
NBOMe-2C-N | 2–(2,5-dimethoxyphenyl-4-nitro)–N-[(2-methoxyphenyl)methyl]-ethanamine | |
DOI | 1–(4-iodo-2,5-dimethoxyphenyl)propan-2-amine | |
Bromo-dragonfly | 1–(4-bromofuro[2,3-f]benzofuran-8-yl)propan-2-amine | |
DOC | 1–(4-chloro-2,5-dimethoxyphenyl)propan-2-amine | |
DOB-FLY | 1–(4-bromo-2,3,6,7-tetrahydrofuro[2,3-f]benzofuran-8-yl)propan-2-amine | |
2,5-DMA | (2,5-dimethoxyphenyl)-propan-2-amine | |
Aleph-2 | 1-[4–(ethylthio)–2,5-dimethoxyphenyl)propan-2-amine | |
MEM | 1–(4-ethoxy-2,5-dimethoxyphenyl)propan-2-amine | |
Aleph-7 | 1-[2,5-dimethoxy-4–(propylthio)phenyl]propan-2-amine | |
DOET | 1–(4-ethyl-2,5-dimethoxyphenyl)propan-2-amine | |
NB-PEA | N-benzyl-2-phenylethanamine | |
DM-PEA | N,N-dimethyl-2-phenylethanamine | |
6-CAT | 6-chloro-2-aminotetralin | |
beta-methyl-PEA | 2-phenyl-propan-1-amine | |
PEA | 2-phenethylamine | |
M-ALPHA | 1-methylamino-1–(3,4-methylendioxy-phenyl)propane | |
Camfetamine | N-methyl-3-phenylbicyclo[2.2.1]heptan-2-amine | |
2-MeO-MA | 1–(2-methoxyphenyl)–N-methylpropan-2-amine | |
Allylescaline | 2–(4–(allyloxy)–3,5-dimethoxyphenyl)ethanamine | |
DMAA | 4-methylhexan-2-amine | |
4-MAR | 4-methyl-5-phenyl-2-amino-oxazoline | |
Methiopropamine | N-methyl-1-(thiophen-2-yl)propan-2-amine | |
Dimethocaine | (3-dimethylamino-2,2-dimethylpropyl)–4-aminobenzoate | |
4-fluoroephedrine | 1–(4-fluorophenyl)–2–(methylamino)-propan-1-ol | |
4,4'-DMAR | 4-methyl-5-p-tolyl-4,5-dihydrooxazol-2-amine | |
beta-OH-alpha-PPP | 1-phenyl-2–(pyrrolidin-1-yl)propan-1-ol | |
JWH-210 | (4-ethyl-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)methanone | |
JWH-251 | 2–(2-methylphenyl)–1–(1-pentyl-1H-indol-3-yl)-ethanone | |
RCS-8 | 1-[1–(2-cyclohexylethyl)–1H-indol-3-yl]-2–(2-methoxyphenyl)-ethanone | |
AM-694 | [1–(5-fluoropentyl)–1H-indol-3-yl](2-iodophenyl)methanone | |
AM-1221 | (naphthalen-1-yl)(2-methyl-1-[(1-methylpiperidin-2-yl)methyl]-6-nitro-1H-indol-3-yl)methanone | |
(C4)-RCS-4 | (1-butyl-1H-indol-3-yl)(4-methoxyphenyl)-methanone | |
4-Me-JWH-073 | (1-butyl-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone | |
MAM-2201 | [1–(5-fluoropentyl)–1H-indol-3-yl](4-methyl-1-naphthalenyl)-methanone | |
AM-1220 | [1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl]-1-naphthalenyl-methanone | |
Pravadoline | 3–(4-methoxyphenyl)–2-methyl-1-[(2–(4-morpholinyl)ethyl)–1H-indol-3-yl]-methanone | |
WIN 55,212-2 | [2,3-dihydro-5-methyl-3–(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenyl-methanone | |
JWH-302 | 2–(3-methoxyphenyl)–1–(1-pentyl-1H-indol-3-yl)-ethanone | |
AM-2233 | (2-iodophenyl)[1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl]-methanone | |
AM-1248 | [1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl]tricyclo[3.3.1.13,7]dec-1-yl-methanone | |
JWH-072 | 209414-06-2 | 1-naphthalenyl(1-propyl-1H-indol-3-yl)-methanone |
AM-2232 | 5-[3–(1-naphthoyl)–1H-indole-1-yl]pentanenitrile | |
JWH-175 | 3–(1-naphthenylmethyl)–1-pentyl-1H-indole | |
JWH-015 | (2-methyl-1-propyl-1H-indol-3-yl)–1-napthalenyl-methanone | |
JWH-022 | 1-naphthalenyl[1–(4-penten-1-yl)–1H-indol-3-yl]-methanone | |
JWH-387 | (4-bromonaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone | |
JWH-412 | (4-fluoronaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone | |
(no code?) | (2-methyl-1-phenyl-1H-indol-3-yl)–1-naphthalenyl-methanone | |
JWH-203 | 2–(2-chlorophenyl)–1–(1-pentyl-1H-indol-3-yl)-ethanone | |
AM-694 chloropentyl | [1–(5-chloropentyl)–1H-indol-3-yl](2-iodophenyl)-methanone | |
AB-001 | (adamantan-1-yl)(1-pentyl-1H-indol-3-yl)-methanone | |
AM-1241 | (2-iodo-5-nitrophenyl)-[1–(1-methylpiperidin-2-ylmethyl)–1H-indol-3-yl]-methanone | |
UR-144 | (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclo-propyl)methanone | |
XLR-11 | [1–(5-fluoropentyl-1H-indol-3-yl)](2,2,3,3-tetramethylcyclo-propyl)methanone | |
A-796,260 | [1–(2-morpholinoethyl)–1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone | |
A-834,735 | 1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indol-3-yl-(2,2,3,3-tetramethylcyclopropyl)methanone | |
APICA (2NE1) | 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indole-3-carboxamide | |
APINACA (AKB48) | 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide | |
STS-135 | 1–(5-fluoropentyl)–N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indole-3-carboxamide | |
5Cl-UR-144 | [1–(5-chloropentyl)–1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone | |
JWH-073 3-methylbutyl | (1-isopentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone | |
5F-APINACA | 1–(5-fluoropentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide | |
JWH-182 | (1-pentyl-1H-indol-3-yl)(4-propyl-1-naphthalenyl)-methanone | |
4-Me-JWH-022 | (4-methyl-naphthalen-1-yl)[1–(pent-4-en-1-yl)–1H-indol-3-yl]methanone | |
JWH-267 | 824960-76-1 | (2-methoxy-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)methanone |
meta-RCS-4 | (3-methoxy-phenyl)(1-pentyl-1H-indol-3-yl)methanone | |
EAM-2201 | [1–(5-fluoropentyl)–1H-indol-3-yl](4-ethyl-1-naphthalenyl)-methanone | |
PB-22 | quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate | |
5F-PB-22 | quinolin-8-yl 1–(5-fluoropentyl-1H-indole-3-carboxylate | |
BB-22 | 1–(cyclohexylmethyl)–8-quinolinyl-ester-1H-indole-3-carboxylic acid | |
AB-PINACA | N–(1-amino-3-methyl-1-oxobutan-2-yl)–1-pentyl-1H-indazole-3-carboxamide | |
5F-NNE1 | 1–(5-fluoropentyl)–N–(naphthalene-1-yl)–1H-indole-3-carboxamide | |
AB-FUBINACA | N–(1-amino-3-methyl-1-oxobutan-2-yl)–1–(4-fluorobenzyl)–1H-indazole-3-carboxamide | |
ADB-FUBINACA | N–(1-amino-3,3-dimethyl-1-oxobutan-2-yl)–1–(4-fluorobenzyl)–1H-indazole-3-carboxamide | |
ADBICA | N–(1-amino-3,3-dimethyl-1-oxobutan-2-yl)–1-pentyl-1H-indole-3-carboxamide | |
AM-679 | 2-iodophenyl)(1-pentyl-1H-indol-3-yl)methanone | |
JWH-370 | [5–(2-methylphenyl)–1-pentyl-1H-pyrrol-3-yl]-1-naphthalenyl-methanone | |
NNE1 | 1-pentyl-N–(naphthalene-1-yl)–1H-indole-3-carboxamide | |
MAM-2201 chloropentyl | 1–(5-chloropentyl)–1H-indol-3-yl](4-methyl-1-naphthalenyl)-methanone | |
JWH-149 pentenyl | (4-methyl-naphthalen-1-yl)[2-methyl-1–(pent-4-en-1-yl)–1H-indol-3-yl)]methanone | |
AM-694 2-methylphenyl | [1–(5-fluoropentyl)–1H-indol-3-yl](o-tolyl)methanone | |
AM-694 2-ethylphenyl | (2-ethylphenyl)(1–(5-fluoropentyl)–1H-indol-3-yl)methanone | |
AM-2201 chloropentyl | [1–(5-chloropentyl)–1H-indol-3-yl](naphthalen-1-yl)methanone | |
AM-2201 bromopentyl | [1–(5-bromopentyl)–1H-indol-3-yl](naphthalen-1-yl)methanone | |
THJ-2201 | (1–(5-fluoropentyl)–1H-indazol-3-yl)(naphthalene-1-yl)methanone | |
AB-005 | 1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone | |
AB-005 azepane | (1–(1-methylazepan-2-yl)–1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | |
4-HTMPIPO | 4-hydroxy-3,3,4-trimethyl-1–(1-pentyl-1H-indol-3-yl)pentan-1-one | |
AM-2201 4-fluoropentyl | [1–(4-fluoropentyl)–1H-indol-3-yl]-1-naphthenyl-methanone | |
JWH-203 2-iodophenyl | 2–(2-iodophenyl)–1–(1-pentyl-1H-indol-3-yl)ethanone | |
(C6)-UR-144 | (1-hexyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | |
XLR-12 | (2,2,3,3-tetramethylcyclopropyl)[1–(4,4,4-trifluorobutyl)–1H-indol-3-yl]methanone | |
UR-12 | 7-methoxy-1–(2-morpholinoethyl)–N–((1S,4R)–1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl)–1H-indole-3-carboxamide | |
FUB-PB-22 | quinolin-8-yl 1–(4-fluorobenzyl)–1H-indole-3-carboxylate | |
FDU-PB-22 | naphthalen-1-yl 1–(4-fluorobenzyl)–1H-indole-3-carboxylate | |
ADB-PINACA | N–(1-amino-3,3-dimethyl-1-oxobutan-2-yl)–1-pentyl-1H-indazole-3-carboxamide | |
5F-ADBICA | N–(1-amino-3,3-dimethyl-1-oxobutan-2-yl)–1–(5-fluoropentyl)–1H-indole-3-carboxamide | |
XLR-11 4-fluoropentyl | (1–(4-fluoropentyl)–1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | |
THJ-018 | 1-naphthalenyl(1-pentyl-1H-indazol-3-yl)methanone | |
NNE1 indazole | N-naphthalenyl-1-pentyl-1H-indazole-3-carboxamide | |
AB-CHMINACA | N–(1-amino-3-methyl-1-oxobutan-2-yl)–1–(cyclohexylmethyl)–1H-indazole-3-carboxamide | |
EG-018 | naphthalene-1-yl(9-pentyl-9H-carbazol-3-yl)methanone | |
NM-2201 | naphthalene-1-yl 1–(5-fluoropentyl)–1H-indole-3-carboxylate | |
AMB | methyl 2–(1-pentyl-1H-indazole-3-carboxamido–3-methylbutanoate | |
5F-AMB | methyl 2–(1–5-fluoropentyl)–1H-indazole-3-carboxamido)–3-methylbutanoate | |
SDB-006 | N-benzyl-1-pentyl-1H-indole-3-carboxamide | |
5F-SDB-006 | N-benzyl-1–(5-fluoropentyl)–1H-indole-3-carboxamide | |
MMB-FUBINACA | methyl 2–(1–(4-fluorobenzyl)–1H-indazole-3-carboxamido)–3-methylbutanoate | |
PB-22 indazole | quinolin-8-yl 1-pentyl-1H-indazole-3-carboxylate | |
5F-PB-22 indazole | quinolin-8-yl 1–(5-fluoropentyl)–1H-indazole-3-carboxylate | |
3-CAF | naphthalene-2-yl 1–(2-fluorophenyl)–1H-indazole-3-carboxylate | |
ADB-CHMINACA | N–(1-amino-3,3-dimethyl-1-oxobutan-2-yl)–1–(cyclohexylmethyl)–1H-indazole-3-carboxamide | |
FUB-144 | (1–(4-fluorobenzyl)–1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | |
PX-1 | N–(1-amino-1-oxo—3-phenylpropan-2-yl)–1–(5-fluoropentyl)–1H-indole-3-carboxamide | |
PX-2 | N–(1-amino-1-oxo—3-phenylpropan-2-yl)–1–(5-fluoropentyl)–1H-indazole-3-carboxamide | |
MMB-CHMINACA | methyl (1–(cyclohexylmethyl)–1H-indazole-3-carbonyl-L-valinate | |
MDMB-CHMINACA | N-[(1–(cyclohexylmethyl)–1H-indazole-3-yl)carbonyl]-3-methyl-L-valine, methyl ester | |
MDMB-CHMICA | methyl 2–(1–(cyclohexylmethyl)–1H-indole-3-carboxamido)–3,3-dimethylbutanoate | |
FUBIMINA | (1–(5-fluoropentyl)–1H-benzo[d]imidazole-2-yl)(naphthalene-1-yl)methanone | |
FUB-018 | (1–(4-fluorobenzyl)–1H-indol-3-yl)(napthalen-1-yl)methanone | |
MDMB-FUBINACA | methyl 2–(1–(4-fluorobenzyl)–1H-indazole-3-carboxamido)–3,3-dimethylbutanoate | |
FUB-PB-22 indazole | quinolin-8-yl 1–(4-fluorobenzyl)–1H-indazole-3-carboxylate | |
FUB-APINACA | N–(adamantan-1-yl)–1–(4-fluorobenzyl)–1H-indazole-3-carboxamide | |
5F-APICA | N–(1-amino-3-methyl-1-oxobutan-2-yl)–1–(5-fluoropentyl)–1H-indole-3-carboxamide | |
(C6)-CP 47,497 | 2-[(1S,3R)–3-hydroxycyclohexyl]-5–(2-methylheptyl-2-yl)phenol | |
(C11)-CP 47,497 | 2-[(1S,3R)–3-hydroxycyclohexyl]-5–(2-methyldodecanyl-2-yl)phenol | |
HU-331 | 3-hydroxy-2[3-methyl-6–(1-methylethyenyl)–2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dione | |
HU-308 | 4-[4–(1,1-dimethylheptyl)–2,6-dimethoxyphenyl]-6,6-dimethyl-bicyclo[3.1.1]hept-2-ene-2-methanol | |
CB-13 | 1-naphthalenyl[4–(pentyloxy)–1-naphthalenyl]-methanone | |
Bay 38-7271 | 3–(2–(hydroxymethyl)–2,3-dihydro-1H-inden-4-yloxy)phenyl 4,4,4-trifluorobutane-1-sulfonate | |
JTE-907 | N–(benzo[1,3]dioxol-5-ylmethyl)–7-methoxy-2-oxo-8-pentyloxy-1,2-dihydroquinoline-3-carboxamide | |
A-836,339 | N-[3–(2-methoxyethyl)–4,5-dimethylthiazol-2-ylidene]-2,2,3,3-tetramethylcyclopropane-carboxamide | |
Org 27569 | 5-chloro-3-ethyl-N-[4–(piperidin-1-yl)phenethyl)–1H-indole-2-carboximide | |
Org 27759 | 868273-09-0 | N-[4–(dimethylamino)phenethyl]-3-ethyl-5-fluoro-1H-indole-2-carboximide |
Org 29647 | N–(1-benzylpyrrolidin-3-yl)–5-chloro-3-ethyl-1H-indole-2-carboxamide | |
JWH-307 | [5–(2-fluorophenyl)–1-pentyl-1H-pyrrol-3-yl](naphthalene-1-yl)methanone | |
URB-597 | (3’-(aminocarbonyl)[1,1’-biphenyl]-3-yl)-cyclohexyl-carbamate | |
LY-2183240 | 5–(biphenyl-4-ylmethyl)–N,N-dimethyl-1H-tetrazole-1-carboxamide | |
URB-754 | 6-methyl-2–(p-tolylamino)–4H-benzo[d][1,3]oxazin-4-one | |
URB-602 | [1,1'-biphenyl]-3-yl-carbamic acid, cyclohexyl ester | |
O-desmethyl-JTE 2-6 | 4-hydroxy-N–(4-hydroxyphenethyl)–3–(pentylamino)-benzamide | |
URB-937 | 1357160-72-5 | 3’-carbamoyl-6-hydroxy-[1,1’-biphenyl]-3-yl cyclohexylcarbamate |
3'-MeO-PCPr | 1–(3-methoxyphenyl)–N-propylcyclohexan-amine | |
Methoxetamine | 2–(ethylamino)–2–(3-methoxyphenyl)cyclohexanone | |
PCA | 1-phenylcyclohexan-amine | |
BTCP | 1-[1–(benzothiophen-2-yl)cyclohexyl]piperidine | |
4'-Me-PCP | 1–(1-p-tolylcyclohexyl)-piperidine | |
4'-MeO-PCPr | 1–(4-methoxyphenyl)–N-propylcyclohexan-amine | |
4'-MeO-PCP | 1-[1–(4-methoxyphenyl)cyclohexyl]-piperidine | |
3'-MeO-PCP | 1-[1–(3-methoxyphenyl)cyclohexyl]-piperidine | |
PCPr | 1-phenyl-N-propylcyclohexanamine | |
PCMEA | N–(2-methoxyethyl)–1-phenylcyclohexan-amine | |
PCEEA | N–(2-ethoxyethyl)–1-phenylcyclohexan-amine | |
PCMPA | N–(3-methoxypropyl)–1-phenylcyclohexan-amine | |
3'-OH-PCP | 3-[1–(piperidin-1-yl)cyclohexyl]-phenol | |
Methoxyketamine | 2–(methoxyphenyl)–2–(methylamino)cyclohexanone | |
TCE | N-ethyl-1–(thiophen-2-yl)cyclohexanamine | |
NENK | (2–(2-chlorophenyl)–2–(ethylamino)-cyclohexanone) | |
NMT | 2–(1H-indol-3-yl)–N-methyl-ethanamine | |
MiPT | N–(2–(1H-indol-3-yl)ethyl-N-methylpropan-2-amine | |
DiPT | N-[2–(1H-indol-3-yl)ethyl]-N-isopropylpropan-2-amine | |
DPT | N,N-dipropyl-1H-indole-3-ethanamine | |
4-AcO-DET | 3-[2–(diethylamino)ethyl]-1H-indol-4-ol acetate | |
4-HO-MiPT | 3–(2-[isopropyl(methyl)amino]ethyl)–1H-indol-4-ol | |
4-AcO-DiPT | 3-[2–(bis[1-methylethyl]amino)ethyl]-1H-indol-4-ol acetate | |
4-AcO-MiPT | 3–(2-[isopropyl(methyl)amino]ethyl)–1H-indol-4-ol acetate | |
4-AcO-DMT | 3-[2–(dimethylamino)ethyl]-1H-indol-4-ol acetate | |
4-HO-DET | 4-hydroxy-N,N-diethyl-1H-indole-ethanamine | |
4-MeO-DMT | 4-methoxy-N,N-dimethyl-1H-indole-3-ethanamine | |
4-HO-DiPT | 3–(2–(diisopropylamino)ethyl)–1H-indol-4-ol | |
4-HO-MET | 3-[2–(ethyl[methyl]amino)ethyl]-1H-indol-4-ol | |
4-AcO-MET | 3-[2–(ethyl[methyl]amino)ethyl]-1H-indol-4-ol acetate | |
4-HO-DPT | 3–(2–(dipropylamino)ethyl)–1H-indol-4-ol | |
4-AcO-DPT | 3-[2–(dipropylamino)ethyl]-1H-indol-4-ol acetate | |
4-AcO-DALT | 4-acetoxy-N,N-di-2-propen-1-yl-1H-indole-3-ethanamine | |
5-MeO-DALT | 5-methoxy-N,N-di-2-propen-1-yl-1H-indole-3-ethanamine | |
Bufotenine | 3–(2–(dimethylaminoethyl)–1H-indol-5-ol | |
5-MeO-DMT | 2–(5-methoxy-1H-indol-3-yl)–N,N-dimethylethanamine | |
5-MeO-a,N-DMT | N-[2–(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amine | |
5-MeO-AMT | 1–(5-methoxy-1H-indol-3-yl)propan-2-amine | |
5-AcO-DMT | 3-[2–(dimethylamino)-ethyl]-1H-indol-5-ol acetate | |
5-MeO-DPT | N-[2–(5-methoxy-1H-indol-3-yl)ethyl]-N-propylpropan-1-amine | |
5-MeO-DET | N,N-diethyl-2–(5-methoxy-1H-indol-3-yl)ethanamine | |
5-MeO-MET | N-ethyl-2–(5-methoxy-1H-indol-3-yl)–N-methyl-ethanamine | |
DPMP | 2–(diphenylmethyl)-piperidine | |
DPMPy | 2-benzhydrylpyrrolidine | |
Diphenylprolinol | a,a-diphenyl-(pyrrolidin-2-yl)methanol | |
3,4-DCMP | methyl 2–(3,4-dichlorophenyl)–2–(piperdin-2-yl)acetate | |
3-CMP | methyl 2–(3-chlorophenyl)–2–(piperidin-2-yl)acetate | |
4-MMP | methyl 2–(piperidin-2-yl)–2-p-tolylacetate | |
4-FMP | methyl 2–(4-fluorophenyl)–2–(piperidin-2-yl)acetate | |
Ethylphenidate | ethyl 2-phenyl-2–(piperidin-2-yl)acetate | |
Etizolam | 4–(2-chlorophenyl)–2-ethyl-9-methyl-6H-thieno-[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine | |
Phenazepam | 7-bromo-5–(2-chlorophenyl)–1H-benzo[e][1,4]diazepin-2(3H)-one | |
Bromo-alprazolam | 8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3a][1,4]benzodiazepine | |
CL-218,872 | 3-methyl-6-[3–(trifluoromethyl)phenyl][1,2,4]triazol[4,3-b]pyridazine | |
Zopiclone | 6–(5-chloro-2-pyridyl)–6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate | |
Mitragynine | 2–(1,3-dimethoxybuta-1,3-dien-2-yl)–3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine | |
Salvinorin A | (2a,4aR,6aR,7R,9S,10aS10bR)-methyl-9-acetoxy-2–(furan-3-yl)–6a,10b-dimethyl-4,10-dioxododecahydro-1 H-benzo[f]isochromene-7-carboxylate | |
AH-7921 | 3,4-dichloro-N–([1–(dimethylamino)cyclohexyl]methyl)benzamide | |
O-desmethyltramadol | 3-[2–(amino-1-methylethyl)–1-hydroxycyclohexyl]-phenol | |
Desomorphine | 4,5-epoxy-17-methylmorphinan-3-ol | |
Acetylfentanyl | N-phenyl-N-[1–(2-phenethyl)–4-piperidinyl] acetamide | |
o-Fluorobutyrbenzylfentanyl | N–(1-benzylpiperidin-4-yl)–N–(2-fluorophenyl)-butanamide | |
m-Fluorobutyrbenzylfentanyl | N–(1-benzylpiperidin-4-yl)–N–(3-fluorophenyl)-butanamide | |
p-Fluorobutyrbenzylfentanyl | N–(1-benzylpiperidin-4-yl)–N–(4-fluorophenyl)-butanamide | |
alpha-methylfentanyl | 2-methyl-N-phenyl-N-[1–(1-phenylpropan-2-yl)piperidin-4-yl]propanamide | |
Butyrfentanbyl | N–(1-phenethylpiperidin-4-yl)–N-phenylbutyramide | |
MT-45 | 1-cyclohexyl-4–(1,2-diphenylethyl)-piperazine | |
Thio-acetylfentanyl | N-phenyl-N–(1–(2–(thiophen-2-yl)ethyl)piperidin-4-yl)acetamide | |
W-15 | 4-chloro-N–(1-phenethylpiperidin-2-ylidene)benzenesulfonamide | |
W-18 | 4-chloro-N–(1–(4-nitrophenethyl)piperidin-2-ylidene)benzenesulfonamide | |
DBZP | 1,4-dibenzylpiperazine | |
2C-B-BZP | 1–(4-bromo-2,5-dimethoxybenzyl)-piperazine | |
pFPP | 1–(4-fluorophenyl)-piperazine | |
oMeOPP | 1–(2-methoxyphenyl)-piperazine | |
pCPP | 1–(4-chlorophenyl)-piperazine | |
pMeOPP | 1–(4-methoxyphenyl)-piperazine | |
3'-Me-BZP | 1–(3-methylbenzyl)piperazine | |
MBZP | 1-benzyl-4-methylpiperazine | |
pFBT | 8-methyl-8-azabicyclo[3.2.1]octan-3-yl 4-fluorobenzoate | |
WIN 35428 | methyl 3–(4-fluorophenyl)–8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate |
Chile
[edit]This is just a subset of the NPS banned in Chile, comprising the compounds banned on 15 October 2014. Notably these include not only a number of "NBOMe"-phenethylamines already banned in other jurisdictions, but also the less active 3-methoxybenzyl and 4-methoxybenzyl isomers which have not previously been mentioned anywhere else.
Common name | CAS number | Chemical name |
---|---|---|
25C-NBOMe | ||
25I-NBOMe | ||
25I-NBOH | ||
25H-NBOMe | ||
25H-NB3OMe | ||
25H-NB4OMe | ||
25B-NBOMe | ||
25B-NB3OMe | ||
25B-NB4OMe | ||
25C-NB3OMe | ||
25C-NB4OMe | ||
25D-NBOMe | ||
25D-NB3OMe | ||
25D-NB4OMe | ||
25E-NBOMe | ||
25E-NB3OMe | ||
25E-NB4OMe | ||
25I-NB3OMe | 1566571-63-8 | |
25I-NB4OMe | ||
25N-NBOMe | ||
25N-NB3OMe | ||
25N-NB4OMe | ||
25P-NBOMe | ||
25P-NB3OMe | ||
25P-NB4OMe | ||
25T2-NBOMe | ||
25T2-NB3OMe | ||
25T2-NB4OMe | ||
25T4-NBOMe | ||
25T4-NB3OMe | ||
25T4-NB4OMe | ||
25T7-NBOMe | ||
25T7-NB3OMe | ||
25T7-NB4OMe | ||
DOC | ||
DOI | ||
PMMA | ||
2C-T | ||
2C-T-2 | ||
2C-T-7 | ||
2C-C | ||
2C-I | ||
MBDB | ||
BDB | ||
4-HO-DiPT | ||
5-MeO-DMT | ||
5-MeO-MiPT | ||
5-MeO-DALT | ||
DiPT |
Sweden
[edit]Sweden's Public Health Authority recommends substances to be designated as drugs or hazardous to health every few months. The common names are not accompanied by a chemical name but substances can usually be identified elsewhere. [3]
Common name | Chemical name | Date proposed |
---|---|---|
Proscaline | July 2017 | |
RTI-111 | July 2017 | |
Bromazolam | July 2017 | |
Fluoroketamine | July 2017 | |
Deschloroethketamine | July 2017 | |
MO-CHMINACA | July 2017 | |
CUMYL-5F-P7AICA | July 2017 | |
4-F-N-ethylbuphedrone | July 2017 | |
N-isopropylnorhexedrone | July 2017 | |
alpha-PiHP | July 2017 | |
Benzodioxolylfentanyl | July 2017 | |
U-49900 | July 2017 | |
4-F-ethylphenidate | July 2017 | |
Cyclopropylfentanyl | Oct 2017 | |
4-F-isobutyrylfentanyl | Oct 2017 | |
Tetrahydrofuranylfentanyl | Oct 2017 | |
Methoxyacetylfentanyl | Oct 2017 | |
ETH-LAD | Oct 2017 | |
ALD-52 | Oct 2017 | |
U-48800 | Oct 2017 | |
Benzoylfentanyl | Oct 2017 | |
Tetramethylcyclopropylfentanyl | Oct 2017 | |
3-Phenylpropanoylfentanyl | Oct 2017 | |
4-AcO-MET | Oct 2017 | |
4-F-alpha-PiHP | Oct 2017 | |
4-fluoro-N-ethylpentedrone | Oct 2017 | |
6-EAPB | Oct 2017 |
Finland
[edit]The annex to the Government Decree on psychoactive substances banned from the consumer market (1130/2014), as amended by Decree No 899/2016, is amended as follows:
Common name | Chemical name |
---|---|
1-(2,3-dihydro-1H-inden-5-yl)-2-phenyl-2-(pyrrolidine-1-yl)ethan-1-one | |
1p-LSD | N,N-diethyl-6-methyl-1-propionyl-9,10-didehydroergoline-8-carboxamide |
2,3-Dimethyl-5-phenylmorpholine | |
2,3-dimethyl-6-phenylmorpholine | |
2,3-DMEC | 1-(2,3-dimethylphenyl)-2-(ethylamino)propan-1-one |
2,3-DMMC | 1-(2,3-dimethylphenyl)-2-(methylamino)propan-1-one |
2,3-DMPPP | 1-(2,3-dimethylphenyl)-2-(pyrrolidine-1-yl)propan-1-one |
2,4-DMEC | 1-(2,4-dimethylphenyl)-2-(ethylamino)propan-1-one |
2,4-DMMC | 1-(2,4-dimethylphenyl)-2-(methylamino)propan-1-one |
2,4-DMPPP | 1-(2,4-dimethylphenyl)-2-(pyrrolidine-1-yl)propan-1-one |
2,5-Dimethyl-3-phenylmorpholine | |
2,5-DMEC | 1-(2,5-dimethylphenyl)-2-(ethylamino)propan-1-one
2,5-DMMC (1-(2,5-dimethylphenyl)-2-(methylamino)propan-1-one) 2,6-Dimethyl-3-phenylmorpholine 2,6-DMEC (1-(2,6-dimethylphenyl)-2-(ethylamino)propan-1-one) 2,6-DMMC (1-2,6-dimethylphenyl)-2-(methylamino)propan-1-one) 25B-NBF (2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-fluorophenyl)methyl]ethan-1-amine) 25B-NBF isomer (2-(4-bromo-2,5-dimethoxyphenyl)-N-[(3-fluorophenyl)methyl]ethan-1-amine) 25B-NBF isomer (2-(4-bromo-2,5-dimethoxyphenyl)-N-[(4-fluorophenyl)methyl]ethan-1-amine) 25C-NBF (2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-fluorophenyl)methyl]ethanamine) 25B-NBOH (2-({[2-(4-bromo-2,5-dimethoxyphenyl)ethyl]amino}methyl)phenol) 25B-NBOH isomer (3-({[2-(4-bromo-2,5-dimethoxyphenyl)ethyl]amino}methyl)phenol) 25B-NBOH isomer (4-({[2-(4-bromo-2,5-dimethoxyphenyl)ethyl]amino}methyl)phenol) 25C-NBOH (2-({[2-(4-chloro-2,5-dimethoxyphenyl)ethyl]amino}methyl)phenol) 25D-NBOMe (2-(2,5-dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine) 25E-NBOMe (2-(2,5-dimethoxy-4-ethylphenyl)-N-(2-methoxybenzyl)ethanamine) 25G-NBOMe (2-(2,5-dimethoxy-3.4-dimethylphenyl)-N-(2-methoxybenzyl)ethanamine) 25I-NBMD (N-(1,3-benzodiox-4-ylmethyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethanamine) 25I-NBOH (2-({[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]amino}methyl)phenol) 25iP-NBOMe (2-[2,5-dimethoxy-4-(propan-2-yl)phenyl]-N-(2-methoxybenzyl)ethanamine) 25N-NBOMe (2-(2,5-dimethoxy-4-nitrophenyl)-N-(2-methoxybenzyl)ethanamine) 25I-NB34MD (N-(1,3-benzodioxol-5-ylmethyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethanamine) 25I-NBF (N-(2-fluorobenzyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethanamine) 2C-C (2-(2,5-dimethoxy-4-chlorophenyl)ethanamine) 2C-D (2-(2,5-dimethoxy-4-methylphenyl)ethanamine) 2C-E (2-(2,5-dimethoxy-4-ethylphenyl)ethanamine) 2C-G (2-(2,5-dimethoxy-3,4-dimethylphenyl)ethanamine) 2C-N (2-(2,5-dimethoxy-4-nitrophenyl)ethanamine) 2C-P (2-(2,5-dimethoxy-4-(n)-propylphenyl)ethanamine) 2C-T-4 (2-[2,5-dimethoxy-4-(propan-2-ylsulphanyl)phenyl]ethanamine) 2C-TFM (2-[2,5-dimethoxy-4-(trifluoromethyl)phenyl]ethan-1-amine) 3C-E (1-(3,5-dimethoxy-4-ethoxyphenyl)propan-2-amine) 3C-P (1-(3,5-dimethoxy-4-propoxyphenyl)propan-2-amine) 2-Chloro-4,5-MDMA (1-(6-chloro-1,3-benzodioxol-5-yl)-N-methylpropan-2-amine) 3,4-DMA NBOMe (1-(3,4-dimethoxyphenyl)-N-(2-methoxybenzyl)propan-2-amine) 3,4-DMeO-α-PHP (1-(3,4-dimethoxyphenyl)-2-(pyrrolidine-1-yl)hexan-1-one) 3,4-DMPPP (1-(3,4-dimethylphenyl)-2-(pyrrolidine-1-yl)propan-1-one) 3,4-MDPA (N-[1-(1,3-benzodioxole-5-yl)propan-2-yl]propan-1-amine) 3,5-DMEC (1-(3,5-dimethylphenyl)-2-(ethylamino)propan-1-one) 3,6-DMPM (3,6-dimethyl-2-phenylmorpholine) 2F-Phenetrazine (3-ethyl-2-(2-fluorophenyl)morpholine) 3F-Phenetrazine (3-ethyl-2-(3-fluorophenyl)morpholine) 4F-Phenetrazine (3-ethyl-2-(4-fluorophenyl)morpholine) 3F-Phenmetrazine (2-(3-fluorophenyl)-3-methylmorpholine) 2F-NEB (2-(ethylamino)-1-(2-fluorophenyl)butan-1-one) 3F-NEB (2-(ethylamino)-1-(3-fluorophenyl)butan-1-one) 4F-NEB (2-(ethylamino)-1-(4-fluorophenyl)butan-1-one) 3-Chloromethcathinone (3-CMC) (1-(3-chlorophenyl)-2-(methylamino)propan-1-one) 4-Bromo-α-PPP (1-(4-bromophenyl)-2-(pyrrolidine-1-yl)propan-1-one) 4-Bromo-α-pyrollidinovalerophenone (4Br-α-PVP) (1-(4-bromophenyl)-2-(pyrrolidine-1-yl)pentan-1-one) 4-EA NBOMe (1-(4-ethylphenyl)-N-(2-methoxybenzyl)propan-2-amine) 4-Ethylethcathinone (4-EEC) (2-(ethylamino)-1-(4-ethylphenyl)propan-1-one) 4-Fluoro-α-PHP (1-(4-fluorophenyl)-2-(pyrrolidine-1-yl)hexane-1-one) 4-Fluoro-α–pyrrolidinoenanthophenone (1-(4-fluorophenyl)-2-(pyrrolidine-1-yl)heptan-1-one) 4-Fluoro-α-pyrrolidinooctanophenone (4F-α-POP) (1-(4-fluorophenyl)-2-(pyrrolidine-1-yl)octan-1-one) 4-Fluoroethcathinone (4-FEC) (2-(ethylamino)-1-(4-fluorophenyl)propan-1-one) 4F-PBP (1-(fluorophenyl)-2-(pyrrolidine-1-yl)butan-1-one) 4-Chloro-α-PVP (1-(4-chlorophenyl)-2-(pyrrolidine-1-yl)pentan-1-one) 3-MeO-PCMo (4-[1-(3-methoxyphenyl)cyclohexyl]morpholine) 4-MeO-PCMo (4-[1-(4-methoxyphenyl)cyclohexyl]morpholine) 4-MeO-α-PV9 (1-(4-methoxyphenyl)-2-(pyrrolidine-1-yl)octan-1-one) 4-Methoxy-α-pyrrolidinobutanphenone (4-MeO-α-PBP) (1-(4-methoxyphenyl)-2-(pyrrolidine-1-yl)butan-1-one) 4-Methoxy-α–pyrrolidinoenanthophenone (4-MeO-α-PEP) (1-(4-methoxyphenyl)-2-pyrrolidine-1-yl)heptan-1-one) 4-Methylmethylphenidate (methyl-(4-methylphenyl)(piperidin-2-yl)acetate) 4-Methyl-N,N-diethyl cathinone (2-(diethylamino)-1-(4-methylphenyl)propan-1-one) 4-Methyl-N,N-dimethyl cathinone (2-(dimethylamino)-1-(4-methylphenyl)propan-1-one) 4-MMA NBOMe ((2-methoxybenzyl)-N-methyl-1-(4-methylphenyl)propan-2-amine) 5-APB NBOMe (1-(1-benzofuran-5-yl)-N-(2-methoxybenzyl)propan-2-amine) 5C-AKB48 (1-(5-chloropentyl)-N-(tricyclo[3.3.1.13,7]dec-1-yl)-1H-indazole-3-carboxamide) 5-Dihydrobenzofuran pyrovalerone (5-DBFPV) (1-(2,3-dihydro-1-benzofuran-5-yl)-2-(pyrrolidine-1-yl)pentan-1-one ) 5-Fluoropentyl-3-pyridinoylindole ([1-(5-fluoropentyl)-1H-indol-3-yl](pyridin-3-yl)methanone) 5F-AB-FUPPYCA (N-{1-5-fluoropentyl)-5-(4-fluorophenyl)-1H-pyrazole-3-yl]carbonyl}valineamide) 5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) 5F-ADBICA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide) 5F-ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) 5F-AKB48 (1-(5-fluoropentyl)-N-(tricyclo[3.3.1.1 3,7]dec-1-yl)-1H-indazole-3-carboxamide) 5F-AMB (methyl-N-{[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}valinate) 5F-AMB-PICA (methyl-N-{[1-(5-fluoropentyl)-1H-indol-3-yl]carbonyl}valinate) 5F-AMBICA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide) 5F-APP-PICA (N-{[1-(5-fluoropentyl)-1H-indol-3-yl]carbonyl}phenylalanineamide) 5F-APP-PINACA (N-{[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}phenylalanineamide) 5F-EDMB-PINACA (ethyl-N-[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]-3-methylvalinate) 5F-EMB-PINACA (ethyl-N-{[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}valinate) 5F-MDMB-PICA (N-[1-(5-fluoropentyl)-1H-indole-3-carbonyl]-3-methylvalinate) 5F-MDMB-PINACA (methyl-N-{[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}-3-methylvalinate) 5F-PB-22 indazole analog (quinolin-8-yl-1-(5-fluoropentyl)-1H-indazole-3-carboxylate) 5F-PY-PICA ([1-(5-fluoropentyl)-1H-indol-3-yl](pyrrolidine-1-yl)methanone) 5F-PY-PINACA ([1-(5-fluoropentyl)-1H-indazol-3-yl](pyrrolidine-1-yl)methanone) 5F-SDB-005 (naphthalen-2-yl -1-(5-fluoropentyl)-1H-indazole-3-carboxylate) 5F-SDB-006 (N-benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide) 5FUR-144 (XLR-11) ((1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) 5-MeO-EIPT (N-ethyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]propan-2-amine) A-796,260 ({1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)methanone) A-796,260 isomer ((2E)-3,4,4-trimethyl-1-{1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}pent-2-en-1-one) A-834,735 ([1-(tetrahydro-2H-pyran-4-methyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone) A-836,339 (N-[(2E)-3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2(3H)-ylidene]-2,2,3,3-tetramethylcyclopropanecarboxamide) AB-005 ([1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone) AB-CHMFUPPYCA (N-{[1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-yl]karbonyl}valineamide) AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) AB-FUBINACA 2-fluorobenzyl-isomer (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(2-fluorobenzyl)-1H-indazole-3-carboxamide) AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) AB-PINACA N-2-fluoropentyl-isomer (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(2-fluoropentyl)-1H-indazole-3-carboxamide) 4-AcO-DALT (3-{2-[di(prop-2-en-1-yl)amine]ethyl}-1H-indol-4-yl-acetate) 4-AcO-DET (3-[2-(diethylamino)ethyl]-1H-indol-4-yl-acetate) 4-AcO-DIPT (3-{2-[di(propan-2-yl)amine]ethyl}-1H-indol-4-yl-acetate) 4-AcO-DMT (3-[2-(diethylamino)ethyl]-1H-indol-4-yl-acetate) 4-AcO-DPT (3-[2-(dipropylamino)ethyl]-1H-indol-4-yl-acetate) 4-AcO-MET (3-{2-[ethyl(methyl)amine]ethyl}-1H-indol-4-yl-acetate) 4-AcO-MIPT (3-{2-[methyl(propan-2-yl)amine]ethyl}-1H-indol-4-yl-acetate) ADAMANTYL-THPINACA (1-(tetrahydro-2H-pyran-4-ylmethyl)-N-(tricyclo[3.3.1.1 3,7]dec-2-yl)-1H-indazole-3-carboxamide) ADB-CHMICA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indole-3-carboxamide) ADB-CHMINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ADBICA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indole-3-carboxamide) ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) Afloqualone (6-amino-2-(fluoromethyl)-3-(2-methylphenyl)quinazolin-4(3H)-one) α-Methylfentanyl butanamid analog (2-methyl-N-fenyl-N-[1-(1-fenylpropan-2-yl)piperidin-4-yl]propanamide) α-PBT (2-(pyrrolidine-1-yl)-1-(thiophen-2-yl)butan-1-one) α-PPP-MeO (3-methoxy-1-phenyl-2-(pyrrolidine-1-yl)propan-1-one) α-Pyrrolidinobutyrophenone (α-PBP) (1-phenyl-2-(1-pyrrolidine-1-yl)butan-one) α-Pyrrolidinoenanthophenone (α-PEP) (1-phenyl-2-(1-pyrrolidine-1-yl)heptan-1one) α-Pyrrolidinohexiophenone (α-PHP) (1-phenyl-2-(pyrrolidine-1-yl)hexan-1-one) α-Pyrrolidin-isohexaphenone (α-PHiP) (4-methyl-1-phenyl-2-(pyrrolidine-1-yl)pentan-1-one) α-Pyrrolidinononaphenone (α-PNP) (1-phenyl-2-(pyrrolidine-1-yl)nonan-1-one) α-Pyrrolidinooctanophenone (α-POP) (1-phenyl-2-(pyrrolidine-1-yl)octan-1-one) α-Pyrrolidinopropiophenone (PPP) (1-phenyl-2-(pyrrolidine-1-yl)propan-1-one) AKB-57 (1-adamantanyl-1-penthyl-1H-indazole-3-carboxylate) AL-LAD ((6aR,9R)-7-allyl-N,N-diethyl-6,6a,8,9-tetrahydro-4H-indol[4,3-fg]quinoline-9-carboxyamine) Allylescaline (AL) (2-[3,5-dimethoxy-4-(prop-2-en-1-yloxy)phenyl]ethanamine) AM-1220 ({1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}(naphthalen-1-yl)methanone) AM-1220 azepane isomer ([1-(1-methylazepan-3-yl)-1H-indol-3-yl](naphthalen-1-yl)methanone) AM-1248 ({1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}(tricyclo[3.3.1.1 3,7]dec-1-yl)methanone) AM-1248 azepane isomer ([1-(1-methylazepan-3-yl)-1H-indol-3-yl](tricyclo[3.3.1.1 3,7]dec-1-yl)methanone) AM-2201 benzimidazole analog (FUBIMINA) ((1-(5-fluoropentyl)-1H-benzo[d]imidazol-2-yl) (naphthalen-1-yl)methanone) AM-2201 indazole analog ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) AM-2201 indazolecarboxamide analog (1-(5-fluoropentyl)-N-(naphthalen-2-yl)-1H-indazole-3-carboxamide) AM-2201 carboxylate analog quinoline derivate (5F-PB-22) (quinolin-8-yl-1-(5-fluoropentyl)-1H-indol-3-carboxylate) AM-2232 ([3-(naphthalen-1-ylcarbonyl)-1H-indol-1-yl]pentanenitrile) AM-2233 ((2-iodophenyl){1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}methanone) AM-6527 (1-pentyl-N-(naphthalen-1-yl)-1H-indole-3-carboxamide) AM-6527 5-fluoropentyl derivate (1-(5-fluoropentyl)-N-(naphthalen-2-yl)-1H-indole-3-carboxamide) AM-679 ((1-pentyl-1H-indol-3-yl)(2-iodophenyl)methanone) AM-694 (1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone) AM-694 ethyl derivate ((2-ethylphenyl)[1-(5-fluoropentyl)-1H-indol-3-yl]methanone) AM-694 chlorine derivate (1-[(5-chloropentyl)-1H-indol-3-yl](2-iodophenyl)methanone) AM-694 methyl derivate ([1-(5-fluoropentyl)-1H-indol-3-yl]-(2-methylphenyl)methanone) AMB-CHMICA (methyl-N-[1-(cyclohexylmethyl)-3H-indol-1-ium-3-carbonyl]valinate) AMB-CHMINACA (methyl-N-{[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl}valinate) AMB-FUBICA (methyl N-{1-[(4-fluorophenyl)methyl]-1H-indole-3-carbonyl}valinate) AMB-FUBINACA (methyl-N-{[1-(4-fluorobenzyl)-1H-indazol-3-yl]carbonyl}valinate) APP-CHMINACA (N-α-[1-(cyclohexylmethyl)-1H-indazole-3-carbonyl]phenylalanineamide) APP-FUBINACA (N-{[1-(4-methylbenzyl)-1H-indazol-3-yl]carbonyl}phenylalanineamide) 3-Amino-1-phenylbutane (4-phenylbutane-2-amine) 2-Aminoindane (2-AI) (2,3-dihydro-1H-indene-2-amine) 2-(2-Aminopropyl)-2,3-dihydro-1H-indene (2-APDI) (1-(2,3-dihydro-1H-inden-2-yl)propan-2-amine) 3-(2-Aminopropyl)-2,3-dihydro-1H-indene (3-APDI) (1-(2,3-dihydro-1H-inden-3-yl)propan-2-amine) 4-(2-Aminopropyl)-2,3-dihydro-1H-indene (4-APDI) (1-(2,3-dihydro-1H-inden-4-yl)propan-2-amine) 5-(2-Aminopropyl)-2,3-dihydro-1H-indene (5-APDI) (1-(2,3-dihydro-1H-inden-5-yl)propan-2-amine) 6-(2-Aminopropyl)-2,3-dihydro-1H-indene (6-APDI) (1-(2,3-dihydro-1H-inden-6-yl)propan-2-amine) 7-(2-Aminopropyl)-2,3-dihydro-1H-indene (7-APDI) (1-(2,3-dihydro-1H-inden-7-yl)propan-2-amine) 2-(2-Aminopropyl)-2,3-dihydrobenzofurane (2-APDB) (1-(2,3-dihydro-1-benzofuran-2-yl)propan-2-amine) 3-(2-Aminopropyl)-2,3-dihydrobenzofurane (3-APDB) (1-(2,3-dihydro-1-benzofuran-3-yl)propan-2-amine) 4-(2-Aminopropyl)-2,3-dihydrobenzofurane (4-APDB) (1-(2,3-dihydro-1-benzofuran-4-yl)propan-2-amine) 5-(2-Aminopropyl)-2,3-dihydrobenzofurane (5-APDB) (1-(2,3-dihydro-1-benzofuran-5-yl)propan-2-amine) 6-(2-Aminopropyl)-2,3-dihydrobenzofurane (6-APDB) (1-(2,3-dihydro-1-benzofuran-6-yl)propan-2-amine) 7-(2-Aminopropyl)-2,3-dihydrobenzofurane (7-APDB) (1-(2,3-dihydro-1-benzofuran-7-yl)propan-2-amine) 2-(2-Aminopropyl)benzofurane (2-APB) (1-(1-benzofuran-2-yl)propan-2-amine) 3-(2-Aminopropyl)benzofurane (3-APB) (1-(1-benzofuran-3-yl)propan-2-amine) 4-(2-Aminopropyl)benzofurane (4-APB) (1-(1-benzofuran-4-yl)propan-2-amine) 7-(2-Aminopropyl)benzofurane (7-APB) (1-(1-benzofuran-7-yl)propan-2-amine) α-TMT (1-(1H-indol-3-yl)-N,N-dimethylpropan-2-amine) APINACA (1-pentyl-N-(tricyclo[3.3.1.1 3,7]dec-1-yl)-1H-indazole-3-carboxamide) 1-Acetyl-LSD (ALD-52) (1-acetyl-N,N-diethyl-6-methyl-9,10-didehydroergoline-8-carboxamide) BB-22 (quinolin-8-yl 1-(cyclohexylmethyl)-1H-indole-3-carboxylate) Benocyclidine (1-[1-(1-benzothiophen-2-yl)cyclohexyl]piperidine) Benzedrone (4-MBC) (2-(benzylamino)-1-(4-methylphenyl)propan-1-one) 2-Benzylamino-1-(3,4-methylenedioxyphenyl)butan-1-one (BMDB) (1-(1,3-bezodioxol-5-yl)-2-(benzylamino)butan-1-one) 2-Benzylamino-1-(3,4-methylenedioxyphenyl)propan-1-one (BMDP) (1-(1,3-benzodioxol-5-yl)-2-(benzylamino)propan-1-one) 4-Benzylpiperidine (4-(phenylmethyl)piperidine) β-Me-PEA (2-phenylpropan-1-amine) bk-2C-B (2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethanone) bk-IBP (1-(2,3-dihydro-1H-inden-5-yl)-2-(ethylamino)butan-1-one) bk-IVP (1-(2,3-dihydro-1H-inden-5-yl)-2-(ethylamino)pentan-1-one) 5-BPDi (1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidine-1-yl)hexan-1-one) Brefedrone (4-BMC) (1-(4-bromophenyl)-2-(methylamino)propan-1-one) 8-Bromo-2,3,6,7-benzo-dihydro-difurane-ethylamine (2C-B-Fly) (2-(8-bromo-2,3,6,7-tetrahydrofuro[2,3-f][1]benzofuran-4-yl)ethanamine) 4-Bromoamphetamine (4-BA) (1-(4-bromophenyl)propan-2-amine) 2-Bromomethoxetamine (2-(2-bromo-5-methoxyphenyl)-2-(ethylamino)cyclohexanone) 4-Bromoethcathinone (4-BEC) (1-(4-bromophenyl)-2-(ethylamino)propan-1-one) Buphedrone (2-(methylamino)-1-phenylbutan-1-one) Butylone (bk-MBDB) (1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one) CBL-018 (naphthalen-1-yl 1-pentyl-1H-indole-3-carboxylate) 2-CEC (1-(2-chlorophenyl)-2-(ethylamino)propan-1-one) 3-CEC (1-(3-chlorophenyl)-2-(ethylamino)propan-1-one) 4-CEC (1-(4-chlorophenyl)-2-(ethylamino)propan-1-one) 2-CIC (1-(2-chlorophenyl)-2-[(propan-2-yl)amino]propan-1-one) 3-CIC (1-(3-chlorophenyl)-2-[(propan-2-yl)amino]propan-1-one) 4-CIC (1-(4-chlorophenyl)-2-[(propan-2-yl)amino]propan-1-one) 2-CMA (1-(2-chlorophenyl)-N-methylpropan-2-amine) 3-CMA (1-(3-chlorophenyl)-N-methylpropan-2-amine) 4-CMA (1-(4-chlorophenyl)-N-methylpropan-2-amine) CP 47,497 (2-(3-hydroxycyclohexyl)-5-(2-methyloctan-2-yl)phenol); and its C6, C8, C9 homologs CRA-13 ((naphthalen-1-yl[4-pentyloxy)naphthalen-1-yl]methanone) CUMYL-4CN-BINACA (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) CUMYL-5F-P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) CUMYL-5FPICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide) CUMYL-5FPINACA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) CUMYL-BICA (1-butyl-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide) CUMYL-PICA (1-pentyl-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide) CUMYL-PINACA (1-pentyl-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) CUMYL-THPINACA (N-(2-phenylpropan-2-yl)-1-[(tetrahydro-2H-pyran-4-ylmethyl)-1H-indazole-3-carboxamide) DB-MDBP (1-[(2,2-difluoro-1,3-benzodioxol-5-yl)methyl]piperazine) Deschloroketamine (2-(methylamino)-2-phenyl-cyclohexanone) Deschloro-N-ethylketamine (O-PCE) (2-(ethylamino)-2-phenylcyclohexan-1-one) Desoxy-D2PM ((2R)-2-(diphenylmethyl)pyrrolidine) Dibutylone (bk-MMBDB) (1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)butan-1-one) Diphenidine (1-(1,2-difphenylethyl)piperidine) Diphenylprolinol (D2PM) (diphenyl[(2S)-pyrrolidin-2-yl]methanol) Diisopropyltryptamine (DIPT) (N-[2-(1H-indol-3-yl)ethyl]-N-(propan-2-yl)propan-2-amine) Dichloropropane (RTI-111) (methyl-3-(3,4-dichlorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate) Dimethocaine (3-(diethylamino)-2,2-dimethylpropyl-4-aminobenzoate) 2,4-Dimethoxyamphetamine (2.4-DMA) (1-(2,4-dimethoxyphenyl)propan-2-amine) 3,4-Dimethoxy-α-pyrollidinovalerophenone (3,4-DMeO-α-PVP) (1-(3,4-dimethoxyphenyl)-2-(pyrrolidine-1-yl)pentan-1-one) Dimethylone (bk-MDDMA) (1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)propan-1-one) Dimethylamphetamine (N,N-dimethyl-1-phenylpropan-2-amine) 3,4-Dimethylethcathinone (3,4-DMEC) (1-(3,4-dimethylphenyl)-2-(ethylamino)propan-1-one) 3,4-Dimethylmethcathinone (3,4-DMMC) (1-(3,4-dimethylphenyl)-2-(methylamino)propan-1-one) Dipentylone (1-(2H-1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one) Dipentylone isomer (1-(2H-1,3-benzodioxol-4-yl)-2-(dimethylamino)pentan-1-one) DMMA (1-(3,4-dimethoxyphenyl)-N-methylpropan-2-amine) DOC (1-(4-chloro-2,5-dimethoxyphenyl)propan-2-amine) DOF (1-(4-fluoro-2,5-dimethoxyphenyl)propan-2-amine) DOI (1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine) DOIP (1-[2,5-dimethoxy-4-(propan-2-yl)phenyl]propan-2-amine) DOPR (1-(2,5-dimethoxy-4-propylphenyl)propan-2-amine) EAM-2201 ((4-ethylnaphthalen-1-yl)[1-(5-fluoropentyl)-1H-indol-3-yl]methanone) Ephenidine (NEDPA) (N-ethyl-1,2-diphenylethan-1-amine) EFLEA (1-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-hydroxy-N-methylpropan-2-amine) Ephylone (1-(2H-1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one) EG-018 ((naphthalen-1-yl)(9-pentyl-9H-carbazol-3-yl)methanone) EG-2201 ([9-(5-fluoropentyl)-9H-carbazol-3-yl(naphthalen-1-yl)methanone) EMB-FUBINACA (ethyl-N-{[1-(4-fluorobenzyl)-1H-indazol-3-yl]carbonyl}valinate) Escaline (2-(4-ethoxy-3,5-dimethoxyphenyl)ethanamine) Etaqualone (3-(2-ethylphenyl)-2-methylquinazolin-4-one) Ethylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one) ETH-LAD (N,N,6-triethyl-9,10-didehydroergoline-8-carboxamide) Ethylcathinone (2-(ethylamino)-1-phenylpropan-1-one) Ethylnaphthidate (ethylnaphthalen-2-yl(piperidin-2-yl)acetate) 2-Ethylmethcathinone (2-EMC) ((1-(2-ethylphenyl)-2-(methylamino)propan-1-one)) 3-Ethylmethcathinone (3-EMC) ((1-(3-ethylphenyl)-2-(methylamino)propan-1-one)) 4-Ethylmethcathinone (4-EMC) (1-(4-ethylphenyl)-2-(methylamino)propan-1-one) Euthylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one) FDU-PB-22 (naphthalen-1-yl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate) Phenetrazine (3-ethyl-2-phenylmorpholine) 1-phenyl-2-(piperidin-1-yl)butan-1-one 1-phenylethylamine (1-PEA) (1-phenylethanamine) Flefedrone (4-FMC) (1-(4-fluorophenyl)-2-(methylamino)propan-1-one) 4-Fluoroethylphenidate (ethyl-(4-fluorophenyl)(piperidin-2-yl)acetate) 2-Fluorodeschloroketamine (2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one) 3-Fluorodeschloroketamine (2-(3-fluorophenyl)-2-(methylamino)cyclohexan-1-one) 4-Fluorodeschloroketamine (2-(4-fluorophenyl)-2-(methylamino)cyclohexan-1-one) 1-(4-Fluorophenyl)-2-(piperidin-1-yl)pentan-1-one 4-Fluorocathinone (2-amino-1-(4-fluorophenyl)propan-1-one) 2-Fluoromethcathinone (2-FMC) (1-(2-fluorophenyl)-2-(methylamino)propan-1-one) 3-Fluoromethcathinone (3-FMC) (1-(3-fluorophenyl)-2-(methylamino)propan-1-one) 4-Fluoromethylphenidate (methyl-(4-fluorophenyl)(piperidin-2-yl)acetate) 4-Fluoro-N-isopropylnorpentedrone (1-(4-fluorophenyl)-2-(propan-2-ylamine)pentan-1-one) 2-Fluoropentedrone (1-(2-fluorophenyl)-2-(methylamino)pentan-1-one) 3-Fluoropentedrone (1-(3-fluorophenyl)-2-(methylamino)pentan-1-one) 4-Fluoropentedrone (1-(4-fluorophenyl)-2-(methylamino)pentan-1-one) FUB-144 ([1-(4-fluorobenzyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone) FUB-AKB48 (1-(4-fluorobenzyl)-N-(tricyclo[3.3.1.1 3,7]dec-1-yl)-1H-indazole-3-carboxamide) FUB-JWH-018 ([1-(4-fluorobenzyl)-1H-indol-3-yl](naphthalen-1-yl)methanone) FUB-NPB-22 (quinolin-8-yl 1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxylate) FUB-PB-22 (quinolin-8-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate) G-130 (5,5-dimethyl-2-phenylmorpholine) Gamma-butyrolactone (GBL) (dihydrofuran-2(3H)-one) Harmine (7-methoxy-1-methyl-9H-ß-carboline) 4-HO-DET (3-[2-(diethylamino)ethyl]-1H-indol-4-ol) 4-HO-DIPT (3-{2-[di(propan-2-yl)amine]ethyl}-1H-indol-4-ol) 4-HO-MET (3-{2-[ethyl(methyl)amino]ethyl}-1H-indol-4-ol) 4-HO-MIPT (3-{2-[methyl(propan-2-yl))amino]ethyl}-1H-indol-4-ol) 4-HTMPIPO (4-hydroxy-3,3,4-trimethyl-1-(1-pentyl-1H-indol-3-yl)pentan-1-oni) HU-210 ((6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol) [4-(Hydroxymethyl)phenyl](1-pentyl-1H-indol-3-yl)methanone Ibogamine (12-methoxy-ibogamine) iso-Phenmetrazine (5-methyl-2-phenylmorpholine) Isopropylphenidate (propan-2-ylphenyl(piperidin-2-yl)acetate) 4-IT (1-(1H-indol-4-yl)propan-2-amine) 6-IT (1-(1H-indol-6-yl)propan-2-amine) 7-IT (1-(1H-indol-7-yl)propan-2-amine) 4-Iodo-2-aminoindane (4-IAI) (4-iodo-2-methyl-2,3-dihydro-1H-indene) 5-Iodo-2-aminoindane (5-IAI) (5-iodo-2-methyl-2,3-dihydro-1H-indene) JWH-007 ((2-methyl-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone) JWH-015 ((2-methyl-1-propyl-1H-indol-3-yl)(naphthalen-1-yl)methanone) JWH-018 adamantoyl derivate (AB-001) ((1-phenyl-1H-indol-3-yl)(tricyclo[3.3.1.1 3,7]dec-1-yl)methanone) JWH-018 adamantoyl carboxamide derivate (APICA) (1-pentyl-N-(tricyclo[3.3.1.1 3,7]dec-1-yl)-1H-indole-3-carboxamide) JWH-018 indazole analog (THJ-018) (naphthalen-1-yl(1-pentyl-1H-indazol-3-yl)methanone) JWH-018 quinoline carboxylate analog (PB-22) (quinolin-8-yl-1-pentyl-1H-indole-3-carboxylate) JWH-018 N-5-bromopentyl derivate ([1-(5-bromopentyl)-1H-indol-3-yl](naphthalen-1-yl)methanone) JWH-018 N-5-chloropentyl derivate ([1-(5-chloropentyl)-1H-indol-3-yl](naphthalen-1-yl)methanone) JWH-018 cyclohexylmethyl derivative ([1-(cyclohexylmethyl)-1H-indol-3-yl](naphthalene-1-yl)methanone) JWH-019 ((1-hexyl-1H-indol-3-yl)(naphthalen-1-yl)methanone) JWH-022 (naphthalen-1-yl[1(pent-4-en-1-yl)-1H-indol-3-yl]methanone) JWH-030 (naphthalen-1-yl(1-pentyl-1H-pyrrol-3-yl)methanone) JWH-071 ((1-ethyl-1H-indol-3-yl)(naphthalen-1-yl)methanone) JWH-073 methyl derivate ((1-butyl-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone) JWH-122 ((4-methylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone) JWH-122 pentenyl 2-methyl-indol derivate ((4-methylnaphthalen-1-yl)(2-methyl-1(pent-4-en-1-yl)-1H-indol-3-yl)methanone) JWH-122 pentenyl derivate ((4-methylnaphthalen-1-yl)(1-(pent-4-en-1-yl)-1H-indol-3-yl)methanone) JWH-145 (naphthalen-1-yl(1-pentyl-5-phenyl-1H-pyrrol-3-yl)methanone) JWH-182 ((1-pentyl-1H-indol-3-yl)(4-propylnaphthalen-1-yl)methanone) JWH-200 (1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole) JWH-203 (2-(2-chlorophenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone) JWH-210 ((4-ethylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone) JWH-250 (2-(2-methoxhyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone) JWH-250 1-(2-methylen-N-methylen-piperidyl) derivate (2-(2-methoxhyphenyl)-1-{1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}ethanone) JWH-251 (2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone) JWH-302 (2-(3-methoxhyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone) JWH-307 ([5-(2-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone) JWH-307 bromo analog ((5-(2-bromophenyl)-1-pentyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone) JWH-368 ([5-(3-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone) JWH-370 ([5-(2-methylphenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone) JWH-387 ((4-bromonaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone) JWH-398 ((4-chloronaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone) JWH-412 ((4-fluoronaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone) JWH-412 5-fluoropentyl derivate ((4-fluoronaphthalen-1-yl)[1-(5-fluoropentyl)-1H-indol-3-yl]methanone) Camfetamine (N-methyl-3-phenylbicyclo[2.2.1]heptan-2-amine) Clephedrone (1-(4-chlorophenyl)-2-(methylamino)propan-1-one) 2-Chloro-α-PVP (1-(2-chlorophenyl)-2-(pyrrolidine-1-yl)pentan-1-one) 3-Chloro-α-PVP (1-(3-chlorophenyl)-2-(pyrrolidine-1-yl)pentan-1-one) 4'-Chloro-α–pyrrolidinopropiophenone (4'-chlore-α-PPP) (1-(4-chlorophenyl)-2-(pyrrolidine-1-yl)propan-1-one) 4-Chloroamphetamine (4-CA) (1-(4-chlorophenyl)propan-2-amine) 2-Chloro-N,N-dimethylcathinone (1-(2-chlorophenyl)-2-(dimethylamino)propan-1-one) 3-Chloro-N,N-dimethylcathinone (1-(3-chlorophenyl)-2-(dimethylamino)propan-1-one) 4-Chloro-N,N-dimethylcathinone (1-(4-chlorophenyl)-2-(dimethylamino)propan-1-one) Kratom (Mitragyna speciosa) LTI-701 (1-(5-fluoropentyl)-N-phenyl-1H-indole-3-carboxamide) Lysergic acid 2,4-dimethylazetidide (LSZ) ([(2S, 4S)-2,4-dimethylacetidin-1-yl][(8b)-6-methyl-9,10-didehydroergol-8-yl]methanone) M5FPIC (methyl-1-(5-fluoropentyl)-1H-indole-carboxylate) 2-MABB (1-(1-benzofuran-2-yl)-N-methylbutan-2-amine) 3-MABB (1-(1-benzofuran-3-yl)-N-methylbutan-2-amine) 4-MABB (1-(1-benzofuran-4-yl)-N-methylbutan-2-amine) 5-MABB (1-(1-benzofuran-5-yl)-N-methylbutan-2-amine) 6-MABB (1-(1-benzofuran-6-yl)-N-methylbutan-2-amine) 7-MABB (1-(1-benzofuran-7-yl)-N-methylbutan-2-amine) MAM-2201 chloropentyl derivate ([1-(5-chloropentyl)-1H-indol-3-yl](4-methylinaphthalen-1-yl)methanone) 2-MAPDB (1-(2,3-dihydro-1-benzofuran-2-yl)-N-methylpropan-2-amine) 3-MAPDB (1-(2,3-dihydro-1-benzofuran-3-yl)-N-methylpropan-2-amine) 4-MAPDB (1-(2,3-dihydro-1-benzofuran-4-yl)-N-methylpropan-2-amine) 5-MAPDB (1-(2,3-dihydro-1-benzofuran-5-yl)-N-methylpropan-2-amine) 6-MAPDB (1-(2,3-dihydro-1-benzofuran-6-yl)-N-methylpropan-2-amine) 7-MAPDB (1-(2,3-dihydro-1-benzofuran-7-yl)-N-methylpropan-2-amine) 5-MAPDI (1-(2,3-dihydro-1H-inden-5-yl)-N-methylpropan-2-amine) MBDB (1-(1,3-benzodioxol-5-yl)-N-methylbutan-2-amine) MBZP (1-benzyl-4-methylpiperazine) M-CHMIC (1-(cyclohexylmethyl)-2-methyl-1H-indole-3-carboxylate) MDA 19 (N'-(1-hexyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide) MDDM (1-(1,3-benzodioxol-5-yl)-N,N-dimethylpropan-2-amine) MDMB-CHMCZCA (methyl-N-[9-(cyclohexylmethyl)-9H-carbazole-3-carbonyl]-3-methylvalinate) MDMB-FUBINACA (methyl-N-{1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}-3-methylvalinate) MDPHP (1-(1,3-benzodiox-5-yl)-2-(pyrrolidine-1-yl)hexan-1-one) McPT (N-[2-(1H-indol-3-yl)ethyl]-N-methylcyclopropanamine) MDMB-FUBICA (methyl-N-{[1-(4-fluorobenzyl)-1H-indol-3-yl]carboxamide}-3-methylvalinate) Mebroqualone (3-(2-bromophenyl)-2-methylquinazolin-4(3H)-one) 2-MEC (2-(ethylamino)-1-(2-methylphenyl)propan-1-one) 2-Me-DMT (N,N-dimethyl-2-(2-methyl-1H-indol-3-yl)ethanamine) Mexedrone (3-methoxy-2-(methylamino)-1-(4-methylphenyl)propan-1-one) 5-MeO-AMT (1-(5-methoxy-1H-indol-3-yl)propan-2-amine) 5-MeO-DALT (N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-(prop-2-en-1-yl)prop-2-en-1-amine) 5-MeO-DET (N,N-diethyl-2-(5-methoxy-1H-indol-3-yl)ethanamine) 5-MeO-DIBF (N-[2-(5-methoxy-1-benzofuran-3-yl)ethyl]-N-(propan-2-yl)propan-2-amine) 5-MeO-DIPT (N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-(propan-2-yl)propan-2-amine) 5-MeO-DMT (2-(5-methoxy-1H-indol-3-yl)-N,N-dimethylethanamine) 5-MeO-DPT (N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-propylpropan-1-amine) 5-MeO-MALT (N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methyl-prop-2-en-1-amine) 5-MeO-MET (N-ethyl-2-(5-methoxy-1H-indol-3-yl)-N-methylethanamine) 5-MeO-MIPT (N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amine) 2-MeO-PCMMo (4-{[1-(2-methoxyphenyl)cyclohexyl]methyl}morpholine) 3-MeO-PCMMo (4-{[1-(3-methoxyphenyl)cyclohexyl]methyl}morpholine) 4-MeO-PCMMo (4-{[1-(4-methoxyphenyl)cyclohexyl]methyl}morpholine) 2-MeO-PCMo (4-[1-(2-methoxyphenyl)cyclohexyl]morpholine) Mepirapim ((4-methylpiperazin-1-yl)-(1-pentyl-1H-indol-3-yl)methanone) Methallylescaline (MAL) (2-{3,5-dimethoxy-4-[(2-methylprop-2-en-1-yl)oxy]phenyl}ethanamine) Metamfepramone (2-(dimethylamino)-1-phenylpropan-1-one) Methamnetamine (N-methyl-1-(naphthalen-2-yl)propan-2-amine) Metanandamide ((5Z,8Z,11Z,14Z)-N-(1-hydroxypropan-2-yl)icosa-5,8,11,14-tetraenamide) Methedrone (bk-PMMA) (1-(4-methoxyphenyl)-2-(methylamino)propan-1-one) 2-Methoxyamphetamine (1-(2-methoxyphenyl)propan-2-amine) 2-Methoxydiphenidine (2-MeO-diphenidine) (1-[1-(2-methoxyphenyl)-2-phenylethyl]piperidine) 2-Methoxyeticyclidine (2-MeO-PCE) (N-ethyl-1-(2-methoxyphenyl)cyclohexaniamine) 3-Methoxyeticyclidine (3-MeO-PCE) (N-ethyl-1-(3-methoxyphenyl)cyclohexaniamine) 4-Methoxyeticyclidine (4-MeO-PCE) (N-ethyl-1-(4-methoxyphenyl)cyclohexaniamine) 4-Methoxyphenyl (1-methyl-1H-indol-3-yl)methanone 2-Methoxyketamine (2-MeO-ketamine) (2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone) 3-Methoxyketamine (3-MeO-ketamine) (2-(3-methoxyphenyl)-2-(methylamino)cyclohexanone) 4-Methoxyketamine (4-MeO-ketamine) (2-(4-methoxyphenyl)-2-(methylamino)cyclohexanone) 3-Methoxymethcathinone (3-MeOMC) (1-(3-methoxyphenyl)-2-(methylamino)propan-1-one) 5-Methoxy-N-isopropyltryptamine (5-MeO-NiPT) (N-[2-(5-methoxy-1H-indol-3-yl)ethyl]propan-2-amine) Methoxypiperamide ((4-methoxyphenyl)(4-methylpiperazin-1-yl)methanone) 4'-Methoxy-α-pyrrolidinepropiophenone (MOPPP) (1-(4-methoxyphenyl)-2-(pyrrolidine-1-yl)propan-1-one) 4-Methoxy-α-pyrrolidinevalerophenone (4-MeO-α-PVP) (1-(4-methoxyphenyl)-2-(pyrrolidine-1-yl)pentan-1-one) 4,5-Methylenedioxy-2-aminoindane (4,5-MDAI) (7,8-dihydro-6H-indeno[4,5-d][1,3]dioxol-7-amine) 5,6-Methylenedioxy-2-aminoindane (MDAI) (6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine) 1-(3,4-Methylenedioxyphenyl)-2-methyl-2-pyrrolidinyl-1-propanone (MDMPP) (1-(1,3-benzodioxol-5-yl)-2-methyl-2-(pyrrolidine-1-yl)propan-1-one) 3’,4'-Methylenedioxy-α-pyrrolidinobutyrophenone (MDPBP) (1-(1,3-benzodioxol-5-yl)-2-(pyrrolidine-1-yl)butan-1-one) 3’,4'-Methylenedioxy-α-pyrrolidinopropiophenone (MDPPP) (1-(1,3-benzodioxol-5-yl)-2-(pyrrolidine-1-yl)propan-1-one) 1-Methylamino-1-(3,4-methylenedioxyphenyl)propane (M-ALPHA) (1-(1,3-benzodioxol-5-yl)-N-methylpropan-1-amine) 4-Methylbufedron (4-Me-MABP) (2-(methylamino)-1-(4-methylphenyl)butan-1-one) 4-Methylethcathinone (4-MEC) (2-(ethylamino-1-(4-methylphenyl)propan-1-one) 3-Methylethcathinone (3-MEC) (2-(ethylamino)-1-(3-methylphenyl)propan-1-one) 4-Methylphendimetrazine (3,4-dimethyl-2-(4-methylphenyl)morpholine) 4-Methylmethamphetamine (4-MMA) (N-methyl-1-(4-methylphenyl)propan-2-amine) 2-Methylmethcathinone (2-MMC) (2-(methylamino)-1-(2-methylphenyl)propan-1-one) 3-Methylmethcathinone (3-MMC) (2-(methylamino)-1-(3-methylphenyl)propan-1-one) 4-Methyl-N-ethylnorpentedrone (2-(ethylamino)-1-(4-methylphenyl)pentan-1-one) 4-Methylpentedrone (2-(methylamino)-1-(4-methylphenyl)pentan-1-one) 4-Methyl-α-pyrrolidinbutyrophenone (MPBP) (1-(4-methylphenyl)-2-(pyrrolidine-1-yl)butan-1-one) 4-Methyl-α-pyrrolidinhexanophenone (MPHP) (1-(4-methylphenyl)-2-(pyrrolidine-1-yl)hexan-1-one) 4-Methyl-α-pyrrolidinepropiophenone (4'-methyl-α-PPP) (1-(4-methylphenyl)-2-(pyrrolidine-1-yl)propan-1-one) Methylmethaqualone (3-(2,4-dimethylphenyl)-2-methylquinazolin-4(3H)-one) Methylmorphenate (methyl-(morpholin-3-yl)(phenyl)acetate) Methylnaphthidate (HDMP-28) (methylnaphthalen-2-yl(piperidin-2-yl)acetate) MN-18 (N-(naphthalen-1-yl)-1-pentyl-1H-indazole-3-carboxamide) Modafiendz (2-{[bis(4-fluorophenyl)methyl]sulfinyl}-N-methylacetamide) MO-CHMINACA (1-methoxy-3,3-dimethyl-1-oxobutan-2-yl 1-(cyclohexylmethyl)-1H-indazole-3-carboxylate) 2-MPH (3-methyl-2-(2-methylphenyl)morpholine) 3-MPH (3-methyl-2-(3-methylphenyl)morpholine) 4-MPH (3-methyl-2-(4-methylphenyl)morpholine) N-(2-methoxyethyl)-N-(1-methylethyl)-2-(1-pentyl-1H-indol-3-yl)-4-tiazol methanamine N,N-diallyltryptamine (DALT) (N-[2-(1H-indol-3-yl)ethyl]-N-(prop-2-en-1-yl)prop-2-en-1-amine) N,N-diethyl-2-(1-pentyl-1H-indol-3-yl)-4-tiazol methanamine N,N-dipropyltryptamine (DPT) (N-[2-(1H-indol-3-yl)ethyl]-N-propylpropan-1-amine) 1-Nafyron (1-(naphthalen-1-yl)-2-(pyrrolidine-1-yl)pentan-1-one) Nafyron (1-(naphthalen-2-yl)-2-pyrrolidine-1-yl)pentan-1-one) 2-(N-ethyl-2-aminopropyl)benzofuran (2-EAPB) (1-(1-benzofuran-2-yl)-N-ethylpropan-2-amine)3-(N-ethyl-2-aminopropyl)benzofuran (3-EAPB) (1-(1-benzofuran-3-yl)-N-ethylpropan-2-amine) 4-(N-ethyl-2-aminopropyl)benzofuran (4-EAPB) (1-(1-benzofuran -4-yl)-N-ethylpropan-2-amine) 5-(N-ethyl-2-aminopropyl)benzofuran (5-EAPB) (1-(1-benzofuran -5-yl)-N-ethylpropan-2-amine) 6-(N-ethyl-2-aminopropyl)benzofuran (6-EAPB) (1-(1-benzofuran -6-yl)-N-ethylpropan-2-amine) 7-(N-ethyl-2-aminopropyl)benzofuran (7-EAPB) (1-(1-benzofuran -7-yl)-N-ethylpropan-2-amine) N-ethyl-2C-B (2-(4-bromo-2,5-dimethoxyphenyl)-N-ethylethanamine) N-ethylbuphedrone (2-(ethylamino)-1-phenylbutan-1-one) N-ethylhexedrone (2-(ethylamino)-1-phenylhexan-1-one) N-ethylnorketamine (2-(2-chlorophenyl)-2-(ethylamino)cyclohexanone) N-ethylnorpentedrone (α-ethylaminopentiophenone) (2-(ethylamino)-1-phenylpentan-1-one) NiPP (1-phenyl-2-[(propan-2-yl)amino]pentan-1-one) Nitracaine (3-(N,N-diethylamino-2,2-dimethylpropyl)-4-nitrobenzoate) NM-2201 (Naphthalen-1-yl-1-(5-fluoropentyl)-1H-indole-3-carboxylate) N-methyl-2-aminoindane (N-methyl-2AI) (N-methyl-2,3-dihydro-1H-indene-2-amine) N-methyl-bk-MMDA-2 (1-(6-methoxy-1,3-benzodiox-5-yl)-2-(methylamino)propan-1-one) 2-(N-methyl-2-aminopropyl)benzofuran (2-MAPB) (1-(1-benzofuran-2-yl)-N-methylpropan-2-amine) 3-(N-methyl-2-aminopropyl)benzofuran (3-MAPB) (1-(1-benzofuran-3-yl)-N-methylpropan-2-amine) 4-(N-methyl-2-aminopropyl)benzofuran (4-MAPB) (1-(1-benzofuran-4-yl)-N-methylpropan-2-amine) 5-(N-methyl-2-aminopropyl)benzofuran (5-MAPB) (1-(1-benzofuran-5-yl)-N-methylpropan-2-amine) 6-(N-methyl-2-aminopropyl)benzofuran (6-MAPB) (1-(1-benzofuran-6-yl)-N-methylpropan-2-amine) 7-(N-methyl-2-aminopropyl)benzofuran (7-MAPB) (1-(1-benzofuran-7-yl)-N-methylpropan-2-amine) N-methylbenzedrone (2-[benzyl(methyl)amino]-1-(4-methylphenyl)propan-1-one) N-methylbenzedrone isomer (2-[benzyl(methyl)amino]-1-(2-methylphenyl)propan-1-one) N-methylbenzedrone isomer (2-[benzyl(methyl)amino]-1-(3-methylphenyl)propan-1-one) N-methyl-bk-MMDA-5 (1-(7-methoxy-2H-1,3-benzodioxol-5-yl)-2-(methylamino)propan-1-one) N-methyl-2C-B (2-(4-bromo-2,5-dimethoxyphenyl)-N-methylethanamine) N-methyl-N-ethyltryptamine (MET) (N-ethyl-2-(1H-indol-3-yl)-N-methylethanamine) N-methyl-N-isopropyltryptamine (MIPT) (N-[2-(1H-indol-3-yl)ethyl]-N-methylpropan-2-amine) Normephedrone (2-amino-1-(4-methylphenyl)propan-1-one) NPDPA (N-(1,2-diphenylethyl)propan-2-amine) N-propylamphetamine (PA) (N-(1-phenylpropan-2-yl)propan-1-amine) Org 27569 (5-chloro-3-ethyl-N-{2-[4-(piperidin-1-yl)phenyl]ethyl}-1H-indol-2-carboxamide) Org 27759 (N-{2-[4-(dimethylamino)phenyl]ethyl}-3-ethyl-5-fluoro-1H-indole-2-carboxamide) Org 29647 (N-(1-benzylpyrrolidin-3-yl)-5-chloro-3-ethyl-1H-indol-2-carboxamide) PB-22 indazole analog (quinolin-8-yl 1-pentyl-1H-indazole-3-carboxylate) PDM-35 (3,5-dimethyl-2-phenylmorpholine) Pentedrone (2-(methylamino)-1-phenylpentan-1-one) Pentylone (1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one) p-Fluorophenylpiperazine (pFPP) (1-(4-fluorophenyl)piperazine) 3-(p-fluorobenzoyl)tropane (pFBT) (8-methyl-8-azabicyclo[3.2.1]oct-3-yl-4-fluorobenzoate) p-Methoxyphenylpiperazine (pMeOPP) (1-(4-methoxyphenyl)piperazine) p-Methoxy-N-ethylamphetamine (PMEA) (N-ethyl-1-(4-methoxyphenyl)propan-2-amine) 2-PPDi (1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidine-1-yl)butan-1-one) Pravadoline (WIN 48,098) ((4-methoxyphenyl){3-methyl-2-[2-(morpholin-4-yl)ethyl]-1,2,3,4-tetrahydroisoquinolin-4-yl}methanone) Propylone (1-(2H-1,3-benzodioxol-5-yl)-2-(propylamino)propan-1-one) Propylphenidate (propyl-2-phenyl-2-(piperidin-2-yl)acetate) Propylcathinone (1-phenyl-2-(propylamino)propan-1-one) Pyrazolam (8-bromo-1-methyl-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine) RCS-4 ((4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone) RCS-4 ortho isomer ((2-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone) RCS-4(C4) (4-methoxyphenyl-(1-butyl-1H-indol-3-yl)methanone) RH-34 (3-{2-[(2-methoxybenzyl)amino]ethyl}-quinazoline-2,4(1H,3H)-dione) Salvia Divinorum (containing salvinorin A and B) SDB-005 (naphthalen-1-yl-1-pentyl-1H-indazole-3-carboxylate) SDB-006 (N-benzyl-1-pentyl-1H-indole-3-carboxamide) STS-135 (1-(5-fluoropentyl)-N-(tricyclo[3.3.1.1]dec-1-yl)-1H-indole-3-carboxamide) 1-Cyclohexylmethyl-2-(4-ethoxybenzyl)-N,N-diethyl-1H-benzimidazole-5-carboxamide tBuONE (1-(2H-1,3-benzodioxol-5-yl)-2-(tert-butylamino)propan-1-one) TFMPP (1-[3-(trifluoromethyl)phenyl]piperazine) TH-PHP (2-(pyrrolidine-1-yl)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)hexan-1-one) TH-PVP (2-(pyrrolidine-1-yl)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)pentan-1-one) Thienoamphetamine (1-(thiophen-2-yl)propan-2-amine) trans-CP 47,497-C8 (4-(2,2-dimethylnonyl)-2-methyl-1-(3-methylcyclohexyl)benzene) 2,4,6-Trimethoxyamphetamine (TMA-6) (1-(2,4,6-trimethoxyphenyl)propan-2-amine) 2,4,5-Trimethylmethcathinone (2,4,5-TMMC) (2-(methylamino)-1-(2,4,5-trimethylphenyl)propan-1-one) UR-144 ((2-pentyl-1,2-dihydroisoquinolin-4-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) W-15 (4-chloro-N-(1-phenylethylpiperidin-2-ylidene)-benzenesulfonamide) W-18 (4-chloro-N-{1-[2-(4-nitrophenyl)ethyl]piperidin-2-ylidene}benzenesulfonamide) WIN 55212-2 (1,4-dihydronaphthalen-1-yl[5-methyl-3-(morpholin-4-ylmethyl)-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl]methanone) |
25B-NBF | 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-fluorophenyl)methyl]ethan-1-amine |
25B-NBF isomer | 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(3-fluorophenyl)methyl]ethan-1-amine |
25B-NBF isomer | 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(4-fluorophenyl)methyl]ethan-1-amine |
25B-NBOH | 2-({[2-(4-bromo-2,5-dimethoxyphenyl)ethyl]amino}methyl)phenol |
25B-NBOH isomer | 3-({[2-(4-bromo-2,5-dimethoxyphenyl)ethyl]amino}methyl)phenol |
25B-NBOH isomer | 4-({[2-(4-bromo-2,5-dimethoxyphenyl)ethyl]amino}methyl)phenol |
2C-TFM | 2-[2,5-dimethoxy-4-(trifluoromethyl)phenyl]ethan-1-amine |
2F-NEB | 2-(ethylamino)-1-(2-fluorophenyl)butan-1-one |
3F-NEB | 2-(ethylamino)-1-(3-fluorophenyl)butan-1-one |
3MeO-PCMo | 4-[1-(3-methoxyphenyl)cyclohexyl]morpholine |
4F-NEB | 2-(ethylamino)-1-(4-fluorophenyl)butan-1-one |
4MeO-PCMo | 4-[1-(4-methoxyphenyl)cyclohexyl]morpholine |
5F-ADB-PINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide |
5F-EDMB-PINACA | ethyl N-[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]-3-methylvalinate |
5F-MDMB-PICA | N-[1-(5-fluoropentyl)-1H-indole-3-carbonyl]-3-methylvalinate |
AB-PINACA N-2-fluoropentyl-isomer | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(2-fluoropentyl)-1H-indazole-3-carboxamide |
α-PHiP | 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one |
α-PPP-MeO | 3-methoxy-1-phenyl-2-(pyrrolidin-1-yl)propan-1-one |
AMB-FUBICA | methyl N-{1-[(4-fluorophenyl)methyl]-1H-indole-3-carbonyl}valinate |
APP-CHMINACA | N-α-[1-(cyclohexylmethyl)-1H-indazole-3-carbonyl]phenylenediamine |
5-BPDi | 1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)hexan-1-one |
CUMYL-5F-P7AICA | 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide |
Deschloro-N-ethylketamine (O-PCE) | 2-(ethylamino)-2-phenylcyclohexan-1-one |
Dichloropropane (RTI-111) | methyl-3-(3,4-dichlorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate |
Dipentylone | 1-(2H-1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one |
Dipentylone isomer | 1-(2H-1,3-benzodioxol-4-yl)-2-(dimethylamino)pentan-1-one |
Ephenidine (NEDPA) | N-ethyl-1,2-diphenylethan-1-amine |
EG-018 | (naphthalen-1-yl)(9-pentyl-9H-carbazol-3-yl)methanone |
ETH-LAD | N,N,6-triethyl-9,10-didehydroergoline-8-carboxamide |
2-Fluorodeschloroketamine | 2-(2-fluorophenyl)-2-(methylamino)cyclohexyl-1-one |
3-Fluorodeschloroketamine | 2-(3-fluorophenyl)-2-(methylamino)cyclohexyl-1-one |
4-Fluorodeschloroketamine | 2-(4-fluorophenyl)-2-(methylamino)cyclohexyl-1-one |
2-Fluoropentedrone | 1-(2-fluorophenyl)-2-(methylamino)pentan-1-one |
3-Fluoropentedrone | 1-(3-fluorophenyl)-2-(methylamino)pentan-1-one |
4-Fluoropentedrone | 1-(4-fluorophenyl)-2-(methylamino)pentan-1-one |
FUB-NPB-22 | quinolin-8-yl 1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxylate |
G-130 | 5,5-dimethyl-2-phenylmorpholine |
4-IT | 1-(1H-indol-4-yl)propan-2-amine |
6-IT | 1-(1H-indol-6-yl)propan-2-amine |
7-IT | 1-(1H-indol-7-yl)propan-2-amine |
JWH-071 | (1-ethyl-1H-indol-3-yl)(naphthalen-1-yl)methanone |
5-MAPDI | 1-(2,3-dihydro-1H-inden-5-yl)-N-methylpropan-2-amine |
MDA 19 | N'-(1-Hexyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide |
MDMB-FUBINACA | methyl-N-{1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}-3-methylvalinate |
2-MeO-PCMMo | 4-{[1-(2-methoxyphenyl)cyclohexyl]methyl}morpholine |
3-MeO-PCMMo | 4-{[1-(3-methoxyphenyl)cyclohexyl]methyl}morpholine |
4-MeO-PCMMo | 4-{[1-(4-methoxyphenyl)cyclohexyl]methyl}morpholine |
2-MeO-PCMo | 4-[1-(2-methoxyphenyl)cyclohexyl]morpholine |
Methylmorphenate | methyl-(morpholin-3-yl)(phenyl)acetate |
MO-CHMINACA | 1-methoxy-3,3-dimethyl-1-oxobutan-2-yl 1-(cyclohexylmethyl)-1H-indazole-3-carboxylate |
N-Ethylhexedrone | 2-(ethylamino)-1-phenylhexan-1-one |
N-Ethyl-(nor)-Pentedrone | 2-(ethylamino)-1-phenylpentan-1-one |
N-Methylbenzedrone | 2-[benzyl(methyl)amino]-1-(4-methylphenyl)propan-1-one |
N-Methylbenzedrone isomer | 2-[benzyl(methyl)amino]-1-(2-methylphenyl)propan-1-one |
N-Methylbenzedrone isomer | 2-[benzyl(methyl)amino]-1-(3-methylphenyl)propan-1-one |
N-methyl-bk-MMDA-5 | 1-(7-methoxy-2H-1,3-benzodioxol-5-yl)-2-(methylamino)propan-1-one |
NPDPA | N-(1,2-diphenylethyl)propan-2-amine |
SDB-005 | naphthalen-1-yl-1-pentyl-1H-indazole-3-carboxylate |
TH-PVP | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)pentan-1-one |
1-(1,3-difenyylipropan-2-yyli)pyrrolidiini
1-(2,3-dihydro-1H-inden-5-yyli)-2-fenyyli-2-(pyrrolidin-1-yyli)etan-1-oni
1B-LSD (4-butyryyli-N,N-dietyyli-7-metyyli-4,6,6a,7,8,9-heksahydroindoli[4,3-fg]kinoliini-9-karboksamidi)
1-cP-LSD (4-(syklopropaanikarbonyyli)-N,N-dietyyli-7-metyyli-4,6,6a,7,8,9-heksahydroindoli[4,3-fg]kinoliini-9-karboksamidi)
1P-ETH-LAD (N,N,6-trietyyli-1-propanoyyli-9,10-didehydroergoliini-8-karboksamidi)
1p-LSD (N,N-dietyyli-6-metyyli-1-propanoyyli-9,10-didehydroergoliini-8-karboksamidi)
2,3-Dimetyyli-5-fenyylimorfoliini
2,3-Dimetyyli-6-fenyylimorfoliini
2,3-DMEC (1-(2,3-dimetyylifenyyli)-2-(etyyliamino)propan-1-oni)
2,3-DMMC (1-(2,3-dimetyylifenyyli)-2-(metyyliamino)propan-1-oni)
2,3-DMPPP (1-(2,3-dimetyylifenyyli)-2-(pyrrolidin-1-yyli)propan-1-oni)
2,4-DMEC (1-(2,4-dimetyylifenyyli)-2-(etyyliamino)propan-1-oni)
2,4-DMMC (1-(2,4-dimetyylifenyyli)-2-(metyyliamino)propan-1-oni)
2,4-DMPPP (1-(2,4-dimetyylifenyyli)-2-(pyrrolidin-1-yyli)propan-1-oni)
2,5-Dimetyyli-3-fenyylimorfoliini
2,5-DMEC (1-(2,5-dimetyylifenyyli)-2-(etyyliamino)propan-1-oni)
2,5-DMMC (1-(2,5-dimetyylifenyyli)-2-(metyyliamino)propan-1-oni)
2,6-Dimetyyli-3-fenyylimorfoliini
2,6-DMEC (1-(2,6-dimetyylifenyyli)-2-(etyyliamino)propan-1-oni)
2,6-DMMC (1-(2,6-dimetyylifenyyli)-2-(metyyliamino)propan-1-oni)
25B-NBF (2-(4-bromi-2,5-dimetoksifenyyli)-N-[(2-fluorifenyyli)metyyli]etan-1-amiini)
25B-NBF:n isomeeri (2-(4-bromi-2,5-dimetoksifenyyli)-N-[(3-fluorifenyyli)metyyli]etan-1-amiini)
25B-NBF:n isomeeri (2-(4-bromi-2,5-dimetoksifenyyli)-N-[(4-fluorifenyyli)metyyli]etan-1-amiini)
25C-NBF (2-(4-kloori-2,5-dimetoksifenyyli)-N-[(2-fluorifenyyli)metyyli]etanamiini)
25B-NBOH (2-({[2-(4-bromi-2,5-dimetoksifenyyli)etyyli]amino}metyyli)fenoli)
25B-NBOH:n isomeeri (3-({[2-(4-bromi-2,5-dimetoksifenyyli)etyyli]amino}metyyli)fenoli)
25B-NBOH:n isomeeri (4-({[2-(4-bromi-2,5-dimetoksifenyyli)etyyli]amino}metyyli)fenoli)
25C-NBOH (2-({[2-(4-kloori-2,5-dimetoksifenyyli)etyyli]amino}metyyli)fenoli)
25E-NBOH (2-({[2-(4-etyyli-2,5-dimetoksifenyyli)etyyli]amino}metyyli)fenoli)
25D-NBOMe (2-(2,5-dimetoksi-4-metyylifenyyli)-N-(2-metoksibentsyyli)etaaniamiini)
25E-NBOMe (2-(2,5-dimetoksi-4-etyylifenyyli)-N-(2-metoksibentsyyli)etaaniamiini)
25G-NBOMe (2-(2,5-dimetoksi-3,4-dimetyylifenyyli)-N-(2-metoksibentsyyli)etaaniamiini)
25I-NB4OMe (2-(4-jodi-2,5-dimetoksifenyyli)-N-[(4-metoksifenyyli)metyyli]etan-1-amiini)
25I-NBMD (N-(1,3-bentsodioks-4-yylimetyyli)-2-(4-jodi-2,5-dimetoksifenyyli)etaaniamiini)
25I-NBOH (2-({[2-(4-jodi-2,5-dimetoksifenyyli)etyyli]amino}metyyli)fenoli)
25iP-NBOMe (2-[2,5-dimetoksi-4-(propan-2-yyli)fenyyli]-N-(2-metoksibentsyyli)etaaniamiini)
25N-NBOMe (2-(2,5-dimetoksi-4-nitrofenyyli)-N-(2-metoksibentsyyli)etaaniamiini)
25I-NB34MD (N-(1,3-bentsodioksol-5-yylimetyyli)-2-(4-jodi-2,5-dimetoksifenyyli)etanamiini)
25I-NBF (N-(2-fluoribentsyyli)-2-(4-jodi-2,5-dimetoksifenyyli)etanamiini)
2C-C (2-(2,5-dimetoksi-4-kloorifenyyli)etaaniamiini)
2C-D (2-(2,5-dimetoksi-4-metyylifenyyli)etaaniamiini)
2C-E (2-(2,5-dimetoksi-4-etyylifenyyli)etaaniamiini)
2C-G (2-(2,5-dimetoksi-3,4-dimetyylifenyyli)etaaniamiini)
2C-N (2-(2,5-dimetoksi-4-nitrofenyyli)etaaniamiini)
2C-P (2-(2,5-dimetoksi-4-(n)-propyylifenyyli)etaaniamiini)
2C-T-4 (2-[2,5-dimetoksi-4-(propan-2-yylisulfanyyli)fenyyli]etaaniamiini)
2C-TFM (2-[2,5-dimetoksi-4-(trifluorimetyyli)fenyyli]etan-1-amiini)
2F-QMPSB (kinolin-8-yyli 3-((4,4-difluoripiperidin-1-yyli)sulfonyyli)-4-metyylibentsoaatti)
2F-Viminoli (2-[di(butan-2-yyli)amino]-1-[1-(2-fluoribentsyyli)-1H-pyrrol-2-yyli]etan-1-oli)
3C-E (1-(3,5-dimetoksi-4-etoksifenyyli)propan-2-amiini)
3C-P (1-(3,5-dimetoksi-4-propoksifenyyli)propan-2-amiini)
2-Kloori-4,5-MDMA (1-(6-kloori-1,3-bentsodioksol-5-yyli)-N-metyylipropan-2-amiini)
3,4-DMA NBOMe (1-(3,4-dimetoksifenyyli)-N-(2-metoksibentsyyli)propan-2-amiini)
3,4-DMeO-α-PHP (1-(3,4-dimetoksifenyyli)-2-(pyrrolidin-1-yyli)heksan-1-oni)
3,4-DMPPP (1-(3,4-dimetyylifenyyli)-2-(pyrrolidin-1-yyli)propan-1-oni)
3,4-MDPA (N-[1-(1,3-bentsodioksol-5-yyli)propan-2-yyli]propan-1-amiini)
3,5-DMEC (1-(3,5-dimetyylifenyyli)-2-(etyyliamino)propan-1-oni)
3,6-DMPM (3,6-dimetyyli-2-fenyylimorfoliini)
2F-α-PHiP (1-(2-fluorifenyyli)-4-metyyli-2-(pyrrolidin-1-yyli)pentan-1-oni)
3F-α-PHiP (1-(3-fluorifenyyli)-4-metyyli-2-(pyrrolidin-1-yyli)pentan-1-oni)
3F-α-PHiP (1-(3-fluorifenyyli)-4-metyyli-2-(pyrrolidin-1-yyli)pentan-1-oni)
3F-α-PHP (1-(3-fluorifenyyli)-2-(pyrrolidin-1-yyli)heksan-1-oni)
4F-α-PHiP (1-(4-fluorifenyyli)-4-metyyli-2-(pyrrolidin-1-yyli)pentan-1-oni)
2F-Fenetratsiini (3-etyyli-2-(2-fluorifenyyli)morfoliini)
3F-Fenetratsiini (3-etyyli-2-(3-fluorifenyyli)morfoliini)
4F-Fenetratsiini (3-etyyli-2-(4-fluorifenyyli)morfoliini)
3F-Fenmetratsiini (2-(3-fluorifenyyli)-3-metyylimorfoliini)
4F-Furanyylifentanyyli (N-(4-fluorifenyyli)-N-(1-fenetyylipiperidin-4-yyli)furaani-2-karboksamidi)
4F-MDMB-BICA (metyyli 2-({[1-(4-fluoributyyli)-1H-indol-3-yyli]karbonyyli}amino)-3,3-dimetyylibutanoaatti)
2F-NEB (2-(etyyliamino)-1-(2-fluorifenyyli)butan-1-oni)
3F-NEB (2-(etyyliamino)-1-(3-fluorifenyyli)butan-1-oni)
4F-NEB (2-(etyyliamino)-1-(4-fluorifenyyli)butan-1-oni)
2-Fluorietyyliamfetamiini (2-FEA) (N-etyyli-1-(2-fluorifenyyli)propan-2-amiini)
3F-α-PVP (1-(3-fluorifenyyli)-2-(pyrrolidin-1-yyli)pentan-1-oni)
3-Kloorimetkatinoni (3-CMC) (1-(3-kloorifenyyli)-2-(metyyliamino)propan-1-oni)
3,4-dikloorietkatinoni (3,4-DCEC) (1-(3,4-dikloorifenyyli)-2-(etyyliamino)propan-1-oni)
4-Bromi-α-PPP (1-(4-bromifenyyli)-2-(pyrrolidin-1-yyli)propan-1-oni)
4-Bromi-α-pyrrolidiinivalerofenoni (4Br-α-PVP) (1-(4-bromifenyyli)-2-(pyrrolidin-1-yyli)pentan-1-oni)
4-EA NBOMe (1-(4-etyylifenyyli)-N-(2-metoksibentsyyli)propan-2-amiini)
4-Etyylietkatinoni (4-EEC) (2-(etyyliamino)-1-(4-etyylifenyyli)propan-1-oni)
4-Fluori-α-PHP (1-(4-fluorifenyyli)-2-(pyrrolidin-1-yyli)heksan-1-oni)
4-Fluori-α-pyrrolidiinienantofenoni (4F-α-PEP) (1-(4-fluorifenyyli)-2-(pyrrolidin-1-yyli)heptan-1-oni)
4-Fluori-α-pyrrolidiinioktafenoni (4F-α-POP) (1-(4-fluorifenyyli)-2-(pyrrolidin-1-yyli)oktan-1-oni)
4-Fluorietkatinoni (4-FEC) (2-(etyyliamino)-1-(4-fluorifenyyli)propan-1-oni)
4-Fluorietyyliamfetamiini (4-FEA) (N-etyyli-1-(4-fluorifenyyli)propan-2-amiini)
4F-PBP (1-(fluorifenyyli)-2-(pyrrolidin-1-yyli)butan-1-oni)
4-Kloori-α-PVP (1-(4-kloorifenyyli)-2-(pyrrolidin-1-yyli)pentan-1-oni)
3-MeO-PCMo (4-[1-(3-metoksifenyyli)sykloheksyyli]morfoliini)
4-MeO-PCMo (4-[1-(4-metoksifenyyli)sykloheksyyli]morfoliini)
4-MeO-α-PV9 (1-(4-metoksifenyyli)-2-(pyrrolidin-1-yyli)oktan-1-oni)
4-Metoksi-α-pyrrolidiinibutanfenoni (4-MeO-α-PBP) (1-(4-metoksifenyyli)-2-(pyrrolidin-1-yyli)butan-1-oni)
4-Metoksi-α-pyrrolidiinienantofenoni (4-MeO-α-PEP) (1-(4-metoksifenyyli)-2-(pyrrolidin-1-yyli)heptan-1-oni)
4-Metyylimetyylifenidaatti (metyyli-(4-metyylifenyyli)(piperidin-2-yyli)asetaatti)
4-Metyyli-N,N-dietyylikatinoni (2-(dietyyliamino)-1-(4-metyylifenyyli)propan-1-oni)
4-Metyyli-N,N-dimetyylikatinoni (2-(dimetyyliamino)-1-(4-metyylifenyyli)propan-1-oni)
4-MMA NBOMe (N-(2-metoksibentsyyli)-N-metyyli-1-(4-metyylifenyyli)propan-2-amiini)
5-APB NBOMe (1-(bentsofuran-5-yyli)-N-[(2-metoksibentsyyli)metyyli]propan-2-amiini)
5C-AKB48 (1-(5-klooripentyyli)-N-(trisyklo[3.3.1.13,7]dek-1-yyli)-1H-indatsoli-3-karboksamidi)
5Cl-AB-PINACA (N-(1-amino-3-metyyli-1-oksobutan-2-yyli)-1-(5-klooripentyyli)-2,3-dihydro-1H-indatsoli-3-karboksamidi)
5Cl-bk-MPA (1-(5-klooritiofen-2-yyli)-2-(metyyliamino)propan-1-oni)
5Cl-MDMB-PINACA (metyyli 2-{[1-(5-klooripentyyli)-1H-indatsoli-3-karbonyyli]amino}-3,3-dimetyylibutanoaatti)
5Cl-THJ-018 ([1-(5-klooripentyyli)-1H-indatsol-3-yyli](naftalen-1-yyli)metanoni)
5-Dihydrobentsofuraanipyrovaleroni (5-DBFPV) (1-(2,3-dihydro-1-bentsofuran-5-yyli)-2-(pyrrolidin-1-yyli)pentan-1-oni)
5F-3,5-AB-PFUPPYCA (N-(1-amino-3-metyyli-1-oksobutan-2-yyli)-1-(5-fluoripentyyli)-3-(4-fluorifenyyli)-1H-pyratsoli-5-karboksamidi)
5-Fluoripentyyli-3-pyridinyyli-indoli ([1-(5-fluoripentyyli)-1H-indol-3-yyli](pyridin-3-yyli)metanoni)
5F-AB-FUPPYCA(N-{[1-(5-fluoripentyyli)-5-(4-fluorifenyyli)-1H-pyratsol-3-yyli]karbonyyli}valiiniamidi)
5F-AB-PINACA (N-(1-amino-3-metyyli-1-oksobutan-2-yyli)-1-(5-fluoripentyyli)-1H-indatsoli-3-karboksamidi)
5F-AB-P7AICA (N-(1-amino-3-metyyli-1-oksobutan-2-yyli)-1-(5-fluoripentyyli)-1H-pyrroli[2,3-b]pyridiini-3-karboksamidi)
5F-ADBICA (N-(1-amino-3,3-dimetyyli-1-oksobutan-2-yyli)-1-(5-fluoripentyyli)-1H-indoli-3-karboksamidi)
5F-ADB-PINACA (N-(1-amino-3,3-dimetyyli-1-oksobutan-2-yyli)-1-(5-fluoripentyyli)-1H-indatsoli-3-karboksamidi)
5F-AMB-PICA (metyyli-N-{[1-(5-fluoripentyyli)-1H-indol-3-yyli]karbonyyli}valinaatti)
5F-AMBICA (N-(1-amino-3-metyyli-1-oksobutan-2-yyli)-1-(5-fluoripentyyli)-1H-indoli-3-karboksamidi)
5F-A-P7AICA (N-(adamantan-1-yyli)-1-(5-fluoripentyyli)-1H-pyrroli[2,3-b]pyridiini-3-karboksamidi)
5F-APP-PICA (N-{[1-(5-fluoripentyyli)-1H-indol-3-yyli]karbonyyli}fenyylialaniiniamidi)
5F-APP-PINACA (N-{[1-(5-fluoripentyyli)-1H-indatsol-3-yyli]karbonyyli}fenyylialaniiniamidi)
5F-EDMB-PINACA (etyyli-N-[1-(5-fluoripentyyli)-1H-indatsoli-3-karbonyyli]-3-metyylivalinaatti)
5F-EMB-PINACA (etyyli-N-{[1-(5-fluoripentyyli)-1H-indatsol-3-yyli]karbonyyli}valinaatti)
5F-MDMB-P7AICA (metyyli 2-{[1-(5-fluoripentyyli)-1H-pyrrolo[2,3-b]pyridin-3-yyli]formamido}-3,3-dimetyylibutanoaatti)
5F-PB-22 indatsolianalogi (kinolin-8-yyli-1-(5-fluoripentyyli)-1H-indatsoli-3-karboksylaatti)
5F-PY-PICA ([1-(5-fluoripentyyli)-1H-indol-3-yyli](pyrrolidin-1-yyli)metanoni)
5F-PY-PINACA ([1-(5-fluoripentyyli)-1H-indatsol-3-yyli](pyrrolidin-1-yyli)metanoni)
5F-SDB-005 (naftalen-2-yyli-1-(5-fluoripentyyli)-1H-indatsoli-3-karboksylaatti)
5F-SDB-006 (N-bentsyyli-1-(5-fluoripentyyli)-1H-indoli-3-karboksamidi)
5-MeO-EIPT (N-etyyli-N-[2-(5-metoksi-1H-indol-3-yyli)etyyli]propan-2-amiini)
5-MeO-pyr-T (5-metoksi-3-[2-(pyrrolidin-1-yyli)etyyli]-1H-indoli)
6-BR-DMPEA (2-bromi-4,5-dimetoksifenetyyliamiini)
A-796,260 ({1-[2-(morfolin-4-yyli)etyyli]-1H-indol-3-yyli}(2,2,3,3-tetrametyylisyklopropyyli)metanoni)
A-796,260:n isomeeri ((2E)-3,4,4-trimetyyli-1-{1-[2-(morfolin-4-yyli)etyyli]-1H-indol-3-yyli}pent-2-en-1-oni)
A-834,735 ([1-(tetrahydro-2H-pyraani-4-metyyli)-1H-indol-3-yyli]-(2,2,3,3-tetrametyylisyklopropyyli)metanoni)
A-836,339 (N-[(2E)-3-(2-metoksietyyli)-4,5-dimetyyli-1,3-tiatsoli-2(3H)-ylideeni]-2,2,3,3-tetrametyylisyklopropaanikarboksamidi)
A-CHMINACA (N-(adamantan-1-yyli)-1-(sykloheksyylimetyyli)-1H-indatsoli-3-karboksamidi)
AB-005 ([1-[(1-metyyli-2-piperidinyyli)metyyli]-1H-indoli-3-yyli](2,2,3,3-tetrametyylisyklopropyyli)-metanoni)
AB-CHMFUPPYCA (N-{[1-(sykloheksyylimetyyli)-3-(4-fluorifenyyli)-1H-pyratsol-5-yyli]karbonyyli}valiiniamidi)
AB-FUBINACA:n 2-fluoribentsyyli-isomeeri (N-(1-amino-3-metyyli-1-oksobutan-2-yyli)-1-(2-fluoribentsyyli)-1H-indatsoli-3-karboksamidi)
AB-PINACA:n N-2-fluoripentyyli-isomeeri (N-(1-amino-3-metyyli-1-oksobutan-2-yyli)-1-(2-fluoripentyyli)-1H-indatsoli-3-karboksamidi)
4-AcO-DALT (3-{2-[di(prop-2-en-1-yyli)amino]etyyli}-1H-indol-4-yyli-asetaatti)
4-AcO-DET (3-[2-(dietyyliamino)etyyli]-1H-indol-4-yyli-asetaatti)
4-AcO-DIPT (3-{2-[di(propan-2-yyli)amino]etyyli}-1H-indol-4-yyli-asetaatti)
4-AcO-DMT (3-[2-(dimetyyliamino)etyyli]-1H-indol-4-yyli-asetaatti)
4-AcO-DPT (3-[2-(dipropyyliamino)etyyli]-1H-indol-4-yyli-asetaatti)
4-AcO-MET (3-{2-[etyyli(metyyli)amino]etyyli}-1H-indol-4-yyli-asetaatti)
4-AcO-MIPT (3-{2-[metyyli(propan-2-yyli)amino]etyyli}-1H-indol-4-yyli-asetaatti)
ADAMANTYL-THPINACA (1-(tetrahydro-2H-pyran-4-yylimetyyli)-N-(trisyklo[3.3.1.1 3,7]dek-2-yyli)-1H-indatsoli-3-karboksamidi)
ADB-BUTINACA (N-(1-amino-3,3-dimetyyli-1-oksobutan-2-yyli)-1-butyyli-1H-indatsoli-3-karboksamidi)
ADB-CHMICA (N-(1-amino-3,3-dimetyyli-1-oksobutan-2-yyli)-1-(sykloheksyylimetyyli)-1H-indoli-3-karboksamidi)
ADBICA (N-(1-amino-3,3-dimetyyli-1-oksobutan-2-yyli)-1-pentyyli-1H-indoli-3-karboksamidi)
ADB-PINACA (N-(1-amino-3,3-dimetyyli-1-oksobutan-2-yyli)-1-pentyyli-1H-indatsoli-3-karboksamidi)
Aflokvaloni (6-amino-2-(fluorimetyyli)-3-(2-metyylifenyyli)kinatsolin-4(3H)-oni)
α-Metyylifentanyylin butaaniamidianalogi (2-metyyli-N-fenyyli-N-[1-(1-fenyylipropan-2-yyli)piperidin-4-yyli]propanamidi)
α-PBT (2-(pyrrolidin-1-yyli)-1-(tiofen-2-yyli)butan-1-oni)
α-PPP-MeO (3-metoksi-1-fenyyli-2-(pyrrolidin-1-yyli)propan-1-oni)
α-Pyrrolidiinibutyrofenoni (α-PBP) (1-fenyyli-2-(pyrrolidin-1-yyli)butan-1-oni)
α-Pyrrolidiinienantofenoni (α-PEP) (1-fenyyli-2-(pyrrolidin-1-yyli)heptan-1-oni)
α-Pyrrolidiini-isoheksafenoni (α-PHiP) (4-metyyli-1-fenyyli-2-(pyrrolidin-1-yyli)pentan-1-oni)
α-Pyrrolidiininonafenoni (α-PNP) (1-fenyyli-2-(pyrrolidin-1-yyli)nonan-1-oni)
α-Pyrrolidiinioktafenoni (α-POP) (1-fenyyli-2-(pyrrolidin-1-yyli)oktan-1-oni)
α-Pyrrolidiinipropiofenoni (PPP) (1-fenyyli-2-(pyrrolidin-1-yyli)propan-1-oni)
AKB-57 (1-adamantanyyli-1-pentyyli-1H-indatsoli-3-karboksylaatti)
AL-LAD ((6aR,9R)-7-allyyli-N,N-dietyyli-6,6a,8,9-tetrahydro-4H-indoli[4,3-fg]kinoliini-9-karboksiamiini)
Allyylieskaliini (AL) (2-[3,5-dimetoksi-4-(prop-2-eeni-1-yylioksi)fenyyli]etaaniamiini)
AM-1220 ({1-[(1-metyylipiperidin-2-yyli)metyyli]-1H-indol-3-yyli}(naftalen-1-yyli)metanoni)
AM-1220:n atsepaani-isomeeri ([1-(1-metyyliatsepan-3-yyli)-1H-indol-3-yyli](naftalen-1-yyli)metanoni)
AM-1248 ({1-[(1-metyylipiperidin-2-yyli)metyyli]-1H-indol-3-yyli}(trisyklo[3.3.1.1 3,7]dek-1-yyli)metanoni)
AM-1248:n atsepaani-isomeeri ([1-(1-metyyliatsepan-3-yyli)-1H-indoli-3-yyli](trisyklo[3.3.1.1 3,7]dek-1-yyli)metanoni)
AM-2201:n bentsimidatsolianalogi (FUBIMINA) ((1-(5-fluoripentyyli)-1H-bentso[d]imidatsoli-2-yyli)(naftaleeni-1-yyli)metanoni)
AM-2201:n indatsolianalogi ([1-(5-fluoripentyyli)-1H-indatsol-3-yyli](naftalen-1-yyli)metanoni)
AM-2201:n indatsolikarboksamidianalogi (1-(5-fluoripentyyli)-N-(naftalen-2-yyli)-1H-indatsoli-3-karboksamidi)
AM-2232 ([3-(naftalen-1-yylikarbonyyli)-1H-indol-1-yyli]pentaaninitriili)
AM-2233 ((2-jodifenyyli){1-[(1-metyylipiperidin-2-yyli)metyyli]-1H-indol-3-yyli}metanoni)
AM-6527 (1-pentyyli-N-(naftalen-1-yyli)-1H-indoli-3-karboksamidi)
AM-6527:n 5-fluoripentyylijohdos (1-(5-fluoripentyyli)-N-(naftalen-2-yyli)-1H-indoli-3-karboksamidi)
AM-679 ((1-pentyyli-1H-indol-3-yyli)(2-jodifenyyli)metanoni)
AM-694 (1-[(5-fluoripentyyli)-1H-indol-3-yyli]-(2-jodifenyyli)metanoni)
AM-694:n etyylijohdos ((2-etyylifenyyli)[1-(5-fluoripentyyli)-1H-indol-3-yyli]metanoni)
AM-694:n kloorijohdos (1-[(5-klooripentyyli)-1H-indol-3-yyli]-(2-jodifenyyli)metanoni)
AM-694:n metyylijohdos ([1-(5-fluoripentyyli)-1H-indol-3-yyli](2-metyylifenyyli)metanoni)
AMAPN (2-(metyyliamino)-1-(naftalen-1-yyli)propan-1-oni)
AMB-CHMICA (metyyli-N-[1-(sykloheksyylimetyyli)-3H-indol-1-iumi-3-karbonyyli]valinaatti)
AMB-CHMINACA (metyyli-N-{[1-(sykloheksyylimetyyli)-1H-indatsol-3-yyli]karbonyyli}valinaatti)
AMB-4en-PICA (metyyli N-[1-(pent-4-en-1-yyli)-1H-indoli-3-karbonyyli]valinaatti)
AMB-FUBICA (metyyli-N-{1-[(4-fluorifenyyli)metyyli]-1H-indoli-3-karbonyyli}valinaatti)
APP-BINACA (N-(1-amino-1-okso-3-fenyylipropan-2-yyli)-1-butyyli-1H-indatsoli-3-karboksamidi)
APP-CHMINACA (N-α-[1-(sykloheksyylimetyyli)-1H-indatsoli-3-karbonyyli]fenyylialaniiniamidi)
APP-FUBINACA (N-{[1-(4-metyylibentsyyli)-1H-indatsol-3-yyli]karbonyyli}fenyylialaniiniamidi)
3-Amino-1-fenyylibutaani (4-fenyylibutaani-2-amiini)
2-Aminoindaani (2-AI) (2,3-dihydro-1H-indeeni-2-amiini)
2-(2-Aminopropyyli)-2,3-dihydro-1H-indeeni (2-APDI) (1-(2,3-dihydro-1H-inden-2-yyli)propaani-2-amiini)
3-(2-Aminopropyyli)-2,3-dihydro-1H-indeeni (3-APDI) (1-(2,3-dihydro-1H-inden-3-yyli)propaani-2-amiini)
4-(2-Aminopropyyli)-2,3-dihydro-1H-indeeni (4-APDI) (1-(2,3-dihydro-1H-inden-4-yyli)propaani-2-amiini)
5-(2-Aminopropyyli)-2,3-dihydro-1H-indeeni (5-APDI) (1-(2,3-dihydro-1H-inden-5-yyli)propaani-2-amiini)
6-(2-Aminopropyyli)-2,3-dihydro-1H-indeeni (6-APDI) (1-(2,3-dihydro-1H-inden-6-yyli)propaani-2-amiini)
7-(2-Aminopropyyli)-2,3-dihydro-1H-indeeni (7-APDI) (1-(2,3-dihydro-1H-inden-7-yyli)propaani-2-amiini)
2-(2-Aminopropyyli)-2,3-dihydrobentsofuraani (2-APDB) (1-(2,3-dihydro-1-bentsofuran-2-yyli)propaani-2-amiini)
3-(2-Aminopropyyli)-2,3-dihydrobentsofuraani (3-APDB) (1-(2,3-dihydro-1-bentsofuran-3-yyli)propaani-2-amiini)
4-(2-Aminopropyyli)-2,3-dihydrobentsofuraani (4-APDB) (1-(2,3-dihydro-1-bentsofuran-4-yyli)propaani-2-amiini)
5-(2-Aminopropyyli)-2,3-dihydrobentsofuraani (5-APDB) (1-(2,3-dihydro-1-bentsofuran-5-yyli)propaani-2-amiini)
6-(2-Aminopropyyli)-2,3-dihydrobentsofuraani (6-APDB) (1-(2,3-dihydro-1-bentsofuran-6-yyli)propaani-2-amiini)
7-(2-Aminopropyyli)-2,3-dihydrobentsofuraani (7-APDB) (1-(2,3-dihydro-1-bentsofuran-7-yyli)propaani-2-amiini)
2-(2-Aminopropyyli)bentsofuraani (2-APB) (1-(1-bentsofuran-2-yyli)propaani-2-amiini)
3-(2-Aminopropyyli)bentsofuraani (3-APB) (1-(1-bentsofuran-3-yyli)propaani-2-amiini)
4-(2-Aminopropyyli)bentsofuraani (4-APB) (1-(1-bentsofuran-4-yyli)propaani-2-amiini)
7-(2-Aminopropyyli)bentsofuraani (7-APB) (1-(1-bentsofuran-7-yyli)propaani-2-amiini)
α-TMT (1-(1H-indol-3-yyli)-N,N-dimetyylipropan-2-amiini)
APINACA (1-pentyyli-N-(trisyklo[3.3.1.1 3,7]dek-1-yyli)-1H-indatsoli-3-karboksamidi)
1-Asetyyli-LSD (ALD-52) (1-asetyyli-N,N-dietyyli-6-metyyli-9,10-didehydroergoliini-8-karboksiamidi)
BB-22 (kinolin-8-yyli 1-(sykloheksyylimetyyli)-1H-indoli-3-karboksylaatti)
Benosyklidiini (1-[1-(1-bentsotiofen-2-yyli)sykloheksyyli]piperidiini)
Bentsedroni (4-MBC) (2-(bentsyyliamino)-1-(4-metyylifenyyli)propan-1-oni)
BENZYL-4CN-BINACA (N-bentsyyli-1-(4-syanobutyyli)-1H-indatsoli-3-karboksamidi)
2-Bentsyyliamino-1-(3,4-metyleenidioksifenyyli)butan-1-oni (BMDB) (1-(1,3-bentsodioksol-5-yyli)-2-(bentsyyliamino)butan-1-oni)
2-Bentsyyliamino-1-(3,4-metyleenidioksifenyyli)propan-1-oni (BMDP) (1-(1,3-bentsodioksol-5-yyli)-2-(bentsyyliamino)propan-1-oni)
4-Bentsyylipiperidiini (4-(fenyylimetyyli)piperidiini)
β-Me-PEA (2-fenyylipropan-1-amiini)
bk-2C-B (2-amino-1-(4-bromi-2,5-dimetoksifenyyli)etanoni)
bk-IBP (1-(2,3-dihydro-1H-inden-5-yyli)-2-(etyyliamino)butan-1-oni)
bk-IVP (1-(2,3-dihydro-1H-inden-5-yyli)-2-(etyyliamino)pentan-1-oni)
bk-MPA (2-(metyyliamino)-1-(tiofen-2-yyli)propan-1-oni)
BOD (2-(2,5-dimetoksi-4-metyylifenyyli)-2-metoksietan-1-amiini)
5-BPDi (1-(2,3-dihydro-1H-inden-5-yyli)-2-(pyrrolidin-1-yyli)heksan-1-oni)
Brefedroni (4-BMC) (1-(4-bromifenyyli)-2-(metyyliamino)propan-1-oni)
1-(4-Bromi-2,5-dimetoksifenyyli)etanamiini
8-Bromi-2,3,6,7-bentso-dihydro-difuraani-etyyliamiini (2C-B-Fly) (2-(8-bromi-2,3,6,7-tetrahydrofuro[2,3-f][1]bentsofuran-4-yyli)etaaniamiini)
4-Bromiamfetamiini (4-BA) (1-(4-bromifenyyli)propan-2-amiini)
2-Bromimetoksetamiini (2-(2-bromi-5-metoksifenyyli)-2-(etyyliamino)sykloheksanoni)
4-Bromoetkatinoni (4-BEC) (1-(4-bromifenyyli)-2-(etyyliamino)propan-1-oni)
2-Bromimetkatinoni (2-BMC) (1-(2-bromifenyyli)-2-(metyyliamino)propan-1-oni)
3-Bromimetkatinoni (3-BMC) (1-(3-bromifenyyli)-2-(metyyliamino)propan-1-oni)
Bromadoliini (4-bromi-N-[2-(dimetyyliamino)sykloheksyyli]bentsamidi)
Bufedroni (2-(metyyliamino)-1-fenyylibutan-1-oni)
Butyloni (bk-MBDB) (1-(1,3-bentsodioksol-5-yyli)-2-(metyyliamino)butan-1-oni)
N-Butyyliheksedroni (2-(butyyliamino)-1-fenyyliheksan-1-oni)
N-Butyylipentyloni (1-(1,3-bentsodioksol-5-yyli)-2-(butyyliamino)pentan-1-oni)
CBL-018 (naftalen-1-yyli-1-pentyyli-1H-indoli-3-karboksylaatti)
2-CEC (1-(2-kloorifenyyli)-2-(etyyliamino)propan-1-oni)
3-CEC (1-(3-kloorifenyyli)-2-(etyyliamino)propan-1-oni)
4-CEC (1-(4-kloorifenyyli)-2-(etyyliamino)propan-1-oni)
3,4-CFP (1-(3-kloori-4-fluorifenyyli)piperatsiini)
2-CIC (1-(2-kloorifenyyli)-2-[(propan-2-yyli)amino]propan-1-oni)
3-CIC (1-(3-kloorifenyyli)-2-[(propan-2-yyli)amino]propan-1-oni)
4-CIC (1-(4-kloorifenyyli)-2-[(propan-2-yyli)amino]propan-1-oni)
2-CMA (1-(2-kloorifenyyli)-N-metyylipropan-2-amiini)
3-CMA (1-(3-kloorifenyyli)-N-metyylipropan-2-amiini)
4-CMA (1-(4-kloorifenyyli)-N-metyylipropan-2-amiini)
CP 47,497 (2-(3-hydroksisykloheksyyli)-5-(2-metyylioktan-2-yyli)fenoli); ja sen C6, C8, C9 homologit
CRA-13 (naftalen-1-yyli-[4-(pentyylioksi)naftalen-1-yyli]metanoni)
CUMYL-4CN-B7AICA (1-(4-syanobutyyli)-N-(2-fenyylipropan-2-yyli)-1H-pyrroli[2,3-b]pyridiini-3-karboksamidi)
CUMYL-5F-P7AICA (1-(5-fluoripentyyli)-N-(2-fenyylipropan-2-yyli)-1H-pyrroli[2,3-b]pyridiini-3-karboksamidi)
CUMYL-5FPICA (1-(5-fluoripentyyli)-N-(2-fenyylipropan-2-yyli)-1H-indoli-3-karboksamidi)
CUMYL-5FPINACA (1-(5-fluoripentyyli)-N-(2-fenyylipropan-2-yyli)-1H-indatsoli-3-karboksamidi)
CUMYL-BICA (1-butyyli-N-(2-fenyylipropan-2-yyli)-1H-indoli-3-karboksamidi)
CUMYL-CBMINACA (1-(syklobutyylimetyyli)-N-(2-fenyylipropan-2-yyli)-1H-indatsoli-3-karboksamidi)
CUMYL-PeGACLONE (2-(1-metyyli-1-fenyylietyyli)-5-pentyyli-pyrido[4,3-b]indol-1-oni)
CUMYL-PICA (1-pentyyli-N-(2-fenyylipropan-2-yyli)-1H-indoli-3-karboksamidi)
CUMYL-PINACA (1-pentyyli-N-(2-fenyylipropan-2-yyli)-1H-indatsoli-3-karboksamidi)
CUMYL-THPINACA (N-(2-fenyylipropan-2-yyli)-1-(tetrahydro-2H-pyran-4-yylimetyyli)-1H-indatsoli-3-karboksamidi)
DB-MDBP (1-[(2,2-difluori-1,3-bentsodioksol-5-yyli)metyyli]piperatsiini)
Desklooriketamiini (2-(metyyliamino)-2-fenyylisykloheksanoni)
Deskloori-N-etyyliketamiini (O-PCE) (2-(etyyliamino)-2-fenyylisykloheksan-1-oni)
Desoksi-D2PM ((2R)-2-(difenyylimetyyli)pyrrolidiini)
Dibutyloni (bk-MMBDB) (1-(1,3-bentsodioksol-5-yyli)-2-(dimetyyliamino)butan-1-oni)
Difenidiini (1-(1,2-difenyylietyyli)piperidiini)
Difenyyliprolinoli (D2PM) (difenyyli[(2S)-pyrrolidin-2-yyli]metanoli)
Di-isopropyylitryptamiini (DIPT) (N-[2-(1H-indol-3-yyli)etyyli]-N-(propan-2-yyli)propan-2-amiini)
Dikloropaani (RTI-111) (metyyli-3-(3,4-dikloorifenyyli)-8-metyyli-8-atsabisyklo[3.2.1]oktaani-2-karboksylaatti)
Dimetokaiini ((3-(dietyyliamino)-2,2-dimetyylipropyyli)-4-aminobentsoaatti)
2,4-Dimetoksiamfetamiini (2,4-DMA) (1-(2,4-dimetoksifenyyli)propan-2-amiini)
3,4-Dimetoksi-α-pyrrolidinovalerofenoni (3,4-DMeO-α-PVP) (1-(3,4-dimetoksifenyyli)-2-(pyrrolidin-1-yyli)pentan-1-oni)
Dimetyloni (bk-MDDMA) (1-(1,3-bentsodioksol-5-yyli)-2-(dimetyyliamino)propan-1-oni)
Dimetyyliamfetamiini (N,N-dimetyyli-1-fenyylipropan-2-amiini)
3,4-Dimetyylietkatinoni (3,4-DMEC) (1-(3,4-dimetyylifenyyli)-2-(etyyliamino)propan-1-oni)
3,4-Dimetyylimetkatinoni (3,4-DMMC) (1-(3,4-dimetyylifenyyli)-2-(metyyliamino)propan-1-oni)
Dipentyloni (1-(2H-1,3-bentsodioksol-5-yyli)-2-(dimetyyliamino)pentan-1-oni)
Dipentylonin isomeeri (1-(2H-1,3-bentsodioksol-4-yyli)-2-(dimetyyliamino)pentan-1-oni)
DMBA-CHMINACA (N-[1-(sykloheksyylimetyyli)-1H-indatsoli-3-karbonyyli]-3-metyylivaliini)
DMMA (1-(3,4-dimetoksifenyyli)-N-metyylipropan-2-amiini)
DOF (1-(4-fluori-2,5-dimetoksifenyyli)propan-2-amiini)
DOI (1-(4-jodi-2,5-dimetoksifenyyli)propan-2-amiini)
DOIP (1-[2,5-dimetoksi-4-(propan-2-yyli)fenyyli]propan-2-amiini)
DOPR (1-(2,5-dimetoksi-4-propyylifenyyli)propan-2-amiini)
DOT (1-[2,5-dimetoksi-4-(metyylisulfanyyli)fenyyli]propan-2-amiini)
EAM-2201 ((4-etyylinaftalen-1-yyli)[1-(5-fluoripentyyli)-1H-indol-3-yyli]metanoni)
Efenidiini (NEDPA) (N-etyyli-1,2-difenyylietaan-1-amiini)
EFLEA (1-(2,3-dihydro-1,4-bentsodioksin-6-yyli)-N-hydroksi-N-metyylipropan-2-amiini)
EG-018 ((naftalen-1-yyli)(9-pentyyli-9H-karbatsol-3-yyli)metanoni)
EG-2201 ([9-(5-fluoripentyyli)-9H-karbatsol-3-yyli(naftalen-1-yyli)metanoni)
EMB-FUBINACA (etyyli-N-{[1-(4-fluoribentsyyli)-1H-indatsol-3-yyli]karbonyyli}valinaatti)
Eskaliini (2-(4-etoksi-3,5-dimetoksifenyyli)etaaniamiini)
Etakvaloni (3-(2-etyylifenyyli)-2-metyylikinatsolin-4-oni)
ETH-LAD (N,N,6-trietyyli-9,10-didehydroergoliini-8-karboksamidi)
4’-Etyyli-α-PVP (1-(4-etyylifenyyli)-2-(pyrrolidin-1-yyli)pentan-1-oni)
Etyylikatinoni (2-(etyyliamino)-1-fenyylipropan-1-oni)
Etyylinaftidaatti (etyylinaftalen-2-yyli(piperidin-2-yyli)asetaatti)
2-Etyylimetkatinoni (2-EMC) ((1-(2-etyylifenyyli)-2-(metyyliamino)propan-1-oni))
3-Etyylimetkatinoni (3-EMC) ((1-(3-etyylifenyyli)-2-(metyyliamino)propan-1-oni))
4-Etyylimetkatinoni (4-EMC) (1-(4-etyylifenyyli)-2-(metyyliamino)propan-1-oni)
Eutyloni (1-(1,3-bentsodioksol-5-yyli)-2-(etyyliamino)butan-1-oni)
FDU-PB-22 (naftalen-1-yyli 1-(4-fluoribentsyyli)-1H-indoli-3-karboksylaatti)
Fenetratsiini (3-etyyli-2-fenyylimorfoliini)
2F-fenmetratsiini (2-(2-fluorifenyyli)-3-metyylimorfoliini)
4F-fenmetratsiini (2-(4-fluorifenyyli)-3-metyylimorfoliini)
1-Fenyyli-2-(piperidin-1-yyli)butan-1-oni
1-Fenyylietyyliamiini (1-PEA) (1-fenyylietaaniamiini) Flefedroni (4-FMC) (1-(4-fluorifenyyli)-2-(metyyliamino)propan-1-oni)
4-Fluoribufedroni (1-(4-fluorifenyyli)-2-(metyyliamino)butan-1-oni)
4-Fluorietyylifenidaatti (etyyli-(4-fluorifenyyli)(piperidin-2-yyli)asetaatti)
2-Fluoridesklooriketamiini (2-(2-fluorifenyyli)-2-(metyyliamino)sykloheksan-1-oni)
3-Fluoridesklooriketamiini (2-(3-fluorifenyyli)-2-(metyyliamino)sykloheksan-1-oni)
4-Fluoridesklooriketamiini (2-(4-fluorifenyyli)-2-(metyyliamino)sykloheksan-1-oni)
1-(4-Fluorifenyyli)-2-(piperidin-1-yyli)pentan-1-oni
3-Fluorietyyliamfetamiini (3-FEA) (N-etyyli-1-(3-fluorifenyyli)propan-2-amiini)
4-Fluorikatinoni (2-amino-1-(4-fluorifenyyli)propan-1-oni)
2-Fluorimetkatinoni (2-FMC) (1-(2-fluorifenyyli)-2-(metyyliamino)propan-1-oni)
3-Fluorimetkatinoni (3-FMC) (1-(3-fluorifenyyli)-2-(metyyliamino)propan-1-oni)
4-Fluorimetyylifenidaatti (metyyli-(4-fluorifenyyli)(piperidin-2-yyli)asetaatti)
2-Fluori-N-etyylipentedroni (2-(etyyliamino)-1-(2-fluorifenyyli)pentan-1-oni)
3-Fluori-N-etyylipentedroni (2-(etyyliamino)-1-(3-fluorifenyyli)pentan-1-oni)
4-Fluori-N-etyylipentedroni (2-(etyyliamino)-1-(4-fluorifenyyli)pentan-1-oni)
4-Fluori-N-isopropyylinorpentedroni (1-(4-fluorifenyyli)-2-(propan-2-yyliamino)pentan-1-oni)
2-Fluoripentedroni (1-(2-fluorifenyyli)-2-(metyyliamino)pentan-1-oni)
3-Fluoripentedroni (1-(3-fluorifenyyli)-2-(metyyliamino)pentan-1-oni)
4-Fluoripentedroni (1-(4-fluorifenyyli)-2-(metyyliamino)pentan-1-oni)
FUB-144 ([1-(4-fluoribentsyyli)-1H-indol-3-yyli](2,2,3,3-tetrametyylisyklopropyyli)metanoni)
FUB-AKB48 (1-(4-fluoribentsyyli)-N-(trisyklo[3.3.1.1 3,7]dek-1-yyli)-1H-indatsoli-3-karboksamidi)
FUB-JWH-018 ([1-(4-fluoribentsyyli)-1H-indol-3-yyli](naftalen-1-yyli)metanoni)
FUB-NPB-22 (kinolin-8-yyli 1-[(4-fluorifenyyli)metyyli]-1H-indatsoli-3-karboksylaatti)
FUB-PB-22 (kinolin-8-yyli-1-(4-fluoribentsyyli)-1H-indoli-3-karboksylaatti)
G-130 (5,5-dimetyyli-2-fenyyli-morfoliini)
Gammabutyrolaktoni (GBL) (dihydrofuran-2(3H)-oni)
Harmiini (7-metoksi-1-metyyli-9H-ß-karboliini)
4-HO-DET (3-[2-(dietyyliamino)etyyli]-1H-indol-4-oli)
4-HO-DIPT (3-{2[di(propan-2-yyli)amino]etyyli}-1H-indol-4-oli)
4-HO-McPT (3-{2-[syklopropyylimetyyliamino]etyyli}-1H-indol-4-oli)
5-HO-McPT (3-{2-[syklopropyylimetyyliamino]etyyli}-1H-indol-5-oli)
6-HO-McPT (3-{2-[syklopropyylimetyyliamino]etyyli}-1H-indol-6-oli)
7-HO-McPT (3-{2-[syklopropyylimetyyliamino]etyyli}-1H-indol-7-oli)
4-HO-MET (3-{2-[etyyli(metyyli)amino]etyyli}-1H-indol-4-oli)
4-HO-MIPT (3-{2-[metyyli(propan-2-yyli)amino]etyyli}-1H-indol-4-oli)
4-HO-MPT (3-{2-[metyyli(propyyli)amino]etyyli}-1H-indol-4-oli)
5-HO-MPT (3-{2-[metyylipropyliamino]etyyli}-1H-indol-5-ol)
6-HO-MPT (3-{2-[metyylipropyyliamino]etyyli}-1H-indol-6-ol)
7-HO-MPT (3-{2-[metyylipropyyliamino]etyyli}-1H-indol-7-ol)
2-HO-PCE (2-[1-(etyyliamino)sykloheksyyli]fenoli)
3-HO-PCE (3-[1-(etyyliamino)sykloheksyyli]fenoli)
4-HO-PCE (4-[1-(etyyliamino)sykloheksyyli]fenoli)
2-HO-PCP (2-[1-(piperidin-1-yyli)sykloheksyyli]fenoli)
3-HO-PCP (3-[1-(piperidin-1-yyli)sykloheksyyli]fenoli)
4-HO-PCP (4-[1-(piperidin-1-yyli)sykloheksyyli]fenoli)
4-HTMPIPO (4-hydroksi-3,3,4-trimetyyli-1-(1-pentyyli-1H-indol-3-yyli)pentan-1-oni)
HU-210 ((6aR,10aR)-9-(Hydroksimetyyli)-6,6-dimetyyli-3-(2-metyylioktan-2-yyli)-6a,7,10,10a-tetrahydrobentso[c]kromen-1-oli)
4-(Hydroksimetyylifenyyli)(1-pentyyli-1H-indol-3-yyli)metanoni
Ibogaiini (12-metoksi-ibogamiini)
iso-Fenmetratsiini (5-metyyli-2-fenyylimorfoliini)
Isopropyylifenidaatti (propan-2-yylifenyyli(piperidin-2-yyli)asetaatti)
Isopropyyli-U-47700 (3,4-dikloori-N-[2-(dimetyyliamino)sykloheksyyli]-N-(propan-2-yyli)bentsamidi)
4-IT (1-(1H-indol-4-yyli)propan-2-amiini)
6-IT (1-(1H-indol-6-yyli)propan-2-amiini)
7-IT (1-(1H-indol-7-yyli)propan-2-amiini)
4-Jodi-2-aminoindaani (4-IAI) (4-jodi-2-metyyli-2,3-dihydro-1H-indeeni)
5-Jodi-2-aminoindaani (5-IAI) (5-jodi-2-metyyli-2,3-dihydro-1H-indeeni)
JWH-007 ((2-metyyli-1-pentyyli-1H-indol-3-yyli)(naftalen-1-yyli)metanoni)
JWH-015 ((2-metyyli-1-propyyli-1H-indol-3-yyli)(naftalen-1-yyli)metanoni)
JWH-018:n adamantyylijohdos (AB-001) ((1-fenyyli-1H-indol-3-yyli)(trisyklo[3.3.1.1 3,7]dek-1-yyli)metanoni)
JWH-018:n adamantyylikarboksamidijohdos (APICA) (1-pentyyli-N-(trisyklo[3.3.1.1 3,7]dek-1-yyli)-1H-indoli-3-karboksamidi)
JWH-018:n indatsolianalogi (THJ-018) (naftalen-1-yyli(1-pentyyli-1H-indatsol-3-yyli)metanoni)
JWH-018:n kinoliinikarboksylaattianalogi (PB-22) (kinolin-8-yyli-1-pentyyli-1H-indoli-3-karboksylaatti)
JWH-018:n N-5-bromipentyylijohdos ([1-(5-bromipentyyli)-1H-indol-3-yyli](naftalen-1-yyli)metanoni)
JWH-018:n N-5-klooripentyylijohdos ([1-(5-klooripentyyli)-1H-indol-3-yyli](naftalen-1-yyli)metanoni)
JWH-018:n sykloheksyylimetyylijohdos ([1-(sykloheksyylimetyyli)-1H-indol-3-yyli](naftalen-1-yyli)metanoni)
JWH-019 ((1-heksyyli-1H-indol-3-yyli)(naftalen-1-yyli)metanoni)
JWH-022 (naftalen-1-yyli[1-(pent-4-en-1-yyli)-1H-indol-3-yyli]metanoni)
JWH-030 (naftalen-1-yyli(1-pentyyli-1H-pyrrol-3-yyli)metanoni)
JWH-071 ((1-etyyli-1H-indol-3-yyli)(naftalen-1-yyli)metanoni)
JWH-073:n metyylijohdos ((1-butyyli-1H-indol-3-yyli)(4-metyylinaftalen-1-yyli)metanoni)
JWH-122 ((4-metyylinaftalen-1-yyli)(1-pentyyli-1H-indol-3-yyli)metanoni)
JWH-122:n pentenyyli 2-metyyli-indolijohdos ((4-metyylinaftalen-1-yyli)(2-metyyli-1-(pent-4-en-1-yyli)-1H-indol-3-yyli)metanoni)
JWH-122:n pentenyylijohdos ((4-metyylinaftalen-1-yyli)(1-(pent-4-en-1-yyli)-1H-indol-3-yyli)metanoni)
JWH-145 (naftalen-1-yyli(1-pentyyli-5-fenyyli-1H-pyrrol-3-yyli)metanoni)
JWH-182 ((1-pentyyli-1H-indol-3-yyli)(4-propyylinaftalen-1-yyli)metanoni)
JWH-200 (1-[2-(4-morfolino)etyyli]-3-(1-naftoyyli)indoli)
JWH-203 (2-(2-kloorifenyyli)-1-(1-pentyyli-1H-indol-3-yyli)etanoni)
JWH-210 ((4-etyylinaftalen-1-yyli)(1-pentyyli-1H-indol-3-yyli)metanoni)
JWH-250 (2-(2-metoksifenyyli)-1-(1-pentyyli-1H-indol-3-yyli)etanoni)
JWH-250:n 1-(2-metyleeni-N-metyyli-piperidyyli) -johdos (2-(2-metoksifenyyli)-1-{1-[(1-metyylipiperidin-2-yyli)metyyli]-1H-indol-3-yyli}etanoni)
JWH-251 (2-(2-metyylifenyyli)-1-(1-pentyyli-1H-indol-3-yyli)etanoni)
JWH-302 (2-(3-metoksifenyyli)-1-(1-pentyyli-1H-indol-3-yyli)etanoni)
JWH-307 ([5-(2-fluorifenyyli)-1-pentyyli-1H-pyrrol-3-yyli](naftalen-1-yyli)metanoni)
JWH-307:n bromianalogi ((5-(2-bromifenyyli)-1-pentyyli-1H-pyrrol-3-yyli)(naftalen-1-yyli)metanoni)
JWH-368 ([5-(3-fluorifenyyli)-1-pentyyli-1H-pyrrol-3-yyli](naftalen-1-yyli)metanoni)
JWH-370 ([5-(2-metyylifenyyli)-1-pentyyli-1H-pyrrol-3-yyli](naftalen-1-yyli)metanoni)
JWH-387 ((4-brominaftalen-1-yyli)(1-pentyyli-1H-indol-3-yyli)metanoni)
JWH-398 ((4-kloorinaftalen-1-yyli)(1-pentyyli-1H-indol-3-yyli)metanoni)
JWH-412 ((4-fluorinaftalen-1-yyli)(1-pentyyli-1H-indol-3-yyli)metanoni)
JWH-412:n 5-fluoripentyylijohdos ((4-fluorinaftalen-1-yyli)[1-(5-fluoripentyyli)-1H-indol-3-yyli]metanoni)
Kamfetamiini (N-metyyli-3-fenyylibisyklo[2.2.1]heptan-2-amiini)
Klonipratsepaami (5-(2-kloorifenyyli)-1-(syklopropyylimetyyli)-7-nitro-1,3-dihydro-2H-[1,4]-bentsodiatsepin-2-oni)
2-Kloori-α-PVP (1-(2-kloorifenyyli)-2-(pyrrolidin-1-yyli)pentan-1-oni)
3-Kloori-α-PVP (1-(3-kloorifenyyli)-2-(pyrrolidin-1-yyli)pentan-1-oni)
4'-Kloori-α-pyrrolidiinipropiofenoni (4'-kloori-α-PPP) (1-(4-kloorifenyyli)-2-(pyrrolidin-1-yyli)propan-1-oni)
4-Klooriamfetamiini (4-CA) (1-(4-kloorifenyyli)propan-2-amiini)
2-Koori-N-butyylikatinoni (2-(butyyliamino)-1-(2-kloorifenyyli)propan-1-oni)
3-Kloori-N-butyylikatinoni (2-(butyyliamino)-1-(3-kloorifenyyli)propan-1-oni)
4-Kloori-N-butyylikatinoni (2-(butyyliamino)-1-(4-kloorifenyyli)propan-1-oni)
2-Kloori-N,N-dimetyylikatinoni (1-(2-kloorifenyyli)-2-(dimetyyliamino)propan-1-oni)
3-Kloori-N,N-dimetyylikatinoni (1-(3-kloorifenyyli)-2-(dimetyyliamino)propan-1-oni)
4-Kloori-N,N-dimetyylikatinoni (1-(4-kloorifenyyli)-2-(dimetyyliamino)propan-1-oni)
2-Kooripentedroni (1-(2-kloorifenyyli)-2-(metyyliamino)pentan-1-oni)
3-Klooripentedroni (1-(3-kloorifenyyli)-2-(metyyliamino)pentan-1-oni)
4-Klooripentedroni (1-(4-kloorifenyyli)-2-(metyyliamino)pentan-1-oni)
Kratom (Mitragyna Speciosa)
LTI-701 (1-(5-fluoripentyyli)-N-fenyyli-1H-indoli-3-karboksiamidi)
Lysergihapon 2,4-dimetyyliatsetididi (LSZ) ([(2S, 4S)-2,4-dimetyyliasetidin-1-yyli][(8b)-6-metyyli-9,10-didehydroergol-8-yyli]metanoni)
M5FPIC (metyyli-1-(5-fluoripentyyli)-1H-indoli-karboksylaatti)
2-MABB (1-(1-bentsofuran-2-yyli)-N-metyylibutan-2-amiini)
3-MABB (1-(1-bentsofuran-3-yyli)-N-metyylibutan-2-amiini)
4-MABB (1-(1-bentsofuran-4-yyli)-N-metyylibutan-2-amiini)
5-MABB (1-(1-bentsofuran-5-yyli)-N-metyylibutan-2-amiini)
6-MABB (1-(1-bentsofuran-6-yyli)-N-metyylibutan-2-amiini)
7-MABB (1-(1-bentsofuran-7-yyli)-N-metyylibutan-2-amiini)
MAM-2201 klooripentyylijohdos ([1-(5-klooripentyyli)-1H-indol-3-yyli](4-metyylinaftalen-1-yyli)metanoni)
2-MAPDB (1-(2,3-dihydro-1-bentsofuran-2-yyli)-N-metyylipropan-2-amiini)
3-MAPDB (1-(2,3-dihydro-1-bentsofuran-3-yyli)-N-metyylipropan-2-amiini)
4-MAPDB (1-(2,3-dihydro-1-bentsofuran-4-yyli)-N-metyylipropan-2-amiini)
5-MAPDB (1-(2,3-dihydro-1-bentsofuran-5-yyli)-N-metyylipropan-2-amiini)
6-MAPDB (1-(2,3-dihydro-1-bentsofuran-6-yyli)-N-metyylipropan-2-amiini)
7-MAPDB (1-(2,3-dihydro-1-bentsofuran-7-yyli)-N-metyylipropan-2-amiini)
5-MAPDI (1-(2,3-dihydro-1H-inden-5-yyli)-N-metyylipropan-2-amiini)
MBA-CHMINACA (N-[1-(sykloheksyylimetyyli)-1H-indatsoli-3-karbonyyli]valiini)
MBDB (1-(1,3-bentsodioksol-5-yyli)-N-metyylibutan-2-amiini)
MBZP (1-bentsyyli-4-metyylipiperatsiini)
M-CHMIC (1-(sykloheksyylimetyyli)-2-metyyli-1H-indoli-3-karboksylaatti)
MDA 19 (N'-(1-heksyyli-2-okso-1,2-dihydro-3H-indol-3-yylideeni)bentsohydratsidi)
MDDM (1-(1,3-bentsodioksol-5-yyli)-N,N-dimetyylipropan-2-amiini)
MDMB-CHMCZCA (metyyli-N-[9-(sykloheksyylimetyyli)-9H-karbatsoli-3-karbonyyli]-3-metyylivalinaatti)
MDMB-CHMINACA (metyyli 2-[1-(sykloheksyylimetyyli)-1H-indatsoli-3-karboksiamido]-3,3-dimetyylibutanoaatti)
MDMB-4en-PINACA (metyyli 3-metyyli-N-[1-(pent-4-en-1-yyli)-1H-indatsoli-3-karbonyyli]valinaatti)
MDMB-FUBINACA (metyyli-N-{1-[(4-fluorifenyyli)metyyli]-1H-indatsoli-3-karbonyyli}-3-metyylivalinaatti)
MDPHP (1-(1,3-bentsodioks-5-yyli)-2-(pyrrolidin-1-yyli)heksan-1-oni)
McPT(N-[2-(1H-indol-3-yyli)etyyli]-N-metyylisyklopropanamiini)
MDMB-FUBICA (metyyli-N-{[1-(4-fluoribentsyyli)-1H-indol-3-yyli]karbonyyli}-3-metyylivalinaatti)
MDPEP (1-(1,3-bentsodioksol-5-yyli)-2-(pyrrolidin-1-yyli)heptan-1-oni)
Mebrokvaloni (3-(2-bromofenyyli)-2-metyylikinatsolin-4(3H)-oni)
2-MEC (2-(etyyliamino)-1-(2-metyylifenyyli)propan-1-oni)
2-Me-DMT (N,N-dimetyyli-2-(2-metyyli-1H-indoli-3-yyli)etaaniamiini)
Meksedroni (3-metoksi-2-(metyyliamino)-1-(4-metyylifenyyli)propan-1-oni)
5-MeO-AMT (1-(5-metoksi-1H-indol-3-yyli)propan-2-amiini)
5-MeO-DALT (N-[2-(5-metoksi-1H-indol-3-yyli)etyyli]-N-(prop-2-en-1-yyli)prop-2-en-1-amiini)
5-MeO-DET (N,N-dietyyli-2-(5-metoksi-1H-indol-3-yyli)etaaniamiini)
5-MeO-DIBF (N-[2-(5-metoksi-1-bentsofuran-3-yyli)etyyli]-N-(propan-2-yyli)propan-2-amiini)
5-MeO-DIPT (N-[2-(5-metoksi-1H-indol-3-yyli)etyyli]-N-(propan-2-yyli)propan-2-amiini)
5-MeO-DMT (2-(5-metoksi-1H-indol-3-yyli)-N,N-dimetyylietaaniamiini)
5-MeO-DPT (N-[2-(5-metoksi-1H-indol-3-yyli)etyyli]-N-propyylipropan-1-amiini)
5-MeO-MALT (N-[2-(5-metoksi-1H-indol-3-yyli)etyyli]-N-metyyli-prop-2-eeni-1-amiini)
5-MeO-MET (N-etyyli-2-(5-metoksi-1H-indol-3-yyli)-N-metyylietaaniamiini)
5-MeO-MiPT (N-[2-(5-metoksi-1H-indol-3-yyli)etyyli]-N-metyylipropan-2-amiini)
2-MeO-PCMMo (4-{[1-(2-metoksifenyyli)sykloheksyyli]metyyli}morfoliini)
3-MeO-PCMMo (4-{[1-(3-metoksifenyyli)sykloheksyyli]metyyli}morfoliini)
4-MeO-PCMMo (4-{[1-(4-metoksifenyyli)sykloheksyyli]metyyli}morfoliini)
2-MeO-PCMo (4-[1-(2-metoksifenyyli)sykloheksyyli]morfoliini)
Mepirapiimi ((4-metyylipiperatsiini-1-yyli)-(1-pentyyli-1H-indoli-3-yyli)metanoni)
Metallyylieskaliini (MAL) (2-{3,5-dimetoksi-4-[(2-metyyliprop-2-en-1-yyli)oksi]fenyyli}etaaniamiini)
Metamnetamiini (N-metyyli-1-(naftalen-2-yyli)propan-2-amiini)
Metanandamidi ((5Z,8Z,11Z,14Z)-N-(1-hydroksipropan-2-yyli)ikosa-5,8,11,14-tetraeeniamidi)
Metedroni (bk-PMMA) (1-(4-metoksifenyyli)-2-(metyyliamino)propan-1-oni)
Metodesnitatseeni (N,N-dietyyli-2-[2-[(4-metoksifenyyli)metyyli]bentsimidatsol-1-yyli]etanamiini)
Metonitatseeni (N,N-dietyyli-2-[2-[(4-metoksifenyyli)metyyli]-5-nitrobentsimidatsol-1-yyli]etanamiini)
2-Metoksiamfetamiini (1-(2-metoksifenyyli)propan-2-amiini)
2-Metoksidifenidiini (2-MeO-difenidiini) (1-[1-(2-metoksifenyyli)-2-fenyylietyyli]piperidiini)
2-Metoksietisyklidiini (2-MeO-PCE) (N-etyyli-1-(2-metoksifenyyli)sykloheksaaniamiini)
3-Metoksietisyklidiini (3-MeO-PCE) (N-etyyli-1-(3-metoksifenyyli)sykloheksaaniamiini)
4-Metoksietisyklidiini (4-MeO-PCE) (N-etyyli-1-(4-metoksifenyyli)sykloheksaaniamiini)
2-Metoksiketamiini (2-MeO-ketamiini) (2-(2-metoksifenyyli)-2-(metyyliamino)sykloheksanoni)
3-Metoksiketamiini (3-MeO-ketamiini) (2-(3-metoksifenyyli)-2-(metyyliamino)sykloheksanoni)
4-Metoksiketamiini (4-MeO-ketamiini) (2-(4-metoksifenyyli)-2-(metyyliamino)sykloheksanoni)
3-Metoksimetkatinoni (3-MeOMC) (1-(3-metoksifenyyli)-2-(metyyliamino)propan-1-oni)
5-Metoksi-N-isopropyylitryptamiini (5-MeO-NiPT) (N-[2-(5-metoksi-1H-indol-3-yyli)etyyli]propan-2-amiini)
Metoksipiperamidi ((4-metoksifenyyli)(4-metyylipiperatsin-1-yyli)metanoni)
4'-Metoksi-α-pyrrolidiinipropiofenoni (MOPPP) (1-(4-metoksifenyyli)-2-(pyrrolidin-1-yyli)propan-1-oni)
4-Metoksi-α-pyrrolidiinivalerofenoni (4-MeO-α-PVP) (1-(4-metoksifenyyli)-2-(pyrrolidin-1-yyli)pentan-1-oni)
Metoksipropamiini (2-(3-metoksifenyyli)-2-(propyyliamino)sykloheksan-1-oni)
3,4-Metyleenidioksi-U-47700 (N-[2-(dimetyyliamino)sykloheksyyli]-N-metyyli-2H-1,3-bentsodioksoli-5-karboksamidi)
4,5-Metyleenidioksi-2-aminoindaani (4,5-MDAI) (7,8-dihydro-6H-indeno[4,5-d][1,3]dioksoli-7-amiini)
5,6-Metyleenidioksi-2-aminoindaani (MDAI) (6,7-dihydro-5H-indeno[5,6-d][1,3]dioksoli-6-amiini)
1-(3,4-Metyleenidioksifenyyli)-2-metyyli-2-pyrrolidinyyli-1-propanoni (MDMPP) (1-(1,3-bentsodioksol-5-yyli)-2-metyyli-2-(pyrrolidin-1-yyli)propan-1-oni)
3’,4'-Metyleenidioksi-α-pyrrolidinobutyrofenoni (MDPBP) (1-(1,3-bentsodioksol-5-yyli)-2-(pyrrolidin-1-yyli)butanan-1-oni)
3’,4'-Metyleenidioksi-α-pyrrolidinopropiofenoni (MDPPP) (1-(1,3-bentsodioksol-5-yyli)-2-(pyrrolidin-1-yyli)propan-1-oni)
Metyyli 2-fenyyli-2-(pyrrolidin-1-yyli)asetaatti
N-Metyyli U-479321E (4-bromi-N-(2-(dimetyyliamino)sykloheksyyli)-N-metyylibentsamidi)
2-Metyyliamfetamiini (1-(2-metyylifenyyli)propan-2-amiini)
3-Metyyliamfetamiini (1-(3-metyylifenyyli)propan-2-amiini)
1-Metyyliamino-1-(3,4-metyleenidioksifenyyli)propaani (M-ALPHA) (1-(1,3-bentsodioksol-5-yyli)-N-metyylipropaani-1-amiini)
4-Metyylibufedroni (4-Me-MABP) (2-(metyyliamino)-1-(4-metyylifenyyli)butan-1-oni)
3-Metyylietkatinoni (3-MEC) (2-(etyyliamino)-1-(3-metyylifenyyli)propan-1-oni)
4-Metyylifendimetratsiini (3,4-dimetyyli-2-(4-metyylifenyyli)morfoliini)
3-Metyyliflefedroni (1-(4-fluori-3-metyylifenyyli)-2-(metyyliamino)propan-1-oni)
4-Metyylimetamfetamiini (4-MMA) (N-metyyli-1-(4-metyylifenyyli)propan-2-amiini)
2-Metyylimetkatinoni (2-MMC) (2-(metyyliamino)-1-(2-metyylifenyyli)propan-1-oni)
3-Metyylimetkatinoni (3-MMC) (2-(metyyliamino)-1-(3-metyylifenyyli)propan-1-oni)
4-Metyyli-N-etyylinorpentedroni (2-(etyyliamino)-1-(4-metyylifenyyli)pentan-1-oni)
4-Metyylipentedroni (2-(metyyliamino)-1-(4-metyylifenyyli)pentan-1-oni)
4-Metyyli-α-pyrrolidiinibutyrofenoni (MPBP) (1-(4-metyylifenyyli)-2-(pyrrolidin-1-yyli)butan-1-oni)
4-Metyyli-α-pyrrolidiiniheksanofenoni (MPHP) (1-(4-metyylifenyyli)-2-(pyrrolidin-1-yyli)heksan-1-oni)
4-Metyyli-α-pyrrolidiinipropiofenoni (4'-metyyli-α-PPP) (1-(4-metyylifenyyli)-2-(pyrrolidin-1-yyli)propan-1-oni)
2-Metyyli-AP-237 (1-[2-metyyli-4-(3-fenyyliprop-2-en-1-yyli)piperatsin-1-yyli]butan-1-oni)
4'-Metyyli-α-PiHP (4-metyyli-1-(4-metyylifenyyli)-2-(pyrrolidin-1-yyli)pentan-1-oni)
Metyyliklonatsepmaani (5-(2-kloorifenyyli)-1-metyyli-7-nitro-3H-1,4-bentsodiatsepin-2-oni)
Metyylimetakvaloni (3-(2,4-dimetyylifenyyli)-2-metyylikinatsolin-4(3H)-oni)
Metyylimorfenaatti (metyyli-(morfolin-3-yyli)(fenyyli)asetaatti)
Metyylinaftidaatti (HDMP-28) (metyylinaftalen-2-yyli(piperidin-2-yyli)asetaatti)
MN-18 (N-(naftalen-1-yyli)-1-pentyyli-1H-indatsoli-3-karboksamidi)
Modafiendz (2-{[bis(4-fluorifenyyli)metyyli]sulfinyyli}-N-metyyliasetamidi)
MO-CHMINACA (1-metoksi-3,3-dimetyyli-1-oksobutan-2-yyli 1-(sykloheksyylimetyyli)-1H-indatsoli-3-karboksylaatti)
MPhP-2201 (metyyli 3-sykloheksyyli-N-[1-(5-fluoripentyyli)-1H-indoli-3-karbonyyli]alaninaatti)
2-MPH (3-metyyli-2-(2-metyylifenyyli)morfoliini)
3-MPH (3-metyyli-2-(3-metyylifenyyli)morfoliini)
4-MPH (3-metyyli-2-(4-metyylifenyyli)morfoliini)
NEiH (N-etyyli-isoheksedroni) (2-(etyyliamino)-4-metyyli-1-fenyylipentan-1-oni)
NiPH (N-isopropyyliheksedroni) (1-fenyyli-2-[(propan-2-yyli)amino]heksan-1-oni)
N-(2-metoksietyyli)-N-(1-metyylietyyli)-2-(1-pentyyli-1H-indol-3-yyli)-4-tiatsolimetanamiini
N,N-diallyylitryptamiini (DALT) (N-[2-(1H-indol-3-yyli)etyyli]-N-(prop-2-en-1-yyli)prop-2-en-1-amiini)
N,N-dietyyli-2-(1-pentyyli-1H-indol-3-yyli)-4-tiatsolimetanamiini
N,N-dipropyylitryptamiini (DPT) (N-[2-(1H-indol-3-yyli)etyyli]-N-propyylipropan-1-amiini)
1-Nafyroni (1-(naftalen-1-yyli)-2-(pyrrolidin-1-yyli)pentan-1-oni)
Nafyroni (1-(naftalen-2-yyli)-2-pyrrolidin-1-yylipentan-1-oni)
2-(N-etyyli-2-aminopropyyli)bentsofuraani (2-EAPB) (1-(1-bentsofuran-2-yyli)-N-etyylipropan-2-amiini)
3-(N-etyyli-2-aminopropyyli)bentsofuraani (3-EAPB) (1-(1-bentsofuran-3-yyli)-N-etyylipropaani-2-amiini)
4-(N-etyyli-2-aminopropyyli)bentsofuraani (4-EAPB) (1-(1-bentsofuran-4-yyli)-N-etyylipropaani-2-amiini)
5-(N-etyyli-2-aminopropyyli)bentsofuraani (5-EAPB) (1-(1-bentsofuran-5-yyli)-N-etyylipropaani-2-amiini)
6-(N-etyyli-2-aminopropyyli)bentsofuraani (6-EAPB) (1-(1-bentsofuran-6-yyli)-N-etyylipropaani-2-amiini)
7-(N-etyyli-2-aminopropyyli)bentsofuraani (7-EAPB) (1-(1-bentsofuran-7-yyli)-N-etyylipropaani-2-amiini)
N-etyyli-2C-B (2-(4-bromi-2,5-dimetoksifenyyli)-N-etyylietaaniamiini)
N-etyylibufedroni (NEB) (2-(etyyliamino)-1-fenyylibutan-1-oni)
N-etyylinorketamiini (2-(2-kloorifenyyli)-2-(etyyliamino)sykloheksanoni)
N-etyylinorpentedroni (α-etyyliaminopentiofenoni) (2-(etyyliamino)-1-fenyylipentan-1-oni)
NiPP (1-fenyyli-2-[(propan-2-yyli)amino]pentan-1-oni)
Nitrakaiini (3-(N,N-dietyyliamino)-2,2-dimetyylipropyyli-4-nitrobentsoaatti)
NM-2201 (Naftalen-1-yyli-1-(5-fluoripentyyli)-1H-indoli-3-karboksylaatti)
N-metyyli-2-aminoindaani (N-metyyli-2AI) (N-metyyli-2,3-dihydro-1H-indeeni-2-amiini)
2-(N-metyyli-2-aminopropyyli)bentsofuraani (2-MAPB) (1-(1-bentsofuran-2-yyli)-N-metyylipropaani-2-amiini)
3-(N-metyyli-2-aminopropyyli)bentsofuraani (3-MAPB) (1-(1-bentsofuran-3-yyli)-N-metyylipropaani-2-amiini)
4-(N-metyyli-2-aminopropyyli)bentsofuraani (4-MAPB) (1-(1-bentsofuran-4-yyli)-N-metyylipropaani-2-amiini)
5-(N-metyyli-2-aminopropyyli)bentsofuraani (5-MAPB) (1-(1-bentsofuran-5-yyli)-N-metyylipropaani-2-amiini)
6-(N-metyyli-2-aminopropyyli)bentsofuraani (6-MAPB) (1-(1-bentsofuran-6-yyli)-N-metyylipropaani-2-amiini)
7-(N-metyyli-2-aminopropyyli)bentsofuraani (7-MAPB) (1-(1-bentsofuran-7-yyli)-N-metyylipropaani-2-amiini)
N-metyylibentsedroni (2-[bentsyyli(metyyli)amino]-1-(4-metyylifenyyli)propan-1-oni)
N-metyylibentsedronin isomeeri (2-[bentsyyli(metyyli)amino]-1-(2-metyylifenyyli)propan-1-oni)
N-metyylibentsedronin isomeeri (2-[bentsyyli(metyyli)amino]-1-(3-metyylifenyyli)propan-1-oni)
N-metyyli-bk-MMDA-2 (1-(6-metoksi-1,3-bentsodioks-5-yyli)-2-(metyyliamino)propan-1-oni)
N-metyyli-bk-MMDA-5 (1-(7-metoksi-2H-1,3-bentsodioksol-5-yyli)-2-(metyyliamino)propan-1-oni)
N-metyyli-2C-B (2-(4-bromi-2,5-dimetoksifenyyli)-N-metyylietaaniamiini)
N-metyyli-N-etyylitryptamiini (MET) (N-etyyli-2-(1H-indol-3-yyli)-N-metyylietaaniamiini)
N-metyyli-N-isopropyylitryptamiini (MIPT) (N-[2-(1H-indol-3-yyli)etyyli]-N-metyylipropan-2-amiini)
Normefedroni (2-amino-1-(4-metyylifenyyli)propan-1-oni)
NPDPA (N-(1,2-difenyylietyyli)propan-2-amiini)
N-propyyliamfetamiini (PA) (N-(1-fenyylipropan-2-yyli)propan-1-amiini)
N-propyylinorpentedroni (1-fenyyli-2-(propyyliamino)pentan-1-oni)
Org 27569 (5-kloori-3-etyyli-N-{2-[4-(piperidin-1-yyli)fenyyli]etyyli}-1H-indoli-2-karboksamidi)
Org 27759 (N-{2-[4-(dimetyyliamino)fenyyli]etyyli}-3-etyyli-5-fluori-1H-indoli-2-karboksamidi)
Org 29647 (N-(1-bentsyylipyrrolidin-3-yyli)-5-kloori-3-etyyli-1H-indoli-2-karboksamidi)
PB-22 indatsolianalogi (kinolin-8-yyli 1-pentyyli-1H-indatsoli-3-karboksylaatti)
PDM-35 (3,5-dimetyyli-2-fenyylimorfoliini)
Pentyloni (1-(1,3-bentsodioksol-5-yyli)-2-(metyyliamino)pentan-1-oni)
p-Fluorifenyylipiperatsiini (pFPP) (1-(4-fluorifenyyli)piperatsiini)
3-(p-fluoribentsoyyli)tropaani (pFBT) (8-metyyli-8-atsabisyklo[3.2.1]okt-3-yyli-4-fluoribentsoaatti)
3-(p-Metoksibentsoyyli)-N-metyyli-indoli
p-Metoksifenyylipiperatsiini (pMeOPP) (1-(4-metoksifenyyli)piperatsiini)
p-Metoksi-N-etyyliamfetamiini (PMEA) (N-etyyli-1-(4-metoksifenyyli)propan-2-amiini)
α-PCYP (2-sykloheksyyli-1-fenyyli-2-(pyrrolidin-1-yyli)etan-1-oni)
Piperidyylitiambuteeni (1-(4,4-di(tiofen-2-yyli)but-3-en-2-yyli)piperidiini)
PPAP (1-fenyyli-N-propyylipentaani-2-amiini)
5-PPDi (1-(2,3-dihydro-1H-inden-5-yyli)-2-(pyrrolidin-1-yyli)butan-1-oni)
Pravadoliini (WIN 48,098) ((4-metoksifenyyli){3-metyyli-2-[2-(morfolin-4-yyli)etyyli]-1,2,3,4-tetrahydroisokinolin-4-yyli}metanoni)
Propyloni (1-(2H-1,3-bentsodioksol-5-yyli)-2-(propyyliamino)propan-1-oni)
Propyylifenidaatti (propyyli-2-fenyyli-2-(piperidin-2-yyli)asetaatti)
Propyylikatinoni (1-fenyyli-2-(propyyliamino)propan-1-oni)
RCS-4 ((4-metoksifenyyli)(1-pentyyli-1H-indol-3-yyli)metanoni)
RCS-4:n orto-isomeeri ((2-metoksifenyyli)(1-pentyyli-1H-indol-3-yyli)metanoni)
RCS-4(C4) (4-metoksifenyyli-(1-butyyli-1H-indol-3-yyli)metanoni)
RH-34 (3-{2-[(2-metoksibentsyyli)amino]etyyli}-kinatsolin-2,4(1H,3H)-dioni)
Salvia Divinorum (sisältäen salvinoriini A ja B)
SDB-005 (naftalen-1-yyli-1-pentyyli-1H-indatsoli-3-karboksylaatti)
SDB-006 (N-bentsyyli-1-pentyyli-1H-indoli-3-karboksamidi)
SL-164 (5-kloori-3-(4-kloori-2-metyylifenyyli)-2-metyyli-4(3H)-kinatsolinoni)
STS-135 (1-(5-fluoripentyyli)-N-(trisyklo[3.3.1.1]dek-1-yyli)-1H-indoli-3-karboksamidi)
1-Sykloheksyylimetyyli-2-(4-etoksibentsyyli)-N,N-dietyyli-1H-bentsimidatsoli-5-karboksamidi
tBuONE (1-(2H-1,3-bentsodioksol-5-yyli)-2-(tert-butyyliamino)propan-1-oni)
TFMPP (1-(3-trifluorimetyylifenyyli)piperatsiini)
TH-PBP (2-(pyrrolidin-1-yyli)-1-(5,6,7,8-tetrahydronaftalen-2-yyli)butan-1-oni)
TH-PHP (2-(pyrrolidin-1-yyli)-1-(5,6,7,8-tetrahydronaftalen-2-yyli)heksan-1-oni)
TH-PVP (2-(pyrrolidin-1-yyli)-1-(5,6,7,8-tetrahydronaftalen-2-yyli)pentan-1-oni)
Ro 07-4065 (7-kloori-5-(2,6-difluorifenyyli)-1-metyyli-3H-1,4-bentsodiatsepin-2-oni)
Tienoamfetamiini (1-(tiofen-2-yyli)propaani-2-amiini)
trans-CP 47,497-C8 (4-(2,2-dimetyylinonyyli)-2-metyyli-1-(3-metyylisykloheksyyli)bentseeni)
2,4,6-Trimetoksiamfetamiini (TMA-6) (1-(2,4,6-trimetoksifenyyli)propan-2-amiini)
2,4,5-Trimetyylimetkatinoni (2,4,5-TMMC) (2-(metyyliamino)-1-(2,4,5-trimetyylifenyyli)propan-1-oni)
Tropariili (metyyli 8-metyyli-3-fenyyli-8-atsabisyklo[3.2.1]oktaani-2-karboksylaatti)
U-48800 (2-(2,4-dikloorifenyyli)-N-[2-(dimetyyliamino)sykloheksyyli]-N-metyyliasetamidi)
U-49900 (3,4-dikloori-N-[2-(dietyyliamino)sykloheksyyli]-N-metyylibentsamidi)
U-50488 (2-(3,4-dikloorifenyyli)-N-metyyli-N-[2-(pyrrolidin-1-yyli)sykloheksyyli]asetamidi)
U-51754 (2-(3,4-dikloorifenyyli)-N-[2-(dimetyyliamino)sykloheksyyli]-N-metyyliasetamidi)
W-15 (4-kloori-N-(1-fenyylietyylipiperidin-2-ylideeni)bentseenisulfonamidi)
W-18 (4-kloori-N-{1-[2-(4-nitrofenyyli)etyyli]piperidin-2-yylideeni}bentseenisulfoniamiini)
WIN 35428 (metyyli 3-(4-fluorifenyyli)-8-metyyli-8-azabisyklo[3.2.1]oktaani-2-karboksylaatti)
WIN 55212-2 (1,4-dihydronaftalen-1-yyli[5-metyyli-3-(morfolin-4-yylimetyyli)-2,3-dihydro[1,4]oksatsino[2,3,4-hi]indol-6-yyli]metanoni)
References
[edit]- ^ Maurer HH, Kraemer T, Springer D, Staack RF. Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis. Ther Drug Monit. 2004 Apr;26(2):127-31. PMID 15228152
- ^ Davis S, Rands-Trevor K, Boyd S, Edirisinghe M. The characterisation of two halogenated cathinone analogues: 3,5-difluoromethcathinone and 3,5-dichloromethcathinone. Forensic Sci Int. 2012 Apr 10;217(1-3):139-45. PMID 22088945 doi:10.1016/j.forsciint.2011.10.042
- ^ "Alabama Senate Bill 333 - Controlled substances, Schedule I, additional synthetic controlled substances and analogue substances included in, trafficking in controlled substance analogues, requisite weight increased, Secs. 13A-12-231, 20-2-23 am'd". March 2014. Retrieved 28 September 2015.
- ^ Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem
- ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015.
- ^ "指定薬物名称・構造式一覧(平成27年9月16日現在)" (PDF) (in Japanese). 厚生労働省. 16 September 2015. Retrieved 8 October 2015.
- ^ Regulated Drug Rule 2016
- ^ WADA Prohibited List 2016